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ISUMMARY
The molecular characterisation of the major glycoproteins of 
pneumonia virus of mice (PVM) was undertaken to identify the molecular basis for 
different pathogenicities for two strains of PVM. One is highly pathogenic and 
passaged entirely in mice (strain J3666) whilst the other is non-pathogenic and has 
been passaged entirely in tissue culture (strain 15).
Characterisation of the fusion proteins of these two strains revealed 
little amino acid changes that may account for their pathogenicities. Of the 537 amino 
acid long fusion protein, only four amino acid changes were observed between the two 
strains. None of the changes were located within the region encoding the cleavage site 
of the F0 polypeptide and the altered amino acids were distributed throughout the 
fusion protein. The amino acids changes were considered to be fairly conservative and 
may represent adaptation of the two strains to their different modes of passaging. 
However, the importance of these changes with regards to cleavage cannot be ruled 
out since one or more of these changes may be located within the 3-dimensional 
structure of the F0 cleavage site.
Nucleotide sequence analysis of the attachment (G) glycoproteins of 
these two strains of PVM showed only two amino acids changes within the 
extracellular domain of the protein. However, the G proteins of the two strain differed 
from each other in that the G protein of strain J3666 possessed a N-terminal extension 
compared to that of strain 15. This amino acid extension forms the cytoplasmic domain 
of the G protein in strain J3666 but appears to be lacking in that of strain 15. 
Furthermore, the G proteins of both strains of PVM were synthesised from the second, 
but not the same, initiation codon. In PVM strain J3666, the first available initiation 
codon coded for a short polypeptide o f 12 amino acids whereas that of strain 15 coded 
for a short polypeptide of 33 amino acids.
Expression of the G genes in vitro produced polypeptides which were 
approximately 3K larger than their predicted molecular weights. Synthesis of 
polypeptides due to internal initiation during translation were observed for the G gene 
of strain J3666. Expression of the G genes using recombinant vaccinia virus expressing 
the T7 RNA polymerase showed that the G proteins of both strains of PVM were 
expressed on the surface of cells transfected in vitro. Thus, the signals required for the 
correct processing and transport of the G proteins of PVM are not contained within 
the cytoplasmic domain of the proteins.
The first steps of an investigation of possible ribosomal frameshifting 
event occurring within the G gene o f PVM strain 15 was undertaken. The initiation 
codon of the major and short ORF's o f the G gene of PVM strain 15 were mutated in a 
variety of combinations with a view to fusing these mutated fragments to the 5' end of 
the E. coli P-galactosidase gene that lacks its own initiation codon.
xiv
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INTRODUCTION
1.1. G e n e r a l  :
The Paramyxoviridae family of viruses are classified in group V of the 
Baltimore classification of viruses (Baltimore, 1971, Kingsbury, 1978, Francki et al,
1991). These viruses have a negative sense single stranded RNA genome that is 
transcribed from a single polymerase binding site at the 3' end of the RNA molecule. 
Early work led these viruses to be classified into three genera (paramyxovirus, 
morbillivirus and pneumovirus) based on the characteristics of their attachment 
glycoprotein. The names paramyxo-, morbilli- and pneumo- are derived from the 
Greek: para meaning akin or closely related, myxo meaning 'mucus', morbilli from the 
plural of Latin morbillus - diminutive of morbus, and pneumo meaning 'breath'. The 
paramyxoviruses were demonstrated to have both haemagglutination and 
neuraminidase activity. Mumps virus, parainfluenza viruses 1, 2 and 3, Sendai virus 
and Newcastle disease vims are the best known members of this genus. Measles vims, 
canine distemper vims, rinderpest vims and peste de petits ruminants vims are 
classified as morbillivimses and have haemagglutination but not neuraminidase activity. 
The prototype pneumovims, human respiratory syncytial vims (HRSV), was initially 
classified into a separate genus since it did not demonstrate haemagglutination or 
neuraminidase activity. Subsequent analysis of the viral polypeptides supported this 
classification although another pneumovims, pneumonia vims o f  mice (PVM) 
exhibited haemagglutination activity. Pneumovimses appear as lipid-enveloped 
spherical, pleomorphic or filamentous particles and are associated with infections of 
the respiratory tract. HRSV is a major cause of hospitalisation due to respiratory 
infection in infants under the age o f two. It is for this reason that HRSV has been
studied extensively. The morphology of PVM (Compans et al, 1967; Berthiaume et al,
\
1974) and the number of viral encoded polypeptides (Cash et al, 1977, 1979; Ling and 
Pringle, 1989a) resemble those of HRSV. Other members of this genus are turkey 
rhinotracheitis vims (TRTV) and bovine respiratory syncytial vims (BRSV). Analysis
/
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of the virus polypeptides and sequence data available for the genes of 
paramyxoviruses, morbilliviruses and pneumoviruses have supported classification of 
the Paramyxoviridae family of viruses into three genera.
1.2. C h a r a c t e r is t ic s  o f  PVM :
PVM was first isolated in 1939 from albino Swiss mice. The virus was 
shown to be extremely labile in that incubation at 56°C for 30 minutes completely 
inactivated infectivity whereas incubation at room temperature reduced the infectious 
titre by a hundred-fold. However virus could be stabilised with the addition of 10% 
horse serum although incubation at room temperature reduced the infectious titre by 
five-fold (Horsfall and Hahn, 1939, 1940). A decrease in virulence of PVM was 
observed following inoculation of mice with tissue culture passaged virus (Horsfall and 
Hahn, 1940). Haemagglutination and haemadsorption activities have been found with 
PVM (Mills and Dochez, 1944, Compans et al, 1967).
1.3. Pr e v a l e n c e  and  in f e c t io n  o f  PV M  :
PVM was inadvertently isolated from control mice during attempts to 
isolate viruses from patients suffering from atypical pneumonia following intranasal 
inoculation of mice. The isolated virus was shown to cause an inapparent or persistent 
infection in mice. However, following passage in lung tissue, intranasally inoculated 
healthy recipient mice developed a fatal pneumonia (Horsfall and Hahn, 1939, 1940). 
Neutralising antibodies against PVM have been found in cotton rats, rabbits (Eaton 
and van Herick, 1944), guinea pigs, hamsters, chimpanzees and monkeys (Horsfall and 
Cumen, 1946) although no apparent disease was found in any of these animals. 
Horsfall and Cumen (1946) demonstrated that PVM can cause pneumonia following 
intranasal inoculation of cotton rats and hamsters that did not exhibit neutralising 
antibodies against PVM. In a study of different viruses prevalent in laboratory animal 
colonies for the years 1978-1979, Gannon and Carthew (1980) showed PVM to be
INTRODUCTION
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\present in 61% of rats and 59% of mice examined. No anti-PVM antibodies were 
found in any of the guinea pigs tested. Evidence for neutralising antibodies against 
PVM in 27-35% of human sera was reported (Horsfall and Hahn, 1940, Horsfall et al, 
1943, Horsfall and Cumen, 1946) although Pringle and Eglin (1986) reported 
neutralising antibodies to PVM in 75% of adult human sera. Similar levels of 
seroconversion were observed with sera from Nigeria (Pringle and Eglin, 1986). The 
proportion of seropositive children increased with age as seen for HRSV. The results 
suggest exposure to PVM, or an antigenically related virus, is common. Levels of 
neutralising antibodies were higher in patients suffering from Paget's disease of the 
bone however the clinical consequence of PVM infection in humans is unknown. 
Although PVM is serologically distinct from HRSV, antigenic cross-reactivity has 
been found between the N (Gimenez et al, 1984, Ling and Pringle, 1989a) and P 
proteins (Ling and Pringle, 1989a) of these two viruses.
Weir et al (1988) observed a wasting disease accompanied by 
pneumonia in intranasally inoculated mice. Necropsy found a decrease in fat deposits 
and muscle mass, diffuse pulmonary oedema (swelling of part of the body due to 
congestion of excess body fluid), splenomegaly (abnormal enlargement o f the spleen), 
cyanosis (blue coloration o f the skin due to lack o f oxygen in the blood supply), 
dyspnea (breathlessness or shortness of breath after slight physical effort due to 
diminished capacity of the lungs to cope with the demands put on them) and tachypnea 
(rapid and shallow breathing) (Horsfall and Hahn, 1939, 1940, Weir et al, 1988). 
Changes in the lungs were localised to the lobar regions where thickening and 
enlargement of the alveolar walls, intra-alveolar haemorrhage, fibrin deposition, 
accumulation of macrophages and large mononuclear cells with the alveolar spaces 
were observed (Carthew and Sparrow, 1980, Weir et al, 1988). Tissue staining with 
anti-PVM antibodies revealed the presence of PVM in both the bronchial epithelium 
and the alveolar cells and persistence of the virus only in the alveolar wall (Carthew
Introduction
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\and Sparrow, 1980). However, Weir et al (1988) observed the conducting airways to 
be normal with PVM replication localised solely within the alveolar cells. This data 
supports the findings of Horsfall and Hahn (1940) and Horsfall and Ginsberg (1951) 
indicating replication is restricted to the lungs. Smith et al (1984) failed to observe 
pneumonia in PVM infected mice and determined replication to occur in the upper 
respiratory tract. Differences in these data can be reconciled to the use o f different 
strains of mice, different virus strains, age of mice and duration of infection. Mice used 
in studies by Smith et al (1984) were 25 days old and inoculated with PVM by placing 
the virus on the external nares whereas those used by Weir et al (1988) were over 2 
months of age and inoculated intranasally.
1.4. M o r p h o l o g y  o f  PV M  :
Electron microscopy studies on PVM infected cells revealed three 
forms of the virus. The most common were the filamentous forms with a uniform 
diameter of 100-200 nm with a total length of 2-3 pm (Compans et al, 1967, 
Berthiaume et al, 1974). Weir et al, 1988 calculated these filamentous forms to be 85- 
90 nm in diameter and up to 3 pm in length. The filaments protruded from the cell 
surface with the distal end having an enlarged bulbous tip. Although filamentous forms 
o f HRS V were observed, no enlargement of either end was observed (Berthiaume et 
al, 1974, Weir et al, 1988). The significance of the bulbous structure at one end of the 
virus is unknown. The circular profiles of the virus were 80-120 nm in diameter and 
were cross-sections of spherical particles and not cross-sections of the filamentous 
forms (Compans et al, 1967). The viral envelope is covered in spike-like projections 
12 nm in length, 10 nm apart in HRSV but only 6 nm apart in PVM (Compans et al, 
1967, Berthiaume et al, 1974, Weir et al, 1988). The third type o f structure observed 
was a modification of the filamentous form in which PVM appeared as a horseshoe 
shape with two narrow filamentous structures at either end (Berthiaume et al, 1974).
Introduction
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\The internal structures appeared as electron dense strands extending 
across the circular form and as coiled strands within the filamentous forms which ran 
parallel to the long axis (Compans et al, 1967, Berthiaume et al, 1974, Weir et al, 
1988). Turns of the helical structure were well separated indicating a single-stranded 
genome. The nucleocapsids o f HRSV and PVM were approximately 13.5 nm in 
diameter with a pitch o f the helix of 6.5 nm (Berthiaume et al, 1974) which 
differentiated them from other paramyxoviruses. Infected cells contained dense 
cytoplasmic inclusions with a thread-like appearance similar to those seen under the 
light microscope when stained with acridine orange. Additionally, vesicles were found 
at the surface of the infected cells between the regions of virus budding (Compans et 
al, 1967). This raises the interesting possibility that they represent either defective 
interfering particles with the nucleocapsid as a minor component or that they are 
regions where the matrix protein interacts with a cell membrane component thus 
forming vesicles analogous to the interaction of the matrix (M) protein o f VSV with 
cell membranes in transfected cells which results in évagination (Blondel et al, 1990).
1.5. Pa r a m y x o v ir u s  r e p l ic a t io n /Tr a n s c r ip t io n  :
Comparison o f the terminal 3' and 5' sequence of HRSV with those of 
other paramyxoviruses shows some degree of homology. A feature common to all 
leader sequences of paramyxoviruses is the richness in U sequences (Fig. 1.1 ; Mink et 
al, 1991). Whereas the first two nucleotides of the terminal 3' end are identical to 
those for some paramyxoviruses (measles virus, Sendai virus, PIV3, BPIV3, NDV and 
PIV2), the first three nucleotides (UGC) are identical to those o f VSV and rabies virus 
(RaV). Another feature o f paramyxoviruses is the presence of sequences in the 5' 
trailer complimentary to regions in the leader sequence. Thus, the possibility exists for 
circular forms of the viral genome. Indeed, Udem and Cook (1984) have shown the 
presence of such a form of the measles virus genome in infected cells using electron 
microscopy.
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3' UGCGCUUUUUUACGCAUGUUGUUUGAACGUAUUUGGUUUUUUUAC
III l l l l l l l  I II III Mi l l  II II I I
5' ACGAGAAAAAAAGUGU-CAA-AAACUAAUAUCUCGUAAUUUAGUU
Fig. 1.1: HRSV leader and trailer nucleotide sequences.
Complementarity between 3' and 5' end sequences of HRSV. 
Nucleotide sequence is shown in genomic RNA sense. The vertical lines represent 
pairing between 3' and 5' end nucleotides (Taken from Mink et a l, 1991).
in t r o d u c t io n
The discovery of leader RNA's and the presence o f a nucleation site for 
encapsidation by the nucleocapsid protein (N) protein at the 5' end of the leader RNA 
in VSV led to a theory for the mechanism of viral transcription in negative stranded, 
non-segmented viruses (Baneijee, 1987, Blumberg et al, 1991) in which the N protein 
acts as an anti-terminator of the RNA polymerase. Synthesis o f the leader RNA was 
followed by encapsidation with the N protein while absence o f sufficient N protein 
resulted in the termination o f leader RNA elongation after which synthesis of viral 
mRNA was initiated. Thus factors affecting the concentration o f cytoplasmic N protein 
would have a significant influence on the replicative/transcriptional procedure. It has 
been demonstrated that the N protein is capable o f forming aggregates thereby 
reducing the concentration of free N protein. Interaction of the NS protein (the 
rhabdovirus equivalent of the Paramyxovirus phosphoprotein protein) with free N 
protein may prevent formation of aggregates and thus keep it in a form capable of 
binding to RNA (Baneijee, 1987). Howard and Wertz (1989) demonstrated the effect 
of the N protein concentration of VSV in replication o f DI nucleocapsid in vitro. At 
low concentrations o f the N protein, DI replication was supported whereas at higher 
concentrations aggregates o f the N protein were observed accompanied by an
7
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inhibition o f DI replication. Co-synthesis of the NS and N proteins prevented 
aggregation of the N protein and supported replication of the DI genome even when 
concentrations of the N protein were high. The results demonstrate the importance of 
controlling the concentrations of the N protein during virus replication. Additionally 
the concentration of ATP was found to play a role in regulation of viral transcription. 
The absence of detectable leader RNA's in most paramyxoviruses has raised doubts as 
to the general application of this theory for all negative stranded, non-segmented 
viruses.
Blumberg et al (1991) postulate the presence of two promoter sites 
within the leader sequence, one responsible for initiation of replication with the other 
responsible for initiation of transcription. Additionally, by analogy to tobacco mosaic 
virus (TMV) which has a nucleation site located approximately 900 nucleotides 
downstream of the leader sequence with a bi-directional encapsidation process, 
Blumberg et al (1991) speculated that the process of genome encapsidation in 
paramyxoviruses could proceed from a nucleation site not necessarily located within 
the leader sequence. The role of the terminal sequences in replication has been 
demonstrated in influenza virus (Luytjes et al, 1989), HRSV (Collins et al, 1991) and 
Sendai virus (Park et al, 1991). The negative sense strand of chloramphenicol 
transferase (CAT) gene flanked by 5' and 3' NS gene regions was transcribed from a 
T7 RNA polymerase promoter in vitro and then added to purified influenza virus 
polymerase complex. The resulting RNP complex was transfected into tissue culture 
cells followed by infection of these cells by influenza virus. CAT gene expression was 
measured by the conversion of radiolabelled chloramphenicol. Changing just 3 amino 
acid residues within the 5' end of the RNA resulted in the loss of detectable CAT 
activity. A variation of this protocol in determining the importance of the 3' and 5' 
regions of Sendai virus (Park et at, 1991) and HRSV (Collins et al 1991) in replication 
has also been used. In these cases RNA of CAT gene flanked by 3' and 5' end
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sequences transcribed from a T7 RNA polymerase promoter was directly used to 
transfect virus infected cells. For HRSV replacing the 3' leader sequence with the 5* 
trailer sequence that was 91% or 73% identical to the leader sequence in its first 11 or 
22 nucleotides had no effect on CAT activity. However the addition of 11 
heterologous nucleotides to the 3' leader abolished CAT gene expression indicating the 
conservation of a functionally important domain that is inactive when in an internal 
location. The removal of either 3 nucleotides from the 3' terminal region had no effect 
on CAT activity. For all three virus systems, the CAT reporter RNA was found to be 
packaged into virions by following passage of the virus present in the supernatant o f 
these transfected-infected cells (Luytjes et al, 1989, Park et al, 1991, Collins et al, 
1991). The presence of the complementary sequences at the 3* leader and 5' trailer 
regions may also be involved in choosing between transcription and replication. For 
example, if the viral polymerase binding site is located within the complementary 
regions, then the formation of an RNA duplex within this region might signal start of 
replication while a linear strand signals initiation of transcription or vice versa.
The viral polymerase carries out the functions of both transcription and 
replication of the genome. The switch between transcription and replication is thought 
to be achieved by an association between the polymerase, phosphoprotein and 
nucleocapsid protein. Replication of pneumoviruses occurs within the cytoplasm of the 
cell since HRSV has been shown to replicate in enucleated cells (Pringle, 1987). 
Replication is achieved by copying viral genome into full-length positive sense RNA, 
which is then used as a template for synthesis of the full-length negative, genomic, 
sense RNA.
1.6. P V M G e n o m e :
t
Harter and Choppin (1967) demonstrated that the genome of PVM is a 
single stranded RNA molecule. No effect on replication of PVM was observed in the
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presence of 5-fluoro-2'-deoxyuridine (FUDR), 5-bromo-2'-deoxyuridine (BrdU) or 5- 
iodo-2-deoxyuridine (IUDR), which are inhibitors of DNA synthesis, indicating the 
PVM genome to be an RNA molecule. Haematoxylin and eosin staining revealed 
eosinophilic cytoplasmic inclusions within PVM infected cells. Acridine orange which 
stains double stranded DNA or RNA green and single-stranded DNA or RNA flame 
red showed the genome of PVM to be single-stranded since red colouration was 
observed close to the eosinophilic cytoplasmic inclusions found in PVM infected cells. 
The negative polarity of the PVM genome is inferred from that of HRSV and the 
detection of specific mRNA species in infected cells (Chambers et al, 1990a). Genomic 
HRSV RNA was identified by the failure to amplify RNA in the presence o f the 
protein synthesis inhibitor, cyclohexamide. Under these conditions viral replication is 
inhibited because of its reliance on continued viral protein synthesis whereas viral 
transcription proceeds as normal. The genomic RNA was used in specific annealing 
experiments which demonstrated that the genome of HRSV is of negative polarity 
(Huang and Wertz, 1982).
Chambers et al (1990a) have cloned and sequenced nine of the genes 
encoded by the approximately 16,000 nucleotide long single stranded, negative sense 
RNA genome of PVM. Table 1.1 shows the starts and ends of the known PVM genes 
which show similarity to those of HRSV (Chambers et al, 1990b). The conservation of 
the gene starts within each genome are presumably a requirement for recognition by 
the viral polymerase during transcription o f each genetic unit. HRSV shows 
considerable conservation in its gene start sequences but not in its gene ends whereas 
PVM gene starts and ends are fairly well conserved (Chambers et al, 1990b). However 
no correlation between gene signal (start and ends) and level of transcription has been 
observed. '
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Gene Gene start Gene end
PVM HRSV* PVM HRSV*
1C AGGACAAGU GGGGCAAAU UAGUUAAUU UAGUUAAUAU
IB AGGAUAAAU GGGGCAAAU UAGUUAUAG UAGUAAUUU
N AGGAUAAAU GGGGCAAAU UAUUUAAUU GAGUUAAU
P AGGACAAAU GGGGCAAAU UAGUUAAUU UAGUUAC
M AGGAUAAAU GGGGCAAAU UAGUUAAAU AAGUUAAU
1A(SH) AGGAUAAGU GGGGCAAAU UAGUUAAC UAGUUAAUU
G AGGACAAAU GGGGCAAAU UAGUUAAUG UAGUUACUU
F AGGAUGAGU GGGGCAAAU UAGUUAAUU UAGUUAUAU
M2 (22K) ••AGGACAAAU GGGGCAAAU UAGUUAUAU UAGUUAUU
L Unknown ••♦GGGACAAAA Unknown AUCUUAUAAU
Concensus AGGAC/, TAAA/n u /r, GGGG/aCAAAu/a UAG/j jUUAA/[ j u /G/AA/TIG/r Uu /AA
Table 1.1 : Consensus sequence of PVM and HRSV gene starts and ends.
Nucleotide sequence of the known gene start and ends in PVM and 
HRSV and overall consensus sequence representing conservation in putative 
recognition sites for the viral RNA polymerase during transcription (adapted from 
Chambers et al, 1990b). * Gene start and ends for HRSV are shown for strain A2. 
**Two putative gene starts for the M2 (22K) protein of PVM are also found within 
the F-M2 intergenic region (Chambers et al, 1990b). *** The L gene start of HRSV is 
located within the M2 (22K) gene. Where two or more bases are indicated within the 
consensus sequences, the uppermost base represents that found predominantly.
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\The 'stop-start' model of transcription is thought to account for the 
decreased concentrations of mRNA species representing genes distal to the polymerase 
binding site located within the leader sequence at the 3' end of the genome. Upon 
reaching the polyadenylation signal of the nearest gene, the polymerase dissociates 
from the RNA molecule and either restarts transcription from within the 3' leader 
sequence or can re-initiate mRNA synthesis on the viral RNA molecule at the 
consensus sequence of the next gene. A consequence of this type of 'stop-start' 
transcription is decreasing amounts of mRNA synthesised for each gene, the further 
the gene is located from the 3' polymerase binding site. Chambers et a l (1990a) have 
used this feature to determine the gene order of PVM from the abundance of cDNA 
clones of each gene, which was subsequently confirmed by sequencing the gene 
junctions (Chambers et al, 1990b).
Fig. 1.2 shows the gene order of PVM as determined by Chambers et al 
(1990a) in comparison to that of morbilli viruses and paramyxoviruses. The gene order 
o f morbilliviruses and paramyxoviruses is arranged so that the genes encoding 
structural proteins involved in replication and transcription (nucleocapsid and 
phosphoproteins) are located adjacent to the polymerase binding site and thus would 
be transcribed first. The envelope glycoprotein genes, which encode the proteins 
responsible for fusion and attachment activities of the virus, are located 5' of the matrix 
(M) protein gene and precede transcription of the viral polymerase gene. Transcription 
of the viral polymerase gene immediately following infection is probably not necessary 
since the enzyme is associated with the infecting nucleocapsid and sufficient amounts 
would be present to initiate replication/transcription.
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Morbillivirus
Measles virus 
Canine distemper virus, 
Rinderpest virus,
Peste des petits ruminants.
Paramyxovirus
Pneumovirus
Pneumonia virus o f  mice. 
Human and Bovine 
respiratory syncytial virus.
Turkey rhinotracheitis 
virus
Fig. 1.2 : Gene order of Paramyxoviruses
Gene order of PVM strain 15, as determined by Chambers et a! 
(1990b), compared to that of morbilliviruses and paramyxoviruses. The gene order of 
TRTV is different to that of HRS V and PVM.
j
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The genome of PVM, like HRSV, codes for genes unique to the 
pneumovirus genus. Unlike morbilliviruses and paramyxoviruses the structural genes 
encoding the nucleocapsid (N), phosphoprotein (P) and matrix (M) proteins are 
preceded by two small genes encoding non-structural proteins designated 1C and IB. 
The M gene precedes the SH (1 A) gene followed by the G (attachment) and F (fusion) 
genes. The M2 (22K) gene precedes the viral polymerase gene (L), but unlike HRSV 
where the start of the L gene lies within the M2 gene, no such gene start for PVM L 
gene is found within the M2 gene (Easton and Chambers, personal communication). 
The third pneumovirus, TRTV, is unusual in that the gene order is different to that of 
HRSV and PVM. The F and 22K genes are found to precede the SH and G genes 
(Ling et al, 1992, Yu et al, 1992), indicating a gene order similar to those of 
paramyxoviruses and morbilliviruses. Functions of PVM proteins can be assigned 
primarily by comparison with available data for similar proteins of other pneumovirus, 
morbillivirus and paramyxovirus members, and to some degree by analogy to proteins 
of members of the rhabdovirus genus, particularly VSV for which most information is 
available.
1.6.1. Non-structural proteins flB  and 1C1:
The genes encoding these proteins are unique to the pneumoviruses and 
are located closest to the 3' end of the genome RNA. Correspondingly, they are 
transcribed most efficiently of all the genes. The IB and 1C genes of PVM encode 
polypeptides of 156 and 113 amino acids respectively (Chambers et al, 1991) which 
have a low or no homology with their HRSV counterparts. Although the polypeptides 
of these genes have been observed on polyacrylamide gel electrophoresis (Cash et al, 
1979, Ling and Pringle, 1989a) they have not been not functionally characterised. The 
high abundance of their mRNA's and the absence of the equivalent polypeptides in 
virions of HRSV (Huang et al, 1985) suggest a role in viral replication rather than as
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\structural components of the virion. In pulse chase experiments, the IB protein had a 
half-life of approximately 1 hour. However, turnover of the IB protein was not 
observed when expressed from a baculovirus expression system (J. Evans, personal 
communication ). Cherrie et al (1992) have shown a high cytotoxic T cell (CTL) 
response to the IB protein. Proteins expressed from recombinant vaccinia virus tested 
positive against serum from six of nine volunteers for CTL response against the IB 
protein whereas only a low response to the 1C protein (one o f nine) was observed. 
Under reducing PAGE conditions a polyclonal serum directed against the HRSV 1C 
protein immunoprecipitated a protein o f approximately 13K whereas under non­
reducing conditions, two proteins were observed at approximately 13K and 26K 
regions. These species may represent intra- and inter- disulphide bonded 1C 
aggregates respectively (J. Evans, personal communication.). Similar results have also 
been observed for the HRSV IB protein in which multiple bands were observed under 
the non-reducing conditions. Additionally, neither the 1C or IB proteins co­
precipitated from 'pelleted' HRSV from infected supernatants, indicating these proteins 
to be non-structural (J. Evans, personal communication ). However, the HRSV 1C and 
M proteins were immunoprecipitated from HRSV infected cells with either an anti-M 
MAb or an anti-1C peptide serum indicating an association between the M and 1C 
proteins of HRSV (J. Evans, personal communication.).
1.6.2. Ribonucleocapsid proteins :
The function of the viral nucleocapsid proteins involved in transcription 
and replication of viral genome can be put into context following a brief description of 
the interaction of each of the components. It is generally thought that the N protein 
provides a template by binding to the viral RNA upon which the viral polymerase (L 
protein) subsequently acts. The P protein is thought to play a role in modification of 
the viral polymerase function from replication to transcription possibly in association 
with the N protein. The importance of the N, P and L proteins in viral replication is
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\exemplified by the work of Pattnaik and Wertz (1990) using VSV. Co-expression of 
the VSV N, P and L proteins in vitro was achieved by the use of recombinant vaccinia 
virus expressing the T7 RNA polymerase. Super-infection with non-replicative VSV 
defective interfering (DI) particles resulted in replication and amplification of the DI 
genome exceeding that observed in the presence of helper virus. Pattnaik and Wertz 
(1990) suggest that in the presence of helper virus both the helper virus and DI 
genomes compete for the newly synthesised NS, N and L proteins whereas in the in 
vitro system the requirement for such competition is reduced or eliminated resulting in 
increased replication/amplification of the DI genome. No DI replication was observed 
if either of the N, P or L proteins was omitted. Titration of each protein for optimal DI 
amplification provided evidence that an increase or decrease in concentrations of either 
the L or NS proteins but not the N protein resulted in decreased amplification of the 
DI genome. Following immunoprécipitation from cells transfected with the N protein 
alone radioactive heterodisperse RNA was observed. This RNA was found to be 
derived from the vaccinia virus infected host cells and bound to the expressed N 
protein. Co-expression o f the N protein with either the NS or L protein or both 
proteins abrogated such non-specific binding. The results show that although the N 
protein is capable of binding RNA, specificity for VSV RNA is seen only in the 
presence of the NS and L proteins (Pattnaik and Wertz, 1990). Furthermore, co­
expression of N, P, L, M and G proteins resulted not only in DI replication but also in 
assembly, packaging and release of DI particles into the cell culture medium (Pattnaik 
and Wertz, 1991). In cells co-expressing the NS, N and L proteins and either the M or 
G protein, subsequent infection with DI particles did not result in maturation of the DI 
particle and no progeny DI particles were detected in the cell culture medium. Thus 
both the M and G proteins appear to be crucial in the maturation of VSV and suggests 
an interaction between the M and G proteins during viral maturation (Pattnaik and 
Wertz, 1991).
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162.1. LPROTEIN:
The L gene encodes the major component of the RNA dependent RNA 
polymerase responsible for viral transcription and replication. As yet the L gene of 
PVM has not been sequenced. Since it is located the furthest from the 3' polymerase 
binding site, any mRNA species representing this gene would be found in minimal 
amounts. However, Ling and Pringle (1989a) observed a polypeptide with a molecular 
weight of 19IK on SDS-PAGE gels which was thought to be the L protein. Assuming 
this size is correct it is estimated the L protein of PVM to be approximately 1750 
amino acids long. This figure is smaller than that of HRS V whose L protein is 2165 
amino acids long (Stec el al, 1991), and is also smaller than the L proteins of other 
paramyxoviruses. However the resolution of SDS-PAGE gels used for analysis of 
PVM specific polypeptides would not have given an accurate estimation o f the L 
protein size. It is possible for the L protein to have been up to 200K in molecular 
weight , which would be closer to that of HRS V. Unlike HRS V or BRSV where the 
start of the L gene is located within the M2 (22K) gene (Stec el al, 1991, Zamora and 
Samal, 1992), no open reading frame is found within the M2 gene of PVM or the G 
gene of TRTV (the gene order of TRTV is different to that of HRS V and PVM) which 
could represent the start of the L gene in these viruses (Andrew Easton - personal 
communication, Yu et al, 1992, Ling et al, 1992). The VSV viral polymerase has been 
shown to possess kinase activity required for further phosphorylation o f a 
phosphorylated form of bacterially expressed VSV NS protein (Barik and Baneijee,
1992) and is discussed in more detail later.
1.6,2.2, N AND P PROTEINS:
The nucleocapsid protein (N) of PVM is 1215 nucleotides long 
encoding a protein of 393 amino acids. The predicted molecular weight of the N 
protein is 43,141 which is in close agreement with the 4 IK molecular weight observed
/
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on SDS-PAGE by Ling and Pringle (1989a) and Cash et al (1979). The overall 
homology between the N proteins of PVM and HRSV is 60% although this homology 
varies from 38% for the first 150 amino acids to 74% for the remaining amino acids of 
these two viruses. Within some regions (amino acids 245 to 315) this homology 
increases to 97% (Barr et al, 1991). This high degree of homology probably accounts 
for the cross-reactivity between PVM and HRSV N proteins observed by Ling and 
Pringle (1989a) and Gimenez et al (1984). Although the N protein o f PVM (and 
pneumoviruses in general) are smaller than those of morbilliviruses and 
paramyxoviruses Barr et al (1991) have identified structural features common to these 
proteins, which may be relevant for the function of the protein.
The phosphoprotein (P) of PVM is 903 nucleotides long encoding a 
polypeptide of 295 amino acids with a predicted molecular weight of 29K, which is 
smaller than the 4 IK polypeptide observed on SDS-PAGE gels by Ling and Pringle 
(1989a) and identified by Chambers et al (1990a) as the P protein in hybrid arrest 
translation experiments. In in vitro translation systems this protein migrates with an 
apparent molecular weight of 39K. The discrepancy between predicted and observed 
molecular weights can not be accounted for by phosphorylation of the P protein alone 
but could be a result of failure of these acidic proteins to interact with SDS and also 
the three dimensional conformation of the protein. Additionally, the PVM P gene can 
encode a second smaller polypeptide of 138 amino acids with a predicted molecular 
weight of 16K initiated from an overlapping open reading frame. This is somewhat 
reminiscent of the C proteins of several paramyxoviruses. The 39K P protein o f  PVM 
shares an overall homology of 28% with the P protein of HRSV and 35.6% with the P 
protein of bovine respiratory syncytial virus (BRSV). As was the case for the N 
protein the homology between the P proteins o f PVM and HRSV rises to 64% in some 
regions o f the protein. A low homology between the P proteins of pneumoviruses is 
not surprising since the NS protein of VSV, which is equivalent to the P proteins of
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paramyxoviruses, demonstrated a low homology between different strains o f the same 
virus. The NS protein of the Ogden strain of VSV was found to have a 30% homology 
with the same protein from New Jersey strain of VSV. However although the overall 
homology was low, the C termini o f these proteins were well conserved with a 
homology of approximately 90% suggesting conservation of a functionally important 
domain (Gill etal, 1986, Baneijee, 1987).
By analogy to other paramyxoviruses it is generally considered that the 
viral polymerase interacts with the N and P proteins during transcription and 
replication. The precise mechanism by which the polymerase switches from its 
transcriptive to replicative mode o f functions is as yet unknown although evidence 
suggests a possible role for the P protein. Caravokyri et al (1992) have attributed a 
mutation of a temperature sensitive mutant of HRS V to a single amino acid change in 
the P protein. At the non-permissive temperature no detectable viral protein was 
synthesised, probably due to the absence of mRNA species. These results suggest a 
role for the P protein in viral transcription. Evidence from studies of Sendai virus and 
NDV also indicate the crucial role o f the P protein in viral transcription (Hamaguchi et 
al, 1983, Deshpande and Portner, 1985).
The Far-Western (West-Western) blot analysis technique has been used 
to study the interaction of the N and P proteins of PVM (J. Barr- personal 
communication). The technique involves immobilising PVM infected cell proteins to 
Immobilin™ polyvinylidene difluoride (PVDF) membrane using the Western blotting 
protocol after which the immobilised proteins are renatured in the appropriate buffer. 
Interaction of the proteins can then be assessed by incubation of the immobilised 
proteins with radiolabelled in vitro translated products followed by autoradiography. 
The extent of binding can then be assessed by densitométrie analysis of the 
autoradiograph. Far-Westem blot analysis of N- and C- terminally deleted N protein of 
PVM demonstrated an interaction with the P protein of PVM. The amino terminal half
iMIRQDUCnQN
19
I
\of the N protein was shown to bind to immobilised P protein with a 4.3% affinity when 
compared to the binding affinity of full length N protein (100%). Similarly the C- 
terminal half o f the N protein bound with 17.6% affinity to immobilised P protein. 
Removal of just twelve amino acids from the C-terminus of the N protein resulted in 
reduction of binding affinity to 68.4%. The results show that both the N and C termini 
are important and suggests that the overall structure of the protein is important (J. 
Barr- personal communication).
A number of independent domains located within the P protein were 
identified to be responsible for binding to the N protein (J. Barr- personal 
communication). Similar results for the binding between the NP and P proteins of 
Sendai virus have been observed. Removal of 30 amino acids from the C terminus of 
Sendai virus P protein abolished binding to immobilised NP protein (Homann et al, 
1991) which support the findings of Ryan and Kingsbury (1988). Deletions within the 
Sendai virus NP protein considerably reduced the affinity of the NP protein for the P 
protein indicating that most of the NP protein was required for binding the P protein 
(Homann et al, 1991) . Deletions of the P protein of PVM at either the amino or 
carboxyl terminus totally abolished binding to the full length N protein, suggesting 
these regions were required for binding the N protein (J. Barr- personal 
communication). These results are also in agreement with the findings of Huang et al, 
(1984) and Lambert and Pons (1983) who observed an association between the P and 
viral nucleocapsids of HRSV. Garcia et al (1993) recently demonstrated the presence 
of N-P complexes in HRSV infected cells. Electron microscopic studies revealed the 
presence of cytoplasmic inclusions in which HRSV infected cells were stained with 
MAb's directed against the structural proteins. Inclusions were labelled with MAb's 
specific for the P, N and M2 (22K) proteins but not for the F, G or M proteins. 
Immunofluorescence staining with MAb's for N, P and M2 revealed the presence of 
cytoplasmic O-ring inclusions. Transfection of cells with N, P M2 genes, either alone
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Vor in combination, followed by immunofluorescence and immunoprécipitation analysis 
showed interaction between the N-P and N-M2 (22K) proteins. In N and P co­
transfected cells round aggregates within the cytoplasm were observed. Co- 
transfection of N and M2 or P and M2 showed diffuse cytoplasmic fluorescence 
whereas co-transfection with all three showed O-ring cytoplasmic inclusions similar to 
those found in HRSV infected cells, indicating an interaction between all three 
proteins. SDS-PAGE analysis of immunoprécipitations of transfected cells revealed 
presence of N-P and N-M2 but not P-M2 complexes. These complexes were only 
observed in infected or transfected cells but not when the proteins were co-synthesised 
in rabbit reticulocyte lysate (Garcia et al, 1993).
Fooks et al (1993) expressed measles virus nucleoprotein from a 
recombinant baculovirus in insect cells. Using electron microscopy they saw 
nucleocapsid like structures located within the nucleus and cytoplasm of these cells. 
The nucleocapsid structures were longer than those seen in measles virus infected cells 
and the buoyant density of these baculovirus expressed nucleocapsids was less than 
those observed from measles virus infected cells. This is consistent with the idea that 
the nucleocapsid structures in these insects cells lacked significant amounts of RNA. 
Similar nucleocapsid structures were observed in recombinant vaccinia virus infected 
cells expressing the measles virus N protein (Spehner et al, 1991). Thus, the N protein 
of measles virus is capable of interacting with itself and forming aggregates. Gombart 
et al (1993) used MAb N46 directed against measles virus N protein, which failed to 
react with P protein when expressed alone, to immunoprecipitate N-P complexes from 
cells co-expressing the N and P proteins in in vitro experiments. Again N-P complexes 
were only observed when both proteins were co-expressed. These results confirmed 
the findings of .Huber et al (1991) who inferred an interaction between N and P 
proteins in measles virus following retention of the N protein within the cytoplasm, as 
observed by immunofluorescence, when co-expressed with the P protein, since the N
1 I
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protein of measles virus can localise to the nucleus when expressed alone. Use of P 
protein deletions allowed them to attribute approximately 40% of the C terminal 
region of the P protein to binding to the N protein. Masters and Baneijee (1988a) 
demonstrated an association between the VSV nucleocapsid (N) and phosphoprotein 
(NS) in an in vitro expression system. They determined that N-NS complexes were 
only formed when both proteins were co-translated. Deletion of 21 amino acids o f the 
C terminus o f the VSV NS protein resulted in a decreased ability o f the truncated 
protein to bind to RNP complexes (RNA-N) and had a minor effect on transcription 
(Gill et al, 1986). Horikami et al (1992) showed a requirement for NP-P and P-L 
complexes in Sendai virus. Replication of a Sendai virus defective interfering particle 
(DI) was supported in cells expressing either the NP and P or L and P proteins in the 
same cells. Furthermore they were able to immunoprecipitate NP-P and P-L complexes 
from these cells. A reduction or increase in either the NP or P proteins inhibited 
replication of the DI particle. Although no reason was attributed to the findings that an 
increase in the P protein expression reduced DI replication, it could be argued that an 
imbalance in the N:P ratio switches polymerase function from replication to 
transcription. Baker and Moyer (1988) demonstrated purified NP protein of Sendai 
virus was capable of supporting replication of purified DI nucleocapsids isolated from 
infected cells in vitro. However RNA synthesis was not observed when NP was added 
to detergent disrupted DI nucleocapsids They concluded that the NP protein was 
interacting with another viral nucleocapsid protein presumably the P protein. 
Additionally, they interpreted their results to indicate that the NP protein is capable of 
RNA synthesis from pre-initiated templates only i.e. NP was involved in the elongation 
of already initiated RNA synthesis. Hamaguchi et al (1983) used detergent and salt 
protocols to strip NDV nucleocapsids o f the P and L proteins. Following purification 
of the L and P proteins the effect o f each upon nucleocapsid transcription was
iNTRppUCn ON
22
i
I I
investigated. In re-constitution experiments transcription activity was greater where 
both the L and P proteins than where the L and P proteins were used separately.
The interaction of the phosphoproteins of paramyxoviruses is 
complicated further by the synthesis of polypeptides from within the P gene either from 
1) overlapping reading frames, 2) synthesis from non AUG initiation codons or 3) from 
insertion of non-templated nucleotides during transcription thus altering the reading 
frame as observed for the P/V genes of Sendai virus (Vidal et al, 1990), SV5 (Thomas 
et al, 1988), measles virus (Cattaneo et al, 1989) and human parainfluenza type 2 virus 
(Ohgimoto et al, 1990) and the P/D genes of HPIV3 (Galinski et al, 1992). The P/V 
genes of SV5 are unusual in that the V protein is coded from the first AUG whereas 
the P protein is obtained following insertion of non-templated bases. In all the other 
viruses mentioned above, it is the V protein that is accessed following insertion of non- 
templated bases. The latter is discussed more fully in the context of insertion of non- 
templated bases during transcription of the PVM G gene.
Sendai virus is unusual in that a number of polypeptides are synthesised 
from the P gene. The P protein is synthesised from the major ORF spanning most of 
the gene. The C polypeptide is 204 amino acids long and is synthesised from an AUG 
seven nucleotides downstream of the AUG encoding the 568 amino acid long P 
protein. Additionally, Sendai virus P gene encodes several other polypeptides -C, Y, 
Y', V, W and X (Curran and Kolakofsky, 1988). PIV1 (Matsuoka et al, 1991), canine 
distemper virus (CDV), NDV (McGinnes et al, 1988) and measles virus (Bellini et al, 
1985, Alkhatib et al, 1988) also translate polypeptides from overlapping reading 
frames. The C  polypeptide is unusual in that it is translated from a non-AUG codon 
(ACG) located in-frame upstream of the initiation codon for the C polypeptide (Curran 
and Kolakofsky,' 1988) in Sendai virus and from a GUG codon in PIV1 (Boeck et al, 
1992). Both the C and C  polypeptides are non-structural. The Y and Y  polypeptides 
of Sendai virus are a result of internal initiation from within the C polypeptide coding
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region whereas the V protein is translated from a separate mRNA species arising from 
insertion of a single non-templated G residue at a CCC (negative sense) insertion site 
located within the P gene. The V protein shares the first 316 amino acids in common 
with the N terminus of the P protein with a unique 68 amino acids cysteine-rich C 
terminus. The W polypeptide is a truncated form of the P protein which terminates 
after the addition of two extra codons following insertion o f two, five or eight non- 
templated G residues at the same insertion site as the V polypeptide. Insertion of non- 
templated bases is thought to occur by the same method as polyadenylation of mRNA 
with stuttering at a run of C residues (Thomas et al, 1988, Vidal et al, 1990). Vidal et 
al (1990) have demonstrated this to be a feature of the viral polymerase during 
transcription since no non-templated insertions were found in vaccinia virus 
recombinants containing the full length P gene. The X protein of Sendai virus 
represents 95 amino acids of the C terminus of the P protein and is initiated from an 
internal AUG codon (Curran and Kolakofsky, 1988).
Absence of any mRNA synthesis in a ts mutant of HRSV due to lesion 
in the P protein at the non-permissive temperature, indicated a role for the P protein in 
providing specificity for the N-P complex to bind virus specific RNA (Caravokyri et al, 
1992). This theory correlates with the hypothesis derived from the VSV results where 
in vitro translated N protein was shown to bind non-specifically to RNA (Masters and 
Banerjee, 1988a). However, co-translation of the N and NS proteins in vitro altered 
the specificity of the N protein to become specific for virus RNA (Masters and 
Baneijee, 1988b). These results complement those of Pattnaik and Wertz (1990) which 
have been discussed previously. Buchholz et al (1993) have demonstrated the ability of 
Sendai virus nucleocapsid protein (NP) to form nucleocapsid structures when 
expressed in vitro using the recombinant vaccinia virus T7 RNA polymerase 
expression system. Although these nucleocapsid structures were similar in appearance 
to Sendai virus nucleocapsid structure, they contained non-viral RNA. Deletion
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analysis of the Sendai virus NP protein determined the N-terminal 399 amino acids to 
be involved in formation of nucleocapsid structures whereas the C-terminal (400 to 
524 residue) region does not (Buchholz et al, 1993). Investigations of the non- 
structural polypeptides synthesised from the P gene in Sendai virus suggests a role for 
these polypeptides in transcription and replication. Curran et al (1991) looked at the 
effects of the L, NP and P/C polypeptides expressed in vitro on replication of a Sendai 
defective interfering particle (DIH4). All were found to be required for replication of 
the DI genome. Abolition of expression of the C polypeptide was found to have no 
effect on replication whereas co-expression of the V or W but not the X polypeptide 
reduced amplification o f the DI genome. An increase in genome amplification was 
observed when the level of L protein was increased in the presence o f the V protein 
(representing the N terminal half of the P protein) but not in the presence of a 
polypeptide representing the C terminus of the P protein. These results indicate that 
the N terminus of the P protein of Sendai virus is involved in binding RNA whereas the 
C terminus is involved in binding to nucleocapsid protein which support similar results 
for measles virus P protein (Huber et al, 1991) and VSV NS protein (Gill et al, 1986).
Curran et al (1992) have recently investigated the effect o f Sendai virus 
NP, P/C and L proteins on mRNA synthesis. Extracts of transfected cells expressing, 
either separately or together, the NP, P/C and L proteins were reconstituted with 
purified RNP templates (NP:RNA). Extracts in which all proteins were co-expressed 
showed increased mRNA synthesis compared to those in which either one or two of 
the proteins was omitted. Extracts in which the P/C gene products were replaced with 
P gene only (C polypeptide not expressed) showed a five fold increase in mRNA 
synthesis. The C  polypeptide had an inhibitory effect on transcription. Reconstitution 
of extracts from co-expressed P and C polypeptides with L protein showed a strong 
inhibitory effect on mRNA synthesis whereas mixing of extracts from co-expressed C 
and L polypeptides with P protein showed only a minor inhibitory effect on mRNA
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\synthesis. These result indicate an interaction between the C and P protein affect 
transcriptional levels. Thus for Sendai virus it appears that the variation in the 
concentration of C and V proteins may be responsible for the switch from replication 
to transcription. Since the V protein is only found in all paramyxoviruses, except 
pneumoviruses, it could be a 'luxury' item.
A further complication is the finding that host cell proteins may be 
involved in transcription and replication of the virus. Barik and Baneijee (1991) 
purified a non-phosphorylated form of the VSV NS protein expressed in E. coli, 
designated P0, which was found to be transcriptionally active when reconstituted with 
viral N-RNA template and L protein. However these studies were inconclusive since 
the preparations of L protein and N-RNA template were found to contain protein 
kinase activities, possibly due to kinases associated with the nucleocapsid. However, P 
protein synthesised using reticulocyte lysate was found to be phosphorylated 
(designated Pj) by kinases present in the reticulocyte lysate and was different to that 
expressed in E. coli (Barik and Baneijee, 1992). Extracts prepared from uninfected 
BHK cells were found to phosphorylate bacterially expressed P0 to Pj. Both P0 and P1 
were demonstrated to be transcriptionally inactive. Further phosphorylation of P t to a 
transcriptionally active P2 form was achieved by the addition of purified VSV L 
protein and N-RNA template lacking any protein kinase activity, as measured by their 
inability to phosphorylate P0 to P t (Barik and Baneijee, 1992). Further biochemical 
analysis determined that phosphorylation of the bacterially expressed NS protein to the 
Pj form was achieved by host cell kinase, similar to caesin kinase. Modification of Pj 
to P2, the transcriptionally active form of the NS protein, was achieved by the addition 
of the L protein thereby demonstrating the role of the L protein in phosphorylation 
during maturation of the NS protein. Addition of the non-phosphorylated NS protein 
to just the L protein was not sufficient to restore transcriptional activity demonstrating 
the requirement for the host cell kinase and viral polymerase in a step-wise maturation
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of the NS protein (Baneijee and Bank. 1992, Bank and Baneijee, 1992). Furthermore 
the P2 form of the protein was found to undergo de-phosphorylation and re­
phosphorylation in its phosphate groups attached by the L protein associated kinase 
activity. These results complement the findings of Chattopadhyay and Baneijee (1987) 
who demonstrated the importance o f phosphorylation in transcription. Two conserved 
serine residues in the NS protein sequences o f VSV were identified as important in 
viral transcription by the work of Gill et al (1986), where deletion of domain II 
(containing the serine residues) of the NS protein resulted in a marked reduction of 
transcription. Additionally a third non-conserved serine residue was located with this 
domain. Site directed mutagenesis of the these serine residues to alanine had 
considerable effect on transcription in reconstituted reactions. When either o f the 
conserved serines were mutated, transcriptional levels were decreased by 75% of the 
activity of non-mutated NS protein whilst mutation of both the conserved serines 
reduced transcription by 90%. Mutation of the non-conserved serine only reduced 
RNA synthesis by 35%. When all three serines were changed, transcriptional levels fell 
by 92%. Thus the phosphorylation process of the NS protein appears to be involved in 
the regulation of viral transcription. The results presented above might suggest a role 
for phosphorylation to act as an 'on-off switch for transcription although since 
complete inhibition of transcription following mutagenesis of the serine residues did 
not completely inhibit transcription (Chattopadhyay and Baneijee, 1987), 
phosphorylation of the NS protein might be thought o f as a catalyst o f  viral 
transcription.
Another approach to the study of the role o f the P proteins involves the 
use of monoclonal antibodies. Williams et al (1988) used three MAb's (2A2, 6D11 and 
4F11) raised against purified VSV NS protein to investigate the role of the NS protein. 
Of the three MAb's used, two were inhibitory in in vitro transcription reactions using 
solubilised whole virus against which each of the MAb's was tested. Two of the three
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MAb’s (2A2 and 6D11) inhibited transcription by 90% whereas MAb 4F11 inhibited 
transcription by 65%. Further investigation into the mode of action of MAb's 2A2 and 
6D11 showed MAb 6D11 to inhibit leader RNA synthesis whereas MAb 2A2 did not, 
as observed by the presence of newly synthesised leader RNA during transcription o f a 
VSV DI particle. Furthermore, MAb's 6D11 and 4F11 immunoprecipitated the NS 
protein from purified nucleocapsid preparations whereas MAb 2A2 cross-reacted with 
nucleocapsid associated N protein. The mode of action of each MAb is determined 
from the fact that MAb 6D11 immunoprecipitated the NS protein with only 
background levels of the N protein indicating a dissociation of the NS protein 
following binding of the MAb whereas MAb 4F11 immunoprecipitated all the 
components of the nucleocapsid, indicating a binding to the NS protein in which the 
nucleocapsid remains intact following MAb binding. MAb 2A2 was shown to cross- 
react with a greater affinity for the N protein rather than the NS protein implying 
inhibition of transcription was achieved by binding to both the N and NS proteins. 
Although the use of MAb's may provide some insight into the mode of action of the 
antibodies themselves, they do not provide directly provide evidence for the exact role 
of the nucleocapsid associated proteins.
The importance of the V and C proteins in replication and transcription 
is unknown. Polypeptides synthesised from internal initiation o f the PVM P gene have 
been observed both in vitro and in vivo although they have not been characterised as 
yet (J. Barr, personal communication). However, it has been suggested that the non- 
structural proteins of pneumoviruses may play a similar role (Collins, 1991). Although 
no conclusive evidence exists for the factor responsible for the switch from replication 
to transcription function of the viral protein, evidence to date suggests the P protein 
plays a crucial role in viral transcription and replication. Combining results available 
for the different viruses, and discussed above, it could be argued that although the N 
protein is capable of associating with the viral genome, the interaction o f the N and P
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proteins provide specificity for the N protein to bind viral specific RNA and possible 
interactions between the P and L proteins may switch the function of the viral 
polymerase from replication to transcription.
1.6.3. Membrane associated non-glvcosvlated proteins :
l 6.3.i , M a t r ix  (M) pr o tein  :
The matrix protein of PVM is 257 amino acids long and has some 
homology with its counterparts in HRSV and TRTV (Andrew Easton - personal 
communication). The predicted molecular weight of 28,312 is in close agreement with 
the 27.3K polypeptide identified to be the M protein following immunoprécipitation by 
Ling and Pringle (1989a) and hybrid arrest translation in vitro (Chambers et al, 
1990a). The predicted protein shares a hydrophobic nature with its counterparts in 
other paramyxoviruses. The paramyxovirus matrix protein is thought to play a crucial 
role in virus assembly through interaction between the cell membrane and the viral 
nucleocapsid (Peeples, 1991). This view is supported by several lines o f evidence.
Membrane association of the M protein following reconstitution with 
liposomes in Sendai virus (Caldwell et al, 1986) and NDV (Faaberg and Peeples, 
1988) indicates a direct interaction with membrane components. NDV M protein was 
purified from virions by monoclonal antibody affinity chromatography and prevented 
from forming aggregates by the addition o f bovine serum albumin (BSA). In vitro 
synthesis of liposomes was achieved by the reaction of cholesterol, L-a- 
phosphotidylcholine and a third lipid possessing either a positive, neutral or negative 
charge. In all cases the M protein was found to interact with the liposomes as analysed 
by reactivity of the M-liposomes complex with three M protein specific MAb's 
suggesting a non-electrostatic interaction between the two components. Furthermore 
the ability of M protein aggregates which lacked BSA to bind to the liposomes 
eliminated a role for BSA in mediating the interaction. Since the M proteins of
/
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\paramyxoviruses are hydrophobic, a non-electrostatic interaction with liposomes could 
be mediated by hydrophobic forces (Faaberg and Peeples, 1988). The M protein 
specific MAb’s failed to prevent binding to the liposomes indicating a role for 
hydrophobic forces since the hydrophobic domains of the M protein are unlikely to be 
immunogenic. The possibility exists that these hydrophobic domains may be involved 
in interactions with the nucleocapsid or with membrane bound glycoproteins (Faaberg 
and Peeples, 1988). Chong and Rose (1993) demonstrated an interaction between 
purified VSV M protein and cell membranes and between the membrane bound M 
protein and the RNP core. No interaction of membrane bound G protein and the RNP 
core was observed. Interactions between the M and NP proteins o f Sendai virus were 
observed by Homann et al (1991) in experiments using immobilised proteins to 
investigate protein-protein interactions. However, they also noted interactions between 
the M protein and non-viral (host) proteins. Ogden et al (1986) have demonstrated 
interaction between the VSV M protein and unilamellar vesicles and between the M 
protein and VSV RNP. Unlike Faaberg and Peeples (1988), Ogden et al (1986) could 
only show binding between the VSV M protein and negatively charged unilamellar 
vesicles. VSV RNP's were found to complex with these vesicles with a greater affinity 
in the presence of the M protein. Interestingly, complexed RNP-M bound with greater 
affinity to vesicles not already complexed with the M protein. One explanation 
suggested is the possible reduction in binding sites on M protein saturated RNP's. 
These results suggest that binding of M protein to membrane does not require the 
presence of viral glycoproteins within the cell membrane.
In temperature sensitive mutants of NDV in which the ts lesion lies in 
the M protein, reduction in plaque formation and haemolysis is attributed to the 
absence or reduction in incorporation of the F protein at the non-permissive 
temperature (Peeples and Bratt, 1984). Normal incorporation o f F protein within 
membranes was found in revertants of these ts mutants in which the M protein had
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reverted to normal SDS-PAGE migration. This suggests an interaction between the M 
and F proteins of NDV.
Analysis of temperature sensitive mutants arising from mutations found 
in the M protein by Caravokyri and Pringle (1991) using nucleotide sequencing and 
SDS-PAGE analysis identified an abnormal M protein in a temperature sensitive 
mutant of HRSV causing an increased degradation of the M protein at the non- 
permissive temperature, thus inhibiting viral assembly.
Interestingly, the M protein of measles virus could account for a change 
in the course or type of disease caused by this virus. Analysis of the M proteins of the 
Nagahata strain, an acute measles virus progenitor, and the Biken strain, isolated from 
a patient suffering from SSPE, showed differing abilities to bind to viral nucleocapsids. 
Whereas the M protein from the Nagahata strain was able to bind to the nucleocapsid 
as expected, that of the Biken strain was retained within the cytosol and did not bind 
to the viral nucleocapsid (Hirano et al, 1992). Earlier, nucleotide sequencing and 
polypeptide analysis by SDS-PAGE of a measles virus isolate from a patient afflicted 
with SSPE confirmed the absence of M protein synthesis resulting in the non- 
evagination of the virus. In this case an amber stop codon was found 36 nucleotides 
(12 triplets) into the coding region of the M protein (Cattaneo et al, 1986).
Additionally, by analogy to VSV (Ogden et al, 1986, Black and Lyles, 
1992, Black et al, 1993) and Influenza A virus (Ye et al, 1989), the matrix protein 
may inhibit host cell transcription in a process which requires localisation o f  viral M 
protein to the cell nucleus. Inhibition of transcription was monitored by turnover of 
radiolabelled chloramphenicol incubated with cell extracts following co-transfection 
with recombinant SV40 based expression vectors containing the VSV M protein and 
CAT reporter gene (Black and Lyles, 1992). Northern blot analysis confirmed 
inhibition to be at the transcriptional level following a reduction in the observed CAT
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mRNA concentrations in transfected cells (Black and Lyles, 1992). Digestion with 
trypsin resulted in the removal o f 43 amino acids from the N terminus of the VSV M 
protein. This truncated protein was shown to have a reduced inhibitory effect on 
transcription in vitro (Ogden et al, 1986). Li et al (1993) also demonstrated that M 
protein expressed and purified from insect cells was capable o f inhibiting transcription 
when reconstituted with VSV nucleocapsids. Li et al (1993) also expressed the VSV 
M, N and G proteins in insect cells using a baculovirus expression system. Electron 
microscopy demonstrated that the M protein alone was capable of initiating budding at 
the cell membrane. These results support those of Blondel et al (1990) who used a ts 
mutant (ts lesion attributed to a mutant M protein) to demonstrate that the M protein 
is responsible for cytopathic effect (CPE) in VSV infected cells. At the non-permissive 
temperature, cells transfected with ts M protein appeared normal whereas those at the 
permissive temperature rounded up and became detached. The results of Li et al 
(1993) indicate that no interaction between the glycoproteins and M protein of VSV is 
required to cause evagination, although it is not known whether host cell proteins 
present at the cell surface of insects cells have similar characteristics to the virus 
glycoproteins. These findings are in contrast to those of Pattnaik and Wertz (1991) 
who showed maturation of a non-replicative DI particle did not occur in an in vitro 
replication system in which transfected cells co-expressing the N, NS, L and either the 
M or G protein of VSV prior to super-infection with DI particles. These results 
suggest an interaction between the M and G proteins during VSV maturation. Since 
the M protein of pneumoviruses is considerably smaller than those of morbilliviruses 
and paramyxoviruses, these functions may have been split between the M and M2 
proteins. Recently, Black et al (1993) have identified the VSV M protein domains 
involved in transcription inhibition and membrane attachment. Two mutant M proteins 
were engineered using standard molecular biology techniques. The first mutation 
involved changing of a Met residue to Arg at position 51 o f the M protein o f VSV
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*strain Orsay. This mutation, designated 082M, altered the M protein to that found in 
the ts mutant ts082 which was studied by Coulon et al (1990). The M protein of this 
mutant had been shown to produce a reduced CPE. The second mutation, designated 
MN1, was the deletion of the amino acids 4 to 21 in the M protein of VSV strain San 
Juan. This deletion was similar to that of Blondel et al (1990) who demonstrated that 
deletion of the lysine rich N terminus did not affect the ability of the truncated M 
protein to induce CPE. Inhibition of transcription was monitored by the method of 
Black and Lyles (1992). Cells co-expressing the CAT reporter gene and 082M showed 
minimal inhibition of transcription whereas those expressing the CAT reporter gene 
and MN1 showed marked reduction in transcription as measured by the ability of 
transfected cell extracts to turnover radiolabelled chloramphenicol. Ability of each 
mutant M protein to associate with cell membranes was investigated by the ability of 
each mutant to complement growth at the non-permissive temperature of a ts mutant 
(ts023) whose ts lesion has been attributed to the M protein. Here, 082M was found to 
complement growth of the ts mutant, as measured by plaque assays whereas MN1 did 
not complement growth. These results demonstrate the sites responsible for 
transcription inhibition and virus assembly to be separate and distinct. Additionally, 
each of the mutant proteins were found to localise to the nucleus as efficiently as the 
wild type M protein in immunofluorescence studies. Thus deletion of the lysine rich N 
terminus (MN1) is not involved in the nuclear localisation of the M protein (Black et 
al, 1993). Localisation of the NDV M protein to the nucleus have been observed in 
immunostaining studies (Peeples et al, 1992) and are similar to the findings of Lyles et 
al (1988), who used immunofluorescence to show localisation of the VSV M protein 
to the cell nucleus.
1.63.2. M2 (2210 Protein :
The M2 (22K) protein is only found within members of the 
pneumovirus genus. The M2 protein of PVM encodes a polypeptide of 176 amino
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acids with a predicted molecular weight of 20,165. The basic nature of the predicted 
polypeptide puts it in close agreement with the 23K or 24K polypeptides identified by 
Ling and Pringle (1989a) by two dimensional electrophoresis. The hydropathy profile 
resembles that of the M2 protein of HRSV and TRTV highly conserved between all 
three (Andrew Easton - personal communication). As yet the function of the M2 
protein of pneumoviruses has not been established. The location of the protein within 
the virion has not been determined precisely although fluorescent antibody studies have 
shown it to be associated with internal structures of HRSV such as the N and P 
proteins (Routledge et al, 1987). Similar results were obtained by Garcia et al (1993) 
who demonstrated an interaction between the N and M2 protein by 
immunofluorescence and immunoprécipitation studies (discussed in the N and P 
protein section). This location is distinct from that occupied by the matrix (M) protein. 
These results agree with the findings of Samal et al (1993) who demonstrated an 
interaction between the M2 protein and nucleocapsid (N) protein of BRSV, following 
synthesis of the M2 protein in insects cells. Huang et al (1985) used detergent (triton) 
and salt dissociation methods to show an interaction of the M2 protein with the viral 
membrane. At high salt concentrations the M2 protein was solubilised whereas those 
associated tightly with the nucleocapsid (N, P and L proteins) were not, indicating the 
M2 protein to be membrane associated. However, whereas all of the M2 protein could 
be extracted from virion membranes, a small amount of the M protein remained 
membrane bound (Huang et al 1985). This could suggest, taking in to account the 
ability of the M2 protein to bind to the N protein, a possible involvement in the 
bridging of N and M proteins. Detergent and salt dissociation methods could disrupt a 
loose association with the nucleocapsid but not a tight association with the M protein. 
Thus the M2 protein would be solubilised and appear to be membrane bound. 
Additionally, Connors et al (1992) demonstrated a vaccinia virus recombinant 
expressing the M2 protein to be targeted by CD8+ T cells since depletion of CD8+ T
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cells abrogated protection of immunised mice following infection with HRSV which 
had been observed previously (Nicholas et al, 1991). Nicholas et al (1991) observed a 
reduction in HRSV replication infected mice previously immunised with a vaccinia 
virus recombinant expressing the M2 protein.
Although, paramyxoviruses and morbilliviruses do not have an 
equivalent gene, it is possible that the role of their matrix (M) protein which is 
involved in the structure of the virion and possibly in regulation of transcription 
(Satake and Venkatesan, 1984, Ogden et al, 1986, Black and Lyles, 1992, Black et al,
1993) has been split in the pneumoviruses. A simpler model for the functioning of the 
M2 protein could be where the M2 protein acts as a 'glue' which binds the viral 
nucleocapsid to the M protein which in turn interacts with the envelope associated 
viral glycoproteins. This model presumes that the M2 and M proteins are not involved 
in regulation of transcription as is the case for VSV M protein.
1.6.4. Lipid envelope glycoproteins :
The major antigenic determinants of paramyxoviruses are the 
membrane-bound glycoproteins responsible for entry of viral nucleocapsid into the 
host cell. Attachment of the virus particle to the cell membrane is mediated by the 
attachment glycoprotein and fusion o f viral and cell membranes, allowing entry of the 
nucleocapsid into the cell, is ascribed to the fusion (F) glycoprotein of these viruses. 
Since the fusion and attachment activities of VSV are integrated in the single surface 
glycoprotein, G, comparison with only the Paramyxovirus glycoproteins may be valid.
1.6.4.1. SH (1A) PROTEIN:
The SH gene of PVM is 390 nucleotides long, encodes a polypeptide of 
92 amino acids with a predicted molecular weight of 9,582 for the unglycosylated 
protein and contains a large central hydrophobic region characteristic of pneumovirus 
SH proteins (A. Easton, personal communication). Ling and Pringle (1989b) identified
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\a 12K protein immunoprécipitations of PVM infected cells. The size of this 
polypeptide discounted it as being the F2 subunit of the functionally active F protein. 
However, the size and membrane location of this 12K polypeptide could suggest it to 
be the SH protein of PVM. The SH protein is unusual in that an equivalent is found in 
all members of the pneumovirus genus and only in some members of morbilliviruses 
and paramyxoviruses such as SV5 (Hiebert et al, 1988) and mumps virus (Elango et 
al, 1989, Takeuchi et al, 1991). Although the function of the SH protein is not known, 
there is evidence supporting the membrane-bound association of this protein (Olmsted 
and Collins, 1989, Collins and Mottet, 1993). The SH protein of PVM contains 4 
possible N-linked glycosylation sites. Olmsted and Collins (1989) demonstrated the 
existence of glycosylated and non-glycosylated forms of the SH protein of HRSV. 
Only a small fraction of the protein was glycosylated by the addition of N-linked 
glycosylation at either one or both of the two putative N-linked glycosylation sites 
located within the N- and C- termini of the protein. Similarly the 174 amino acid SH 
protein of TRTV possesses a N-linked glycosylation site within the C terminus of the 
protein indicative o f an extracellularly located domain. This N-linked glycosylation site 
appears to be utilised since a mobility shift of in vitro transcribed and translated TRTV 
SH protein was observed in the presence of microsomal membranes (Ling et al, 1992). 
Indirect immunofluorescence of HRSV infected non-permeabilised cells demonstrated 
the membrane location of the SH protein and implied the C-terminus was exposed 
extracellularly since the anti-SH serum was directed against the C-terminus of the 
protein (Olmsted and Collins, 1989). Following trypsinisation o f membrane bound SH 
protein, an SH C-terminal specific MAb was unable to recognise the protected 
fragment in immunoprécipitation analysis whereas a SH N-terminal specific MAb 
recognised this fragment. These results imply an extracellular location for the SH 
protein C-terminus and a cytoplasmic or membrane embedded location for the SH 
protein N terminus. Sequence analysis of the SH gene of HRSV strain 18537, the
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prototype strain of HRS V subgroup B revealed 76% amino acid homology with that of 
strain A2, the prototype strain of HRSV subgroup A. The amino acid changes were 
located within the C-terminal part of the protein suggesting the SH protein may be 
subject to selective pressure from host immunity (Collins et al, 1990). The SH protein 
of SV5 has also shown to be membrane bound with the N-terminus of the protein 
located cytoplasmically (Hiebert et al, 1988). However, only 5 amino acids of the SH 
protein are exposed extracellularly in SV5. Thus the orientation of the SH proteins 
appear to be analogous to the attachment proteins of these viruses and may play a 
similar role. Collins and Mottet (1993) suggest the SH protein to be involved in either 
entry of the viral nucleocapsid into the cell or in maturation of the virions.
1.6.4.2. Fusion CFT glycoprotein :
The fusion protein of paramyxoviruses is responsible for the fusion of 
viral and cell membranes during infection and also mediates fusion of the membrane of 
infected cells and adjacent cells allowing spread of the virus. The route chosen for 
nucleocapsid entry into the cell involves the fusion of viral and cell membranes at 
neutral pH in paramyxoviruses.
The F gene of PVM is 1657 nucleotides long encoding a polypeptide of 
537 amino acids with a predicted molecular weight of 59K (Chambers et al, 1992). 
This is somewhat larger than the 49K molecular weight observed in hybrid-arrest 
experiments (Chambers et al, 1990a). The gene possesses nine non-coding nucleotides 
at the 5' end of the F gene with synthesis of the F protein starting at the first AUG and 
has a 3' non-coding region of 37 nucleotides (Chambers et al, 1992). The protein 
shares a 40% amino acid homology overall with its counterparts in HRSV and TRTV 
but only a 10% overall homology with the F proteins of NDV, SV5 or Sendai virus. 
The F proteins of HRSV have a high degree of conservation at the amino acid level 
not only between members of the same strain but also between members of subgroups
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\A and B, implying a low level of tolerance to changes within the F protein of these 
viruses (Collins et al, 1984, Elango et al, 1985, Baybutt and Pringle, 1987, Johnson 
and Collins, 1988).
The PVM and HRSV F proteins, like all other Paramyxovirus F 
proteins is synthesised as full length inactive precursor (F0) which is cleaved during 
maturation by host cell proteases, into a functional protein consisting o f disulphide- 
bond linked Fj and F2 subunits. The putative cleavage site for PVM F protein lies 
between amino acids 101 (Arg) and 102 (Phe). The F2 subunit is 101 amino acids long 
whilst the Fj fragment is 436 residues long. As is the case with the Fq polypeptides of 
other paramyxoviruses, the F0 polypeptide of PVM possesses a short N-terminal 
hydrophobic region that may act as the signal peptide which is subsequently cleaved 
during maturation, a C-terminal hydrophobic region thought to act as the 
transmembrane region and a fusion related hydrophobic region located at the N 
terminus of the Fj subunit (Chambers et al, 1992). However F proteins of 
pneumoviruses are unusual in that their F2 subunits have two cysteine residues 
whereas those of morbilliviruses and paramyxoviruses only have one. It is possible that 
both of these cysteines could be involved in disulphide bond formation with the FI 
subunit. The significance of this upon the fusion function o f the F protein is unknown. 
Ling and Pringle (1989b) were able to detect the F0 and Fj polypeptides of PVM on 
reducing SDS-PAGE gels but failed to detect the F2 subunit possibly due to its small 
size and lack of glycosylation.
Although little homology is found between the F proteins of 
paramyxoviruses, Chambers et al (1992) have identified several structural features 
common to these proteins (Fig. 1.3). All the F proteins of paramyxoviruses are type 1 
glycoproteins. The N-terminus of the F2 fragment is predicted to consist o f p-sheet or 
turn structures (F2b) which are separated from C-terminus helical region O^h) by a 
region containing the conserved cysteine residue. The N-terminus of the F j fragment is
38
In t r o d u c t io n
1 1
yINTRODUCTION
Fig. 1.3 : Conserved structural regions of Paramyxovirus fusion proteins.
Paramyxovirus fusion protein conserved structures identified and taken 
from Chambers et al (1992). Regions F2b and F2h correspond to the P-sheet and 
amphipathic a-helical regions of the F2 subunit respectively. The F |h  region 
corresponds to the amphipathic a-helical region whereas the Var and Cys-rich regions 
correspond to the P-sheet regions of the F \ subunit. H and Z regions correspond to the 
heptad repeat regions.
hydrophobic (fusion region) and thought to be involved in the fusion activity of the 
protein by localised disruption of the cell membrane during infection. The findings that 
synthetic peptides representing this region in Sendai virus inhibits cell fusion and virus 
penetration indicate this region is capable of interacting with lipid membranes 
(Richardson ei al, 1986, Richardson and Choppin, 1983). A stretch of heptad repeat 
sequence, designated H, with a high a-helix structure is located next to this fusion 
region. The heptad repeat sequence consists of amino acids that have small side chains 
and are either neutral or hydrophobic occupying positions a and d in an amino acid 
sequence periodicity of a, b, c, d, e, f  and g (Chambers et al, 1990c).
The H is followed by another hydrophobic region with a relatively low 
prediction for a-helix (Fih) adjacent to a variable, cysteine-rich region. The cysteine- 
rich region contains the conserved cysteine residues with a number of proline residues 
indicative of P-sheet structures for this region (Chambers et al, 1992). Located C- 
terminal of the cysteine-rich region is another hydrophobic heptad repeat sequence
/
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region, designated Z. This is analogous to the leucine zipper region of Paramyxovirus 
proteins identified by Buckland and Wild (1989). Finally, the extreme C-terminus of 
the F proteins contains a hydrophobic membrane spanning region followed by a small 
sequence that would be located cytoplasmically. Wathen et al (1989a) expressed the 
HRSV F protein lacking this C-terminus membrane anchor region from a baculovirus 
expression system and observed secretion of the protein into the cell medium. Also, 
expression of full-length F protein in insect cells resulted in limited cleavage of the 
protein implying lack of proteases in insects cells required for the correct processing of 
the proteins.
It has been demonstrated that changes at or around the cleavage site of 
the Fq polypeptides influence not only cell or organ tropism but also the pathogenicity 
of the virus. The molecular basis for these observations are discussed in detail in 
chapter 3. Horvath and Lamb (1992) created F protein mutants with the H region, 
identified by Chambers et a l (1992), of SV5. They determined that only those proteins 
transported to the cell surface showed fusion activity, as measured by the formation of 
syncytia. However, mutant F proteins in which the hydrophobicity o f the region was 
increased did not produce increased fusion activity. Wang et al (1992) utilised the 
ability of transfected wild type NDV F protein to complement mutant NDV viruses in 
plaque assays. Sequence analysis of these mutants revealed changes located within the 
amphipathic a-helix, region H, identified by Chambers et al (1990c). The changes 
were found to be in positions b, c or g of the heptad repeat sequence identified by 
Chambers et al (1990c). Furthermore these changes were found to disrupt the a- 
helical structure of the H region resulting in defective transport of the F 1-F2 protein to 
the cell surface. Anderson et al (1992) used recombinant vaccinia virus to express wild 
type full-length F protein and a mutant F protein of HRSV. The mutant F0 protein was 
not cleaved into the F1 and F2 fragments. Nucleotide sequence analysis o f the mutant F 
protein revealed four amino acids changes compared to the wild type full-length F
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protein. Two of the changes were located within the F2 fragment whereas the 
remaining two were located within the variable region of the Fj fragment. 
Recombinant vaccinia virus expressing chimeric F proteins in which the mutant and 
wild type F2 and Fi regions were interchanged determined changes within the Fi 
fragment to be responsible for abolition of F0 cleavage. Expression of chimeric F 
proteins in which one or the other amino acid identified to be responsible for abolition 
of F0 cleavage in the mutant F protein, showed a decrease, but not abolition, in the 
susceptibility to cleavage of the F0 polypeptide (Anderson et al, 1992). These results 
demonstrate the influence of amino acid changes located away from the cleavage site 
and suggest a conformational change in which the cleavage site is inaccessible to host 
cell proteases during maturation when both amino acid changes are present. However, 
reversion of just one of these amino acid changes results in limited access to the 
cleavage site.
From these analyses it is clear that several distinct regions o f the 
Paramyxovirus fusion protein are essential for the full functioning of the protein and 
that alteration to one or more of these regions can have profound effects on activity. 
This may be the reason for the apparent lack of sequence variation in fusion proteins of 
different HRSV strains and the conserved structural features described above.
1.6.4.3, Attachment(G) glycoprotein :
The characteristics of the attachment glycoproteins was responsible for 
the initial classification of Paramyxoviruses into three genera. It is believed the 
haemagglutinin and neuraminidase activities of these viruses may have resulted from 
the linking of the HA and NA genes of an influenza-like ancestral virus (Blumberg et 
al, 1985, Morrison and Portner, 1991). Although there is little homology between the 
Paramyxovirus attachment proteins, they all belong to the class 2 group of 
glycoproteins. Characteristically, these proteins have a hydrophobic region at the N-
/'
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terminus which functions as the transmembrane region. No large hydrophobic regions 
are found at the C terminus that would be capable of acting as the membrane anchor. 
This N-terminal hydrophobic region is also thought to contain the signal sequence that 
is recognised by the signal recognition particle (SRP). Thus, in contrast to the fusion 
glycoproteins, the C terminus of the attachment glycoproteins is located extracellularly 
with the N terminus located intracellularly. Antigenic studies with anti-G protein 
monoclonal antibodies have shown the existence of two major subgroups (A and B) of 
HRSV based on differences in antigenicity (Mufson et al, 1985; Anderson et al, 1985).
The G protein of HRSV is unusual in that it is considerably smaller than 
its counterparts in paramyxoviruses and morbilliviruses. Whilst those of Sendai virus, 
SV5, NDV, measles virus, mumps virus and PIV3 are 576 (Blumberg et al, 1985), 565 
(Hiebert et al, 1985), 577 (Millar et al, 1986, Jorgensen et al, 1987), 617 (Alkhatib 
and Breidis, 1986), 582 (Waxham et al, 1988) and 572 (Elango et al, 1986a) amino 
acids long, respectively, those of HRSV strains are either 298 or 292 amino acids long 
depending upon the subgroup (Wertz et al, 1985, Satake et al, 1985, Johnson et al, 
1987b, Sullender et al, 1990, 1991, Sullender and Wertz, 1991). The G gene of PVM 
strain 15 is 1330 nucleotides long and encodes a polypeptide of 363 amino acids with a 
predicted molecular weight of 39,836. The major polypeptide, like that for HRSV G 
proteins, is transcribed from the second and not the first initiation codon. The 
haemagglutination activity of PVM resides on the G protein since a MAb that inhibited 
haemagglutination bound to the PVM G protein (Ling and Pringle, 1989b). The larger 
size of the PVM G protein when compared to that of HRSV could be a result of the 
acquisition of the region responsible for haemagglutination. The G protein of PVM is 
of similar length to the 391 residue attachment protein o f TRTV. However, unlike 
PVM and HRSV this protein is transcribed from the first available initiation codon. 
Since the gene order of TRTV is different to that of HRSV and PVM where the G 
gene is located further downstream than in HRSV and PVM it is possible that the first
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initiation codons in the G genes of HRS V and PVM are involved in down-regulation 
o f G gene expression since most of the ribosomes would initiate translation from the 
first available AUG (Kozak 1986). In TRTV the requirement for such a down­
regulating AUG is probably not required since the position of the G gene in TRTV is 
located further downstream than in PVM and HRSV and since genes are transcribed in 
a decreasing amount the further downstream they are located, expression of the G 
gene would already have been down-regulated. Since the pneumovirus attachment 
proteins are considerably smaller than those o f paramyxoviruses and morbilliviruses 
and lack any sequence or structural homology it would be prudent to infer data for the 
PVM G protein from that available for the HRSV G protein.
Levine et al (1987) used two rabbit anti-G monospecific antisera to 
demonstrate the G protein of HRSV to be the attachment protein. One o f the antisera 
was raised against purified G protein and the other against recombinant vaccinia virus 
expressing the HRSV G protein. Both antisera inhibited attachment of the virus to 
HeLa cells in vitro. Accordingly, it is thought the G protein of PVM serves a similar 
function. Ling and Pringle (1989b) demonstrated that the G protein of PVM was both 
N- and O-link glycosylated. In immunoprécipitation studies four G-related 
polypeptides in PVM infected cells were identified. Two were glycosylated forms with 
molecular weights of 76.4K and 62.OK. Appearance of the 76.4K glycosylated form 
preceded the appearance of the 62.OK form by 300 mins in pulse chase experiments. 
The appearance of the 62 .OK form coincided with a reduction in intensity of the 76.4K 
form, suggesting that the 62.OK glycoprotein was derived form the 76.4K protein. 
Polypeptide synthesis in the presence of tunicamycin or digestion of the 76.4K and 
62.OK proteins with glycopeptidase F, which removes N-linked carbohydrates, resulted 
in the reduction of observed molecular weight to 58.4K and 48.2K respectively, thus 
demonstrating the presence o f N-linked sugars. The two forms of proteins synthesised 
in the presence of tunicamycin appeared to be processed normally, indicating that N-
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linked sugars were not required for the correct processing of the G protein. However, 
digestion of either the 76.4K, 62.OK, 58.4K or 48.2K proteins with a mixture of endo- 
a-N-acetlygalactosaminidase and other exoglycosidases considerably reduced the 
observed molecular weights, demonstrating extensive O-linked glycosylation. The 
unglycosylated form of the 76.4K and 62.OK proteins were determined to be 39.6K 
and 37.2-44 8K respectively. Approximately 60% of the apparent 84,000-90,000 
molecular weight of the mature HRSV G protein is contributed by carbohydrate, the 
majority of which is O-linked since the G protein is glycosylated in the presence of 
tunicamycin, an inhibitor of N-linked glycosylation. This is consistent with the high 
proportion of serine and threonine residues, the sites for O-linked glycosylation, 
representing 30% of the total amino acid content of the PVM and HRSV virus G 
proteins (Wertz et al, 1985, 1989, Fernie et al, 1985, this thesis). The G protein of 
TRTV also has a high serine, proline and threonine content of 10%, 14% and 7% 
respectively, though the level of glycosylation has not been established (Ling et al, 
1992).
Collins (1990) demonstrated that the extracellular domain of HRSV G 
protein contains all the information necessary for correct O-glycosylation processing. 
Chimaeric proteins in which the cytoplasmic tail and transmembrane regions were 
swapped between the HRSV G and NDV HN proteins were constructed. The 
chimaeric protein containing the C terminus of the G protein linked to the cytoplasmic 
tail and transmembrane regions of the HN protein were O-glycosylated normally. 
Previously, Olmsted et al (1989) had demonstrated C terminal truncations of the G 
protein to be O-glycosylated. SV40 recombinant viruses expressing either 71, 180 or 
230 o f the N terminal amino acids were found to be O-glycosylated. Furthermore, 
addition of a 13 amino acid peptide to the C termini of these truncated proteins helped 
confirm the surface location of these proteins. Expression of these 'chimaeric' proteins 
from recombinant vaccinia virus followed by immunofluorescence analysis with
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\antisera raised against the 13 amino acid peptide confirmed the surface location of 
these proteins, although detection of the 71 N terminus protein was faint. These 
truncated mutants had previously been used by Vijaya et al (1988) to demonstrate the 
N terminus hydrophobic region to be the transmembrane region. A reporter peptide 
consisting of repeats of an immunodominant epitope of the circumsporozoite protein 
of Plasmodium falciporum was linked to the C termini of these truncated proteins and 
used to make recombinant vaccinia virus. A MAb directed against this reporter peptide 
was used to show cell surface expression of these proteins by immunofluorescence. 
However no surface expression of the hybrid protein containing the 71 N terminus of 
HRSV G protein was observed. Lichtenstein et al (1991) have demonstrated this 
hydrophobic region to be the transmembrane region of HRSV. They further 
demonstrated that this hydrophobic domain consisted of two smaller hydrophobic 
regions in which only the second hydrophobic region was required for membrane 
insertion. The first hydrophobic region was found to be non-essential although the 
possibility of it acting as a transmembrane signal could not be ruled out. Further 
analysis by Olmsted et al (1989) evaluated the immune response of cotton rats to these 
truncated proteins. Only inoculation with the 230 amino acids truncated protein was 
capable of inducing an immune response as measured by serum antibody titres and 
response to HRSV challenge of immunise cotton rats.
Wertz et al (1989) expressed the HRSV G protein in a mutant Chinese 
hamster ovary (CHO) cell line defective in O-glycosylation which was reversible by the 
addition of galactose and N-acetylgalactosamine (NAG) to the medium. Infection of 
this cell line with recombinant vaccinia virus expressing the HRSV G protein and 
varying the composition of the serum free medium with respects to the sugar content 
enabled the analysis of O-glycosylation of the G protein. In the absence of any sugar 
and in the presence of tunicamycin only the unglycosylated form (36 kDa) of the 
protein was observed. In the absence of tunicamycin a protein of 45 kDa representing
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*only N-glycosylated G protein was observed. The sugars attached to this protein were 
found to be of the simple type. Addition of galactose to the serum free medium and the 
absence o f tunicamycin resulted in the production of heterodisperse bands greater than 
45 kDa representing maturation of the N-linked sugars to the complex form. In the 
presence o f tunicamycin, where all N glycosylation was inhibited, and NAG, but not 
galactose, O-glycosylated protein with a molecular weight between 67-68 kDa was 
observed. In the presence of both galactose and NAG but not tunicamycin the fully 
glycosylated G protein with a molecular weight between 88-90 kDa was observed. The 
data demonstrates extensive O-glycosylation of the G protein with some contribution 
by N-linked carbohydrates. Pulse chase experiments showed the 36 kDa 
unglycosylated form to undergo co-translational N-linked glycosylation which matured 
to the complex form and then the addition of O-linked carbohydrate. Furthermore 
surface expression of the G protein measured by indirect immunofluorescence and flow 
cytometry in the absence of either N- or O-glycosylation was observed. However, cell 
surface expression of the unglycosylated protein was severely reduced when N- and O- 
glycosylation were inhibited. These results have corroborated the work o f Collins and 
Mottet (1992) using three inhibitors to identify the glycosylation process of HRSV G 
protein. In the presence of tunicamycin and carbonylcyanide m-chlorophenylhydrazine 
(CCCP, an inhibitor of protein transport from the ER), or monensin, (an inhibitor of 
protein transit between the medial and trans Golgi complex) only the unglycosylated 
form of the G protein was observed. However, in the presence of tunicamycin and 
Brefeldin A, (an inhibitor of vesicular transport from the endoplasmic reticulum (ER) 
which causes disintegration of the medial Golgi complex into either the ER or a ER- 
Golgi intermediary), the G protein accumulated as a smear with a molecular weight of 
68K. Further analysis confirmed this species to be O-glycosylated since it was sensitive 
to digestion with endo H. Furthermore, this species was not capable o f maturing to the 
complex form since sialic acid residues had been added to the protein. Since such
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\residues are not normally associated with the G protein, their presence in the species 
identified above could be a consequence of the action of Brefeldin A upon the Golgi 
complex (Collins and Mottet, 1992). These results suggest the addition of O-linked 
carbohydrate occurs within the trans Golgi compartment with maturation of the 
carbohydrate occurring in a subsequent compartment. These results support the work 
of Lambert (1988) who first demonstrated sensitivity o f HRS V G protein to digestion 
with endo-P-N-acetylgalactosaminidase, O, N or F glycanase. The first two remove O- 
linked glycans whilst the second two remove N-linked glycans.
Palomo et al (1991) investigated the contribution o f the G protein 
carbohydrate content towards immunity. Of a panel of 18 MAb's raised against the 
HRS V G protein in B ALB/C mice inoculated with the Long strain o f HRSV (Garcia- 
Barreno et al, 1989), 5 reacted with the unglycosylated form whereas the majority only 
recognised O-glycosylated G protein that lacked N-glycosylation. Martin-Gallardo et 
al (1993) expressed and purified the unglycosylated HRSV G protein in Salmonella 
typhimurium. Following immunisation o f cotton rats with this protein, antisera was 
shown to contain antibodies that neutralised HRSV in vitro. These results suggest a 
crucial role for carbohydrates for evasion of host immune responses. In the same study 
by Palomo et al (1991) human antisera known to react with the G protein failed to 
prevent binding of these MAb's to the G protein in competitive ELISA experiments. 
Garcia-Barreno et al (1990) characterised at the molecular level changes within the G 
protein responsible for generation of HRSV escape mutants against neutralising anti-G 
MAb (63G; Garcia-Barreno et al, 1989). Following a first round of plaque purification 
isolates were found to contain heterogeneous populations of escape mutants. 
Following a second round of plaque purification the escape mutants were found to be 
homogenous. They suggest that following the second round of plaque purification only 
those that were best adapted survived. Most escape mutants had arisen because of 
frame shift mutations in which insertion or deletion of A residues altered the coding
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region of a third of the C terminus of the G protein. These mutants had a truncation of 
25 amino acids at their C terminus. However, one of the mutants had a deletion of a 
single A residue at position 623 and an insertion of a single A residue at position 648 
of the G gene. This resulted in a change of seven amino acids between positions 205 to 
211 of the amino acid sequence. Binding of the 63G MAb to synthetic peptides from 
around this region found amino acids 204 to 209 to be crucial in recognition by the 
MAb (Garcia-Barreno et al, 1992). The authors suggest this domain to be involved in 
receptor binding since it is located near the four conserved cysteine residues, which 
had been identified by Johnson et al (1987b) as important, and that binding o f the 
MAb 63G interferes with binding of the G protein to the cell surface. These results are 
made even more significant by the findings of Sullender et al (1991) who demonstrated 
frame shifting to occur in naturally occurring isolates of HRSV subgroup B. Rueda et 
al (1991) generated HRSV escape mutants against five anti-G MAb's. Sequence 
analysis of these escape mutants revealed the presence o f in-frame premature stop 
codons that shortened the G protein by 11 to 42 amino acids. However, two o f the 
mutants had amino acid substitutions instead of premature stop codons. Sullender et al 
(1991) and Cane et al (1991) have identified naturally occurring isolates o f HRSV that 
show extensive genetic diversity in their G proteins. Amino-acid homology within the 
ectodomain region of the G protein varied between 80%-99% identity between 
subgroup A viruses (Cane et al, 1991) and 88%-97% identity between subgroup B 
viruses (Sullender et al, 1991). However there is only a 53% identity between the A 
and B subgroup viruses (Johnson et al, 1987b). Thus the mechanisms of amino acid 
substitutions and frame shifting confirms the capacity of the G protein to evolve in 
response to immunological selection pressures (Sullender et al, 1991). The potential 
effects on virus pathogenicity of these alterations is not known.
Although Ling and Pringle (1989b) identified two forms of the PVM G 
protein, both were found to be virion associated. Two forms of the HRSV G protein
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\have also been observed - one associated with the virion and also a soluble form (Gj) 
secreted into the medium. Hendricks el al (1988) characterised the soluble form of the 
HRSV G protein and have shown that it lacks the first 65 or 74 amino acids covering 
the transmembrane region. However, Roberts et al (1993) have recently described the 
soluble form of the G protein to be a result of translation from an initiation codon 
located within (or just beyond) the transmembrane coding region of the HRSV G 
protein at residue 48, the product of which is subsequently proteolytically cleaved at 
the N-terminus. Similar result have been observed for the VSV and rabies virus G 
protein. Chen and Huang (1986) showed the G protein of a ts mutant of VSV to have 
a mutant G protein that was unstable at the higher temperature, thus allowing access to 
proteolytic enzymes. The secreted form of the rabies virus G protein was shown to 
lack the C-terminal membrane anchoring region as a result o f proteolytic cleavage 
during intracellular processing (Morimoto et al, 1993).
It is not known if there is an interaction between the HRSV G and M 
proteins during viral maturation although Nagy et al (1991) have demonstrated the HN 
protein of NDV to play a role in production of viral envelopes. Expression of the NDV 
HN protein from recombinant baculovirus resulted in the formation of enveloped 
particles that were indistinguishable from those in NDV infected cells. They could not 
rule out the possibility of a baculovirus protein substituting for the NDV M protein 
even though no baculovirus nucleocapsids were observed within these particles. 
However, this result does suggest a role for the NDV HN protein in assembly and 
maturation of the virus particle.
T6.4.4. HRSV GLYCOPROTEINS AND SERUM ANTIBODY RESPONSES :
Taylor et al (1984) demonstrated the importance of the F and G 
proteins in eliciting neutralising antibodies. The N and P proteins were found to be 
poor antigens. These results were corroborated the findings of Connors et a l (1991)
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who showed that immunisation of mice with recombinant vaccinia virus expressing the 
P, M, SH, 1C or IB proteins failed to confer protection following HRSV challenge. 
Protection against virus challenge was found to significantly decrease in a short period 
of time following immunisation with recombinant vaccinia virus expressing the N or 
M2 (22K) protein. However, recombinant vaccinia virus expressing the F or G protein 
conferred protection against subsequent HRSV challenge. Routledge et a l (1988) also 
demonstrated antibody response following immunisation with purified P, M2 (22K), F 
or G proteins. Only immunisation with the F and G proteins induced production of 
neutralising antibodies and conferred protection to subsequent HRSV virus challenge. 
Stott et a l (1987) used recombinant vaccinia virus expressing the F, G ,N or IB 
proteins to investigate the contribution towards immunity of individual proteins. 
Immunisation of cotton rats with recombinant vaccinia virus expressing the F or G 
proteins conferred protection to subsequent live virus challenge. However, the 
protection conferred by immunisation with the F protein was heterologous whereas 
that by the G protein was homologous. No protection was conferred following 
immunisation with either the N or IB proteins. Interestingly, histopathology of the 
lungs of cotton rats vaccinated with the recombinant vaccinia virus expressing the F, G 
or N proteins revealed the presence of lesions within the lungs prior to challenge with 
HRSV. No such lesions were observed following vaccination with the recombinant 
vaccinia virus expressing the IB protein. The authors suggest a correlation between 
these lesions and protection conferred by the various proteins. Similar results 
demonstrating protection against subsequent virus challenge in cotton rats or mice 
were observed using either vaccinia virus recombinants expressing the HRSV virus F 
protein (Wertz et al, 1987, Johnson et al, 1987a), G protein (Olmsted et al, 1986; 
Elango et al, 1986b; Stott et al, 1986, Johnson et al, 1987a) or affinity 
chromatography purified F or G protein (Walsh eta l, 1987).
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Garda-Barreno el al (1989) selected escape mutants to an anti-F MAb 
(47F). These mutants were shown to bind to other anti-F MAb's that bound to a 
separate antigenic site. They were able to identify four distinct antigenic sites 
recognised by these MAb's. On the other hand, escape mutants raised against anti-G 
MAb (63G, described above) failed to react with other anti-G MAb's indicating the 
existence of structurally overlapping epitopes for the G protein. Wathen et a l (1989b) 
expressed a chimaeric protein, termed FG, containing the signal and extracellular 
regions o f the HRSV F protein (amino acids 1 to 489) followed by the extracellular 
domain o f the HRSV subgroup A G protein (amino acids 97 to 279) from a 
recombinant baculovirus. This protein was secreted into the medium when expressed 
in insect cells in vitro since the chimaeric protein lacked the transmembrane regions of 
either the HRSV F or G proteins. Immunisation of cotton rats with a crude preparation 
o f this chimaeric protein followed by HRSV challenge demonstrated the induction of 
neutralising antibodies to this protein (Brideau et al, 1989). However the FG chimaeric 
protein conferred greater protection against infection against subgroup A virus than 
that conferred by immunisation with a baculovirus secreted form of the F protein. 
Protection following immunisation with the FG protein was similar to that conferred 
by the secreted F protein when challenged with a subgroup B virus. These results 
suggest the G protein contributes significantly towards immunity. These results also 
highlight the difficulty in generating a vaccine against HRSV. Although the F proteins 
o f the two subgroups of HRSV are fairly well conserved (Collins et al, 1984, Elango 
et al, 1985, Baybutt and Pringle, 1987, Johnson and Collins, 1988), there are 
significant differences between the G protein of not only both subgroups but also 
between isolates within the same subgroup (Anderson et al, 1985, Akerlind et al, 
1988, Cane et al, 1991, Garcia-Barreno et al, 1989, Sullender et al, 1991).
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1.7. Aims of the project  :
Studies of the proteins of HRSV have confirmed the importance of the 
two major glycoproteins in eliciting an immune response in cotton rats and mice. There 
is considerable evidence, presented above, demonstrating the ability of the F protein to 
provide heterologous protection against HRSV infection in experimental animals. 
However since neutralising antibodies against the F protein have been observed in 
human sera, the question arises as to how HRSV can re-infect individuals. The diverse 
variation of the HRSV G protein at the genetic level and the role of glycosylation in 
evading the immune response suggest a crucial role for the G protein in re-infection 
Sequence analysis of PVM genes has demonstrated the similarity to the HRSV genes 
PVM offers the opportunity to study a Pneumovirus infection in its natural host, the 
mouse. Two strains of PVM were available, one that is highly pathogenic when 
inoculated in mice and the other a non-pathogenic strain. The aim of this project was 
to investigate the molecular basis for the differing pathogenicity with respect to the 
two major viral glycoproteins by determining the nucleotide sequence of the virus 
genes. Any differences observed between the two strains may give an insight into the 
molecular basis of Pneumovirus pathogenicity as well as providing comparative 
information about the genetic structure of pneumoviruses and their relationship to 
other paramyxoviruses.
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M A TE R IA LS  A N D  M ETH O D S
2.1. Solutions and buffers :
TE (pH 8.0) : lOmM Tris-HCl (pH 8.0), O.lmM EDTA.
TNE (pH 8.0): lOmM Tris-HCl (pH 8.0), lOOmM NaCl, ImM EDTA.
PBS (pH 7.4): 136mMNaCl, 2.7mM KC1, 1.3mMKH2P 0 4, 1 4mM Na2H P04.
20X SSC (pH 7.4): 3M NaCl, 300mM Tri-sodium citrate.
10X TAE (pH 8.0): 0.4 M Tris-acetate (pH 7.6), 10 mM Na2 EDTA (pH 8.0)
10X TBE (pH 8.0): 0.89M Tris-HCl (pH 8.0 ), 0.89M Boric Acid, 20mM EDTA (pH
8.0).
6 X Tracking buffer : 0.25% (w/v) bromophenol blue, 30% (v/v) glycerol.
3X Boiling mix : 15% (v/v) 2-mercaptoethanol, 6% (w/v) SDS, lOOmM Tris (pH 6.7), 
30% (v/v) glycerol. Bromophenol blue was added till a dark blue colour was obtained.
Phenol : Distilled phenol was melted at 65°C and equilibrated with several changes of 
equal volumes of TNE.
Phenol/Chloroform : Consisted of a mixture containing equal volumes of phenol and 
chloroform.
2.2. Cells :
2.2.1. Bacterial cells used in cloning experiments :
E. coli strain TG2 was the chosen strain for all cloning work except 
when plasmids carrying tetracycline resistance were used in which case the host was E. 
coli strain HB101. The genotype of both strains is shown below :
E. coli TG2 : supE hsdA5 thiA(lac-proAB) A(srl-recA)306::Tnl0(Tetr)
E. coli HB 101 : supE44 hsdS20(rB" mB") recA13 ara-14 proA2 lacYl galK2 rpsL20 
xyl-5 mtl-1
5 4
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2.2.2. Mammalian Cells :
L929: Mouse connective tissue (fibroblast) cell-line used to transiently express
the G gene of PVM.
Cos-7: SV40 transformed African Green Monkey fibroblast cell-line used in
expression from SV40 based expression vector.
HeLa S3 : Human cell-line derived from epithelial carcinoma used in the
propagation of vaccinia virus.
BS-C-1: African Green Monkey kidney cells were used in the propagation of
PVM and titration o f both PVM and vaccinia virus.
HuTK" 143 : were used in the selection of recombinant Vaccinia virus.
2.3. M e d ia  :
2.3.1. Tissue Culture :
In all tissue culture work cells were grown and maintained in GMEM 
supplemented with non-essential amino acids, 0.2mM glutamine, 100 units/ml of 
penicillin, 100 pg/ml of streptomycin and FCS (Gibco-BRL or Applied Protein 
Products Ltd ). The final concentration of FCS depended on the cells and is indicated 
where appropriate.
2.3.2. Luria-Bertani (LB1 medium :
Medium contained the following ingredients per litre :
Tryptone 10 g
NaCl 5 g
Yeast extract 1 0 g
Medium was sterilised by autoclaving at 121°C for 20 mins. LB agar 
plates were made with the same ingredients but containing 1.5% (w/v) Bacto-agar and
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sterilised as above. Indicator plates for selection of recombinant clones also contained 
0.5mM X-Gal and ImM IPTG.
2.3.3. H-Top medium :
H-top medium was used in transformation of M13 and contained the 
following per litre :
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Tryptone 8 g
NaCl 5 g
Yeast extract 5 g
Bacto-agar 7.5 g
Sterilised by autoclaving for 20 mins at 121°C.
2.4. PREPARATION OF PLASMID DNA ;
2.4.1. Small scale plasmid preparation (mini preps):
The method used was a slightly modified version of that of Serghini et 
al (1989). A culture was grown overnight at 37°C with minimal shaking. 1.5 mis was 
centrifuged for 5 mins at 15,000g and the pellet resuspended in lOOpl of TNE buffer 
and lOOpl of phenol/chloroform followed by centrifugation for a further 5 mins at 
15,000g. The top, aqueous, layer was transferred to ffesh microcentrifuge tubes to 
which 3 5 pi of a 10M solution of ammonium acetate and 270pl of cold 100% ethanol 
had previously been added. The mixture was incubated at 4°C for 20 mins and the 
nucleic acids were pelleted by centrifugation for 10 mins at 15,000g. The supernatant 
was removed and traces o f ethanol removed by desiccation under vacuum. The pellet 
of nucleic acids was resuspended in either 30 or 40pl of distilled water since the yields 
of plasmid DNA obtained were dependent upon plasmid copy number. Aliquots of 
lOpl were used in restriction enzyme analysis in the presence of 5 pg of RNase A.
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2.4.2. Medium scale plasmid preparation (maxi preps):
Plasmid DNA was prepared using the alkali lysis method of Bimboim 
and Doly (1979). Unless otherwise stated all steps were carried out at 4°C. Bacteria 
from a 50 ml overnight grown culture were pelleted for 10 mins at 2,000g. The cell 
pellet was resuspended in 3 mis of solution I (50mM glucose, lOmM EDTA (pH 8.0) 
and 25mM Tris-HCl (pH 8.0) solution containing lysozyme at a final concentration of 
5 mg/ml). After a 10 min interval 6  mis of solution II (1% (w/v) SDS and 0.2M 
NaOH). was added. The solutions were mixed by inversion and placed on ice for 10 
mins. 4.5 mis of cold 5M potassium acetate (pH 4.8) was added, mixed by inversion 
and kept on ice for a further 10 mins before centrifugation for 15 mins at 2,000g. The 
supernatant was removed and mixed with an equal volume of buffered phenol and the 
two immiscible phases separated by centrifugation for 15 mins at 2,000g. The top, 
aqueous, layer was removed and mixed with an equal volume of CHCI3 and the two 
immiscible phases separated by centrifugation as before. The aqueous layer was 
transferred to fresh tubes and 1/10 volume of a 3M sodium acetate solution (pH 5.5) 
and 2.5 volumes of cold 100% ethanol added. The mixture was placed on dry ice for 
15 mins and the nucleic acids precipitated by centrifugation for 30 mins at 2,000g. The 
supernatant was removed and the nucleic acids pellet washed with 5 mis of cold 70% 
ethanol. DNA was recovered by centrifugation for 15 mins at 2,000g. Traces of 
ethanol were removed by desiccation under vacuum. The nucleic acids were 
resuspended in 250pl of distilled H2O.
2.4.3. Large scale plasmid preparation :
The method used is a modified version of the maxi-prep protocol 
described above. Unless otherwise stated all steps were carried out at 4°C. Briefly, 
cells from a 500 ml overnight culture were centrifuged at 4,000g for 45 mins, 
resuspended in 8 mis of solution I and incubated at room temperature for 5 mins.
< 1 
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10 mis of solution II was added, mixed by inversion and the mixture placed on ice for 
10 mins. 12 mis of cold 5M potassium acetate (pH 4.8) were added , mixed by 
inversion and placed on ice for a further 10 mins and centrifugated for 30 mins at 
30,000g. The cleared supernatant was removed and mixed with an equal volume of a 
phenol/chloroform solution and the two immiscible phases separated by centrifugation 
for 30 mins at 2,000. The aqueous layer was transferred to fresh tubes, 0.6 volumes of 
isopropanol added and the mixture left at room temperature for 15 mins. DNA was 
recovered by centrifugation for 30 mins at 2,000g. The alcohol layer was removed and 
the nucleic acid pellet desiccated under vacuum. The pellet was resuspended in 1.5 mis 
distilled water and RNase added (lpg/ml final concentration) with incubation at 37°C 
for 30 mins.
2.4.4. Preparation of M13 single stranded DNA :
5 mis of LB medium inoculated with a single M13 plaque were grown 
overnight at 37°C with minimal shaking. 1.5 mis of M13 infected E. coli cells were 
centrifuged at 15,000g for 5 mins. 1.2 mis of the supernatant was transferred to fresh 
tubes to which 250pl of a PEG (33.3mM Polyethylene glycol 6000 (PEG), 2.5M 
NaCl) solution had been added, mixed by flicking and incubated at room temperature 
for 15 mins or overnight at 4°C. Precipitated M l3 was pelleted by centrifugation at 
15,000g for 4 mins and the supernatant discarded. Any remaining supernatant was 
removed after a further centrifugation for 10 seconds at 15,000g. Pelleted M13 was 
then resuspended in 120pl o f Tris-HCl (pH 8.0) and mixed with 50pl o f buffered 
phenol. The two immiscible phases were the separated by centrifugation at 15,000g for 
5 mins. lOOpl o f  the top aqueous layer were mixed with 50pl of CHCI3 and the two 
phases separated as before. 80pl of the aqueous layer was transferred to fresh 
microcentrifuge tubes to which lOpl of 3M sodium acetate and 250pl of cold 100% 
ethanol had been added. The mixture was placed on dry ice for 10 mins and the single- 
stranded DNA pelleted by centrifugation at 15,000g for 10 mins.
1 I 
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2.4.5. CsCl Gradient DNA purification :
DNA prepared using the large scale plasmid prep was diluted to a final 
volume of 3.8 mis with distilled water and 4.2 g of CsCl and 50pl of a 10 mg/ml 
solution of ethidium bromide were added. The mixture was transferred to Beckman 
heat seal tubes (5 ml) and topped up with a solution of 3.8 ml water, 4.2 g CsCl and 
50pl of 10 mg/ml solution of ethidium bromide. The tubes were sealed and centrifuged 
for at least 18 hours at 45,000 rpm at 20°C in a Beckman VTÌ65 rotor.
The visible band of DNA was excised from the CsCl gradient by side 
puncture and the ethidium bromide removed by extraction 6  times with equal volumes 
o f amyl alcohol. Plasmid DNA was dialysed overnight against at least 3 changes of 
5 litres of a 0.1X SSC in order to remove the CsCl. The DNA was precipitated by 
addition of 1/10 volume of 3M sodium acetate (pH 5.5) and 2.5 volumes o f 100% 
ethanol, stored at either -70°C for 4 hrs or overnight at -20°C and then centrifuged at 
2,000g at 4°C for 30 mins. Traces o f alcohol were removed by desiccation under 
vacuum and the total concentration of plasmid DNA estimated by optical density 
(O.D.) reading at 260 nm. 1 O.D. unit was estimated as 40 mg/ml of DNA.
2.5. T r a n s fo r m a t io n s  :
2.5.1. Transformation of E. coli :
2.5.1.1. Preparation of competent E. c o u .
The method used was based on that of Cohen et a l (1972). 70 mis of 
LB medium, inoculated with 1 ml of stationary phase E. coli were grown at 37°C with 
minimal shaking to an O.D. reading at 650 nm of approximately 0.4 and subsequently 
incubated on ice for at least 30 mins. 50 mis of culture was centrifuged at 2000g at 
4°C for 5 mins, resuspended in 25 mis o f a ice-cold solution of 0.1M M gS04 and 
pelleted once again at 2000g at 4°C for 5 mins. The bacteria were resuspended in
m * l 
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12.5 mis of an ice-cold solution of 0 .1M CaCl2 and incubated on ice for 1 hour before 
beginning the transformation procedure
2.5.1.2. Transformation of competent E. c o l i  with plasmid DNA :
DNA was added to an aliquot (lOOpl) of competent bacteria and 
incubated on ice for 30 mins, transferred to 42°C for 2 mins, replaced on ice for a 
further 5 mins and then left at room temperature for 5 mins. 1 ml of sterile LB medium 
was added and the mixture incubated at 37°C with minimal shaking for 40 mins. 
0.33 ml aliquots were then plated onto LB agar plates containing the appropriate 
antibiotic selection and the plates incubated overnight at 37°C.
2.5.1.3. Transfection of competent cells with M 13 :
The protocol was similar to that described above except that after the 
42°C incubation, bacteria were kept on ice for 5 mins and then added to a mixture of 
3 mis of molten H-Top agar containing 75mM X-Gal, 150mM IPTG. 80pl of an 
E. coli culture that had been grown overnight, diluted 1/100 with LB medium and 
incubated at 37°C with minimal shaking for 1 hour was added immediately prior to 
plating out. The mixture was poured onto LB plates and the H-top allowed to set 
before overnight incubation at 37°C.
2.5.2. Transfection of mammalian cells :
2.5,2,1, Calcium phosphate co-precipitation :
DNA was introduced into mammalian cells using a modified protocol of 
Chen and Okayama (1987). Monolayer of cells were grown to 85-90% confluence in 
5 cm plates and maintained in GMEM supplemented with FCS (5% final 
concentration) at 37°C in a 5% C 0 2 atmosphere. 20 pg of CsCl gradient purified 
DNA was mixed with 250pl o f a BBS solution (pH 6.96) [50mM BES (N,N-bis (2- 
hydroxyethyl)-2-aminoethanesulfonic acid), 280mM NaCl, 1.5mM Na2H P 04]. 125pl
o f a 2M CaCI2 solution were added dropwise to the mixture whilst N 2 was gently
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bubbled through to ensure mixing. The resultant mixture was kept at room 
temperature for 20 to 30 mins and then added dropwise the monolayer of cells. The 
cells were maintained at 37°C, in an atmosphere of 3% CO2 for between 6  and 
8 hours, washed twice with 2 mis of sterile PBS and osmotically shocked with 2 mis of 
a 15% glycerol in PBS solution for 2 mins at room temperature. Cells were washed 
twice with PBS, once with GMEM supplemented with FCS to a final concentration of 
5% and then maintained in 4 mis of GMEM supplemented with FCS to a final 
concentration of 5% at 37°C in a 5% C 02 atmosphere. Transfected cells were 
harvested after a further 48 hours.
2.5.2 2. TransfectACE™ Reagent (Gibco-BRLI :
5 pg of plasmid DNA was diluted with lOOpI of Opti-MEM® (Gibco- 
BRL) reduced medium and added to 12pl of TransfectACE™ reagent (diluted in lOOpl 
Opti-MEM® reduced medium) in a polystyrene tube. The TransfectACE™ reagent- 
DNA complex was left at room temperature for 15 mins. Opti-MEM® reduced 
medium was added to a final volume of 1 ml and the total mixture added to cells that 
had been grown to 85-90% confluency at 37°C in 5% C 0 2. After a 6  hr incubation at 
37°C, 5% C 02, 1 ml o f GMEM supplemented with FCS at a final concentration of 
20% medium. Cells were incubated at 37°C, 5% C 0 2 for 48 hours before harvesting.
2.6. E n zy m e s  :
2.6.1. Restriction endonucleases :
DNA to be analysed by restriction endonuclease digestion was prepared 
either by the mini-, maxi- or large scale DNA preparation methods described above. 
All digests were carried out in the manufacturer’s recommended buffers in the presence 
of 1-2 units of enzyme and 0.1 mg/ml BSA. For DNA prepared by the mini- and maxi 
preparation methods, 100 pg/ml RNase A was also added. All digests were carried out
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at 37°C for between 2-6 hours. Restriction enzymes were supplied by either 
Amersham, Gibco-BRL or Pharmacia.
2.6.2. De-phosphorvlation of linearised vector DNA :
To minimise vector re-ligation the 5' terminal phosphate of linearised 
DNA was removed. 2-5 units of calf intestinal phosphatase (CIAP) was added during 
the last hour of restriction endonuclease digestion of vector DNA.
2.6.3. Klenow DNA polymerase :
ImM each of dATP, dTTP, dGTP, dCTP and 1-2 units of Klenow 
DNA polymerase were added to the restriction endonuclease digest reactions and 
incubated for 30 mins at 37°C in order to end-fill digested DNA.
2.6.4. T4 DNA polymerase :
T4 DNA polymerase possesses an equivalent 5'—>3' polymerase but 
more active 3—>5' exonuclease activity than the large fragment of E. coli DNA 
polymerase I (Klenow Fragment). In the presence of excess deoxynucleotides, the 
amount o f 3'—>5' exonuclease activity is reduced considerably when compared to 5'—>3' 
polymerase activity. Additionally the 3'—>5' exonuclease activity is only functional on 
ssDNA or on dsDNA with 3' overhangs but not on 5' overhangs (3' recess). Thus, T4 
DNA polymerase was chosen over DNA polymerase I (Klenow fragment) for blunting 
of 5' and 3' overhangs of dsDNA following digestion with restriction enzymes.
Restriction endonuclease treated DNA was first phenol/chloroform 
extracted and then ethanol precipitated as described in the mini- DNA preparation 
protocol. Linearised DNA was blunted in the presence of ImM each of dATP, dTTP, 
dGTP, dCTP, 33mM Tris-HCl (pH 7.5), 6 6 mM potassium acetate, lOmM magnesium 
acetate, 0.5mM DTT, 0.1 pg BSA and 1-2 units of T4 DNA polymerase and the 
reaction incubated at 37°C for 45 mins. Blunted DNA was then either purified from
LMP agarose gels or phenol/chloroform extracted and ethanol precipitated.
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2.6.5. T4 DNA Ligase :
Ligation of DNA fragments was carried out overnight at 16°C in the 
presence of 6 6 mM Tris-HCl (pH 7.6), 5mM MgCl2> 5mM DTT, 0.1 pg BSA, lmM 
hexaminecobalt chloride, lmM ATP, 0.5mM spermidine HC1 and 1-2 units T4 DNA 
ligase. Typically, the vector DNA to insert DNA ratio varied between 1:2 and 1:5 in a 
final reaction volume of 20-25pl. DNA fragments purified from LMP agarose gels 
were heated to 65°C for 10 mins and the ligation carried out in a final volume of 
between 60-100pl, where the final volume was in at least 3 fold excess of the volume 
of DNA fragment added.
2.6.6. Sequenase® sequencing reactions :
Sequencing reaction of ssDNA (M13 DNA) was performed using the 
Sequenase® (version 2.0) sequencing kit (U S. Biochemical Corporation). 7 pi of 
ssDNA (1 pg) was annealed to 1 pi primer (0.5 pmol) after the addition o f  2 pi 5X 
reaction buffer (200 mM Tris-HCl (pH 7.5), 100 mM MgCl2, 250 mM NaCl) by 
heating to 65°C for 2 mins and then allowed to cool to room temperature over a 
period of 30 mins. Primer extension reactions were performed at room temperature for 
4 mins after the addition of 1 pi 0.1M DTT, 2 pi labelling mix (7.5 pM each o f  dCTP, 
dGTP and dTTP: diluted 5 fold with distilled water), 0.5 pi a-35S dATP and 2 pi of 
Sequenase version 2.0 enzyme diluted 8 -fold in enzyme dilution buffer (lOmM Tris- 
HCl (pH 7.5), 5mM DTT, 0.5 mg/ml BSA). 3.5 pi aliquots were divided between four 
tubes containing 80 pM each of dCTP, dATP, dGTP, dTTP and 8 pM of ddCTP or 
ddATP or ddGTP or ddTTP. These termination reactions were carried out at 37-42°C 
for 4 mins. The reactions were stopped by the addition of 4 pi of stop solution (95% 
formamide, 20mM EDTA, 0.05% (w/v) bromophenol blue and 0.05% xylene cyanol 
FF). The sequence reactions were electrophoresed as described in section 2.7.1.4.
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2.6.7. Exonuclease Bal31 :
Exonuclease Bal31 possesses a 5'—>3' single stranded endonuclease and 
a 3'—>5' exonuclease activity. Its was therefore used to create sequential deletions from 
the ends of linearised dsDNA fragments. Typically, the reaction was carried out in the 
presence of 0.6 M NaCl, 12mM CAC12, 12mM MgCl2, 20mM Tris-HCl (pH 8.0), 
0.2mM EDTA (pH 8.0) and 1-2 units of Ba/31 at 30°C. Aliquots were taken out at 
various intervals and the reaction was stopped by addition of EDTA to a final 
concentration of 3mM. Since the 3'—>5' exonuclease activity is greater than the 5'—>3' 
endonuclease activity the ends of Bal31 treated DNA fragments possess a 5' overhang. 
Thus, all Bal31 digested fragments were phenol/chloroform extracted, ethanol 
precipitated followed by end-blunting of the fragments with T4 DNA polymerase as 
described.
2.6.8. Isolation of PVM infected mRNA :
BS-C-1 cells were infected at a multiplicity of infection of 1 and the 
inoculum replaced with GMEM supplemented with FCS to a final concentration of 
2%. The cells were incubated at 37°C for 24 hours and the medium replaced with 
GMEM containing FCS (2% final concentration) and actinomycin D (2.5 pg/ml) and 
incubated at 37°C for 48 hours. PVM infected cells were harvested and pelleted at 
4000 g for 5 mins at 4°C. The RNA extraction was carried out using a method based 
on that of Kumar and Lindberg (1972). Pelleted cells were resuspended in isotonic 
lysis buffer (150 mM NaCl, 1.5 mM Mg2Cl, 10 mM Tris (pH 7.8), 0.65% NP40) and 
placed on ice for 10 mins. The cell debris was pelleted for 5 mins at 4000 g, 4°C and 
the supernatant extracted with 10 mis of extraction mix (containing equal volumes of 
phenol/chloroform (phenol was equilibrated with 150 mM NaCl, 1.0 mM EDTA, 10
t
mM Tris (pH 7.8)) and phenol extraction buffer (7.0 M urea, 350 mM NaCl, 10 mM 
EDTA, 1% SDS, 10 mM Tris (pH 7.8)) The aqueous phase was re-extracted twice 
with phenol\chloroform and RNA precipitated overnight at -20°C from the final
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aqueous phase following the addition of 2.5 volumes of ethanol. The precipitate was 
resuspended in water to a final concentration of 1 mg\ml.
2.6.9. AMV reverse transcriptase : cDNA synthesis from cellular RNA :
The first strand of cDNA was synthesised from cellular RNA of PVM- 
infected cells using avian myeloblastosis virus (AMV) reverse transcriptase (Life 
Sciences, Inc.). Reverse transcription was carried out in the presence of 0.5mM each 
of dATP, dCTP, dGTP, dTTP, 50mM Tris-HCl (pH 8.3), 6 mM MgCl2, 40mM KC1, 
3pg of poly d(T) (pdT; Pharmacia) and 10 units AMV reverse transcriptase. The 
reaction mixture was incubated at 42°C for 45 mins, phenol/chloroform extracted and 
ethanol precipitated. cDNA was resuspended in 30pl of distilled water. 3pi aliquots 
were used to amplify DNA fragments using the polymerase chain reaction.
2.6.10. In vitro transcription :
T7 RNA polymerase was used to synthesise RNA in vitro. 
Approximately 0.1-0.5 pg of linearised DNA was treated with 25 units of the 
appropriate RNA polymerase in the presence of ImM ATP, GTP, UTP, CTP, 4mM 
Tris-HCl (pH 8.0), 8 mM MgCl2, 2mM spermidine-(HCl)3, 25mM NaCl, 5mM DTT. 
The reaction was incubated at 30°C for 1-2 hours. In vitro transcribed RNA was 
phenol/chloroform extracted, ethanol precipitated and resuspended in 20-30pl of 
distilled water. Where necessary the RNA was stored at -20°C as an aqueous solution.
2.6.11. In vitro translation :
In vitro transcribed RNA was used to synthesise proteins in vitro using 
rabbit reticulocyte lysate (Amersham). The reaction involved incubation of lpl of in 
vitro transcribed RNA with 8 pl of rabbit reticulocyte lysate and 10 pCi 35S-methionine 
at 30°C for 1 hour.
Alternatively in vitro transcribed RNA was translated in the presence of 
wheat germ extract (gift from Dr. R. Wales, Dept. Biological Sciences, University of
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\Warwick). The reaction involved incubation of lui of in vitro transcribed RNA with 
10 pCi 35S-methionine, 3.4|il distilled water, 3 8 pl wheat germ extract, 2.4pl energy 
mix (15mM HEPES (pH 7.6), 2 mM ATP, 4mM creatine phosphate, 1.2 mM DTT, 
0.004 mM GTP, 0.004mM amino acids, 2.4 mM potassium acetate, 0.2 mg/ml creatine 
PK, 0.15 mM spermidine (pH 7.0)). The reaction was incubated for 1 hour at 27°C.
3X reducing boiling mix was added and the reaction electrophoresed on 
a polyacrylamide gel
2.6.12. Indirect immunofluorescence :
Transfected cells were scraped into the medium using a sterile rubber 
policeman and pelleted for 10 mins at 2,000g. The supernatant was removed and the 
cells were resuspended in 0.5 to 1 ml of GMEM supplemented with FCS to a final 
concentration of 5%. Aliquots were transferred onto 8 -well slides and incubated 
overnight at 37°C.
Cells were washed twice with PBS (5 mins each) and permeabilised by 
immersion in cold acetone for 2 x 1 0  mins. Fixed cells were then either stored at -20°C 
or used straight away. Cells were washed three times with PBS and incubated PVM 
anti-G (19/1/C9) monoclonal antibody, diluted 1:100 in PBS, in a moist chamber at 
37°C for 1 hour. Cells were washed three times with PBS and then either incubated 
with 1:400 dilutions o f goat anti-mouse FITC or biotinylated sheep anti-mouse 
antibody in PBS for 1 hour in a moist chamber at 37°C. Cells treated with the 
biotinylated goat anti-mouse antibody were then washed three times with PBS and 
incubated with 1:400 dilution of streptavidin-fluorosceine conjugate or streptavidin- 
Texas red in PBS in a moist chamber at 37°C for 20 mins. Finally, the cells were 
washed three times with PBS and mountant (Citifluor, Amersham or 80% glycerol in 
PBS) added
M A TE R IA LS  A N D M ETH O D S
6 6
1
M
H
\
Fluorescence or Texas-red treated cells were observed under a Zeiss 
UV microscope and photographs taken with a Kodak ektachrome 160 tungsten film.
2.7. G e l  e l e c t r o p h o r e s is  :
2,7.1. DNA Gels :
2.7.11. Agarose gels :
Restriction endonuclease digested DNA was visualised with UV 
illumination after electrophoresis on either a 1% (w/v) or 2 % (w/v) agarose gel 
depending upon the size of DNA fragments. Agarose was dissolved in TBE or TAE 
containing 0.05 pg/ml of ethidium bromide and cast in either a 6  x 8 , 8 x 10.5, 11.5 x 
14 or 20 x 25 cm horizontal tray. 6 X tracking dye buffer was added to samples and the 
gel electrophoresed at between 100 and 180 volts in the presence of TBE buffer 
containing 0.05 gg/ml ethidium bromide.
2.7.1.2. Low melting point agarose gels :
1% (w/v) low melting point agarose gels (LMP) were used to purify 
restriction endonuclease digests of fragments that were subsequently to be used in 
ligation reactions. Gels were cast and electrophoresed under the same conditions as 
ordinary agarose gels at a constant 90 volts. DNA fragments were excised from the 
gel, transferred to fresh Eppendorf tubes and then used in ligations
2.7.1.3. G ëNECLEAN™  DNA PURIFICATION :
DNA bands were purified from 1% TAE agarose gels using the 
GeneClean™ kit (Bio 101 Inc., La Jolla, California, USA) and purified following the 
manufacturer's instructions Briefly, excised DNA bands were heated to 55°C for 
5 mins following dilution with 3 volumes of Nal stock solution and mixed with 
Glassmilk® at a ratio of Igl of Glassmilk® for lpg  o f DNA excised. The 
DNA/Glassmilk mixture was incubated at room temperature for 5 mins, washed
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3 times with New Wash solution and the DNA eluted into water after incubation for 
3 mins at 55°C.
2.7.1.4. Sequencing Gels :
Sequencing reactions were electrophoresed on a 5.7% (w/v) 
acrylamide, 0.3% (w/v) bis-acrylamide containing TBE and 7M urea. Ammonium 
persulphate was added to a final concentration of 0.05% (w/v) and 55pl of TEMED 
was also added per 120 mis of mixture. A 31 x 38.5 cm gel was cast horizontally 
between two glass plates separated by a wedge spacer generating a gel ranging from 
0.4mm to 1.2mm in width. The gel was electrophoresed in TBE running buffer at a 
constant 80 watts. After electrophoresis the gel was fixed by soaking in 10% (v/v) 
acetic acid for at least 1 hour. Gels were dried on a Hoefer Scientific Instruments 
Drygel Sr gel dryer at 80°C for 2 hours and autoradiographed.
2.7.2. Protein gels :
2.7,2.1. Polyacrylamide gf.l electrophoresis (PAGE 1:
Protein samples to be analysed were electrophoresed on a 10% (w/v) 
polyacrylamide running gel with a 6% (w/v) stacking gel (Laemmli, 1970).
The 10% acrylamide running gel consisted of 9.67% (w/v) acrylamide, 
0.33% (w/v) bis-acrylamide, 0.4mM Tris-HCl (pH 8 .8 ), 3.5mM SDS, 4.4mM 
ammonium persulphate and 20pl of TEMED per 50 mis of gel. The mixture was cast 
between two glass plates and 2 mis o f butanol added to the top of the gel. The mixture 
was allowed to polymerise for not less than 2 hrs. The butanol layer was removed and 
the top of the running gel washed several times with distilled water and dried using 3M 
blotting paper. The 6 % (w/v) acrylamide stacking gel consisted o f  5.8% (w/v) 
acrylamide, 0.2% (w/v) bis-acrylamide, 0 .125mM Tris-HCl (pH 6 .8 ), 3.5mM SDS, 
0.9mM ammonium persulphate and 15pl of TEMED per 20 mis of gel. The stacker 
was cast on top of the running gel and the comb gently inserted.
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Polyacrylamide gel electrophoresis was carried out in the presence of a 
running buffer containing 0 .18M glycine, 25mM Tris, 3.5mM SDS. Samples were 
initially run into the stacker gel for 30 mins at 35 mAmps and then run overnight at 
between 8-10 mAmps.
Gels were soaked in a solution of 10% (v/v) acetic acid and 40% (v/v) 
methanol for at least 1 hour and dried on a Hoefer Scientific Instruments Drygel Sr gel 
dryer at 80°C for 2 hours prior autoradiography.
2.7.2.2. Fluorography of protein gels :
Gels were fixed in 40% (v/v) methanol, 10% (v/v) acetic acid, 5% (v/v) 
glycerol overnight followed by Amplify (Amersham, UK) for 30 mins and dried for
2 hours at 80°C. Gels were then exposed to pre-flashed Fuji X-ray film and kept at 
-70°C .
2.8. A m p l if ic a t io n  o f  DNA f r a g m e n t s  by t h e  p o l y m e r a s e  c h a in  
REACTION:
2.8.1. Amplification using Vent™ DNA Polymerase :
Amplification was achieved by 40 cycles of DNA denaturation at 94°C 
for 1.5 mins, oligonucleotide annealing at 55°C for 1.5 mins and extension at 74°C for 
between 2 to 5 mins depending upon size o f fragment to be amplified, in the presence 
of lOmM KC1, lOmM (NH4)2S04, 20mM Tris-HCl (pH 8.8), 2mM M gS04, 0.1% 
Triton X-100, 100 pg/ml BSA, 0.5mM each o f dATP, dTTP, dCTP, dGTP and 1 unit 
of Vent™ DNA polymerase (New England Biolabs, MA, USA).
2.8.2. Amplification using Tag™ DNA Polymerase :
Amplification by PCR was achieved by 40 cycles of; denaturation at 
95°C for 1.5 mins followed by oligonucleotide annealing and extension at 65°C for
3 mins. Amplification was performed in 3 pg/ml gelatin, 0.5mM each of dATP, dCTP,
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\dGTP, dTTP, 0.4mM DTT, 4mM MgCI2 , 30mM KCI, 50mM Tris-HCl (pH 8 3) and 
10 units/ml of Taq™ DNA polymerase (Amplitaq, Cetus).
2.9. T issu e  c u l t u r e  w o r k  :
2.9.1. Growth of cells :
Cells were grown in 25 cm tissue culture flasks and passaged at 4-5 day 
intervals. Cells were rinsed with a versene/trypsin mix and then with 0.25% (w/v) 
trypsin solution. A small amount was retained and the cells incubated at 37°C until all 
were detached. They were then resuspended in either GMEM supplemented with FCS 
to a final concentration of 5% or 10%, seeded at a ratio of 1:4 and maintained at 37°C.
Unless otherwise stated all cells were maintained at 37°C in a 5% C 0 2
atmosphere.
2.9.2. Pneumonia Virus of Mice fPV M l:
PVM strain 15 was originally obtained from the American Type Culture 
Collection (Ling and Pringle, 1989a). PVM strain J3666 was obtained from 
Dr. D. Harter of the Rockefeller Institute, New York. Both strains were propagated in 
BS-C-I cells.
2.9.2.1, Preparation of murine erythrocytes :
Mice were killed in a C 02 saturated environment. Blood was obtained 
from the thoracic cavity after opening the chest and cutting the aorta. Cells were 
washed twice with PBS and resuspended in 5 mis o f PBS and cell concentration was 
determined using a Neubauer haemocytometer.
2.9.2.2. Haemagglutination assay THAI:
¡Serial two-fold dilutions of PVM strain 15 and J3666 (in PBS) were 
prepared in 96-well round bottom plates in 100 pi. To each well, 3 x 104 mouse red 
blood cells were added to give a final volume o f  200pl. Plates were left at room
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temperature for 1-2 hrs and the HA titre determined from the lowest virus dilution in 
which no agglutination was observed.
2.9.2.3, Haemagglutination INHIBITION ASSAY fHI~> :
PVM anti-G monoclonal antibody (19/1/C9) was initially diluted 1 in 
10 and then serially diluted two-fold (in PBS) in 96-well round bottom plates. 5 HA 
units o f virus was added together with 3 x 104 mouse erythrocytes in a final volume of 
200 pi. Plates were left at room temperature for 1-2 hrs. HI titre was determined from 
the highest antibody dilution that inhibited haemagglutination.
2.9.2.4. T itration o f  PVM strains 15 a n dJ3666 :
BS-C-1 cells were grown to confluence as monolayers in either 6-well 
or 12-well tissue culture dishes. The medium was aspirated and 10-fold dilutions of 
PVM strain 15 or J3666 (in PBS) were added to separate wells. The cells were 
incubated for 2 hours at 33°C after which the inoculum was replaced with a 1% (w/v) 
agar overlay containing GMEM supplemented with FCS to a final concentration of 
2%. The agar overlay was allowed to set and the cells incubated at 33°C. When 
plaques were visible, 2% glutaraldehyde was added and the cells left for at least 5 
hours to overnight at room temperature. The agar overlay was removed carefully and 
the cells were stained with 0.075% (w/v) crystal violet solution (in PBS) for 10 mins. 
Excess stain was removed by rinsing each well under running tap water. The plates 
were allowed to dry and the plaques counted.
2-9,2.5. Radioactive labelling of virus infected cells :
BS-C-l cells were grown to confluence as monolayers in 6-well tissue 
culture dishes. The medium was aspirated and the cells washed once with sterile PBS. 
PVM strain 15 or strain J3666 was added to a multiplicity of infection of between 
1 and 2 pfu/cell and the cells incubated at 33°C for 2 hours. The inoculum was 
replaced with GMEM supplemented with FCS to a final concentration of 2% and
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Vincubated at 33°C. When CPE was observed the medium was removed, the monolayer 
washed once with sterile PBS, and serum free GMEM added with a further incubation 
at 33°C for 3 hours. A fresh aliquot of serum free GMEM containing either 100 
pCi/ml 35S L- Cysteine or 50 pCi/ml of 3H-glucosamine hydrochloride was added and 
the cells were incubated for 18-24 hours at 33°C.
For PVM infected cells treated with either tunicamycin or monensin, 
serum free GMEM was supplemented with either 2.5 pg/ml or 0.8pM of tunicamycin 
or monensin respectively at both the pre-labelling and labelling periods described 
above.
2.9,2.6. Radioimmunoprecipitations fRIPl :
PVM infected, labelled cells were scraped into the medium and 
transferred to microcentrifuge tubes. Cells were pelleted by centrifugation at 15,000g 
for 10 mins. The supernatants were transferred to fresh tubes and incubated at 4°C 
overnight following the addition of PEG to a final concentration o f 6% (w/v) Virus 
was precipitated by centrifugation at 15,000g for 10 mins. The pelleted cells and virus 
were washed twice in PBS containing ImM PMSF and resuspended in lOOpl of high 
salt RIP buffer (1% (v/v) Triton X-100, 150mM NaCl, 600mM KC1, 0.5mM MgCl2, 
lOmM Tris-HCl (pH 7.4)) containing ImM PMSF and placed on ice for 1 hour prior 
to storing at -20°C.
Immunoprecipitin (Gibco-BRL, UK) was prepared according to the 
manufacturer's recommendation to reduce sloughing o f formalin fixed Staphylococcus 
aureus cells during the immunoprécipitation procedure. Staphylococcus aureus cells 
were pelleted by centrifugation at 15,000g for 10 mins, resuspended in equal volume 
of 10% (w/v) 2-mercaptoethanol, 3% (w/v) SDS in PBS and heated to  95°C for 30 
mins. Cells were pelleted at 15,000g for 10 mins and resuspended in equal volume of 
RIP buffer.
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50pl of immunoprecipitin (in RIP buffer) and 1 Ofj.1 of FCS were added 
to the cell lysate and virus preparations and incubated on ice for 30 mins. 
Staphylococcus aureus cells were pelleted for 10 mins at 15,000g and the supernatants 
transferred to fresh microcentrifuge tubes. 10pl of PVM anti-G monoclonal antibody 
(19/1/C9- Ling and Pringle, 1989b) was added and the mixture left at 4°C overnight. 
80pl of immunoprecipitin was added and the mixture was placed on ice for 30 mins 
before pelleting the Staphylococcus aureus cells at 15,000g for 10 mins. The 
supernatants were discarded and the cells washed three times with 1 ml of RIP wash 
buffer (0.5M LiCl, lOOmM Tris-HCI (pH 8.9)), containing ImM PMSF. Finally the 
cells were resuspended in 50pl of boiling mix and stored at -20°C. Prior to 
electrophoresis, cells were boiled for 5 mins.
2.9.3. Vaccinia virus :
Wild type vaccinia virus, strain Wr, was obtained from Professor M. A. 
McCrae, Department of Biological Sciences, University of Warwick. Recombinant 
vaccinia virus, vTF7-3 (Fuerst et al, 1986), that expresses the T7 RNA polymerase 
was kindly provided by Dr. R. Elliott of the Glasgow Institute of Virology, Glasgow, 
UK., with the permission o f Dr. B. Moss of the National Institute of Allergy and 
Infectious diseases, Bethesda, Maryland, USA.
2.9,3,1, Preparation of wild type Vaccinia virus stock :
HeLa cells were grown to confluence as monolayers in 175 cm tissue 
culture flasks. The medium was removed and wild type vaccinia virus added to a 
multiplicity o f infection of 0.01 pfu/cell. Following incubation at 37°C for 2 hours, the 
inoculum was replaced with GMEM supplemented with FCS to a final concentration 
of 2% and the pells incubated at 37°C. After 3 days, when extensive CPE was visible, 
the flasks were kept at -70°C till the medium had frozen. The medium was thawed by 
incubation at 37°C and this process of freeze/thaw repeated twice. Cell debris and
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virus were pelleted by centrifugation at 20,000 rpm at 4°C for 2.5 hours, resuspended 
in PBS and sonicated for 4 mins in a sonicating bath. Cell debris was pelleted by 
centrifugation at 4000g at 4°C for 10 mins and the supernatant stored at -70°C.
2.9.3.2. Titration of vaccinia virus :
BS-C-1 cells were used for titration of vaccinia virus using the method 
described in section 2.9.2.4, except virus adsorption and growth was at 37°C
2.9.3.3. Recombinant vaccinia virus :
85-90% confluent monolayers of HeLa cells grown in a 5 cm tissue 
culture dish were infected with wild type vaccinia virus at a multiplicity of infection of 
0.01 pfu/cell The virus was allowed to adsorb for 2 hours at 37°C. Infected cells were 
subsequently transfected with CsCl purified DNA of pSC 11 constructs containing the 
G genes o f PVM strains 15 and J3666 using the Gibco-BRL TransfectACE protocol 
described in section 2.5.2.2.
Transfected cells were scraped into the medium, transferred to plastic 
universal tubes and freeze/thaw treated as described above. Cell debris was pelleted by 
centrifugation at 2000g at 4°C for 10 mins. Recombinant vaccinia virus was selected 
by titration of the supernatant.
2 9.3.4, Selection of recombinant vaccinia virus :
HuTK" 143 cells, which lack thymidine kinase activity, were grown to 
confluence as monolayers. The medium was replaced with supernatant containing 
recombinant vaccinia virus (prepared above) and the cells incubated for 2 hours at 
37°C. The inoculum was replaced with 1% (w/v) agar overlay containing GMEM 
supplemented with FCS (final concentration o f 2%) and 25 gg/ml BrdU. The agar was
t
allowed to set and the cells then incubated at 37°C. After 3-4 days 2 mis of agar 
overlay containing serum free GMEM and 20 pg/ml of X-gal was added, the agar
allowed to set and the cells incubated at 37°C, 5% CO2 . Recombinant vaccinia virus
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MATERIALS AND METHODS
plaques were thus distinguished from spontaneous revertants by their blue appearance. 
A sterile Pasteur pipette was inserted into the agar overlay and the blue plaques 
transferred into 500pl GMEM supplemented with FCS (final concentration of 2%) 
medium. They then underwent three ffeeze/thaw cycles and amplified HuTK' 143 
cells.
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\3.1. In t r o d u c t io n  :
Viral infection of the Paramyxoviridae family of viruses is initiated by 
the concerted action of two major viral surface glycoproteins. The first, designated G, 
is responsible for the attachment of the virus particle to the host cell receptor and is 
referred to as the attachment protein. This protein varies in its general characteristics 
between the morbillivirus, paramyxovirus and pneumoviruses. The second 
glycoprotein (designated F) is responsible for fusion o f viral and cell membrane, 
allowing entry of the viral genome into the cell, and fusion of infected cell and adjacent 
cell allowing the spread of the virus (Pringle 1987, Morrison 1988).
Chambers et al (1992) have recently published the nucleotide and 
predicted amino acid sequence o f the F gene of a non-pathogenic strain of Pneumonia 
virus of mice (PVM, strain 15), that has been passaged entirely in tissue culture. They 
found little (10%) amino acid homology with the F proteins of the morbillivirus and 
paramyxovirus and only a 40% homology with the F proteins of human respiratory 
syncytial virus (HRSV) and turkey rhinotracheitis virus (TRTV), the other members of 
the Pneumovirus genus. However the structural features o f the protein were consistent 
with those of the other members o f the Paramyxoviridae family as described in chapter 
1. Another strain of PVM, J3666, was obtained from Dr. D. Harter of the Rockefeller 
Institute, New York which has been passaged entirely in mice and is highly pathogenic.
Work on virulent and avirulent strains o f Newcastle disease virus 
(NDV) has shown the pathogenicity of each strain to be related to the susceptibility of 
the F0 polypeptide to cleavage by certain proteases (Nagai et al, 1976, Nagai and 
Klenk, 1977). It was anticipated that sequence analysis o f this gene of PVM strain 
J3666 might reveal amino acid changes at or in close proximity to the cleavage site of 
the F0 polypeptide. Sequence analysis of the F gene of virulent and avirulent strains of 
NDV have attributed changes at the cleavage site of Fq to the relative pathogenicity of
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the virus. Early tissue culture work by Nagai et a l (1976) and Nagai and Klenk (1977) 
showed a correlation between the virulence and susceptibility to cleavage of the F0 
polypeptide. Sequence analysis of the F genes of the different strains of NDV by 
Glickman et a l (1988) and Toyoda et al (1987) found that cleavage occurred between 
the amino acids Arg and Phe in all virulent strains of NDV whereas Phe had been 
substituted by Leu in all avirulent strains . Thus the amino terminus of the F [ subunit 
of virulent strains of NDV began with a Phe residue whereas that of the avirulent 
strains began with Leu. Additionally, in the virulent strains of NDV the putative 
cleavage site was located within a hexapeptide consisting of four (or five) basic amino 
acids with an intervening Gin residue (Arg-Arg-Gln-Arg/Lys-Arg-Phe) whereas in the 
avirulent strains the first and fourth residues were replaced with the neutral amino acid, 
GHy.
Recently, Morrison et a l (1993) demonstrated that altering the cleavage 
site of a virulent strain of NDV (Arg-Phe) to Arg-Gly had no effect on cleavage of the 
F0 polypeptide and that the fusion activity was equivalent to that of the wild type. 
However, when the cleavage site was changed to Arg-Leu, the F0 polypeptide was no 
longer cleaved and no fusion activity was observed. The fusion function of this 
polypeptide was regained after digestion with trypsin. The authors suggested several 
explanations for these observations of which the most plausible is that the presence of 
Leu alters the conformation of the F0 polypeptide and makes the cleavage site 
inaccessible to proteases during maturation. These findings are somewhat complicated 
by the work of Horvath and Lamb (1992) on SV5 in which Phe had been substituted 
with Leu but no effect on either fusion or cleavage was observed. Morrison et al 
(1993) suggested several reasons for this discrepancy. For example, the substitution of 
Phe by Leu may not alter the 3-D conformation around the fusion domain, or the F0 
polypeptide of SV5 could be cleaved by a different protease to that of NDV.
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The F protein of Sendai virus, responsible for respiratory tract 
infections of rodents and responsible for fatal pneumonia in laboratory mice (Ishida 
and Homma, 1978), is unusual in comparison to that of other members of 
Paramyxoviridae whose F0 polypeptide cleavage occurs intracellularly during 
maturation. Sendai virus F0 polypeptide is cleaved extracellularly by some proteases in 
order to activate the fusion activity (Muramatsu and Homma, 1980, Tashiro and 
Homma, 1983) and Sendai virus host range and cell/organ tropism is determined by 
the presence of these proteases. Sequence analysis of Sendai virus F protein has shown 
the cleavage site to be between positions 116 and 117 (Arg-Phe; Blumberg et al 
,1985) which is readily cleaved in vitro by trypsin. However sequence analysis o f 
various Sendai virus mutants and their revertants has determined that amino acid 
changes at or close to the cleavage site are responsible for the variation in 
susceptibility of the F0 polypeptide to different proteases. Interestingly, a single amino 
acid change of Arg (116) to lie not only conferred trypsin resistance but also 
susceptibility to chymotrypsin. However, a single amino acid change of Phe to Ser at 
position 117 does not inhibit trypsin digestion but permits digestion with chicken 
plasmin. Other amino acid changes near the cleavage site are responsible for cleavage 
by either chymotrypsin, elastase, plasmin and factor X (Itoh et al, 1987, Hsu et al, 
1987, Itoh and Homma, 1988, Ogasawara et al, 1992). Thus it was of interest to 
determine whether the pathogenicity of strain J3666 o f PVM could be due to amino 
acid changes located within its F protein when compared to that of strain 15.
3.2. r e s u l t s  :
3.2.1. Amplification of full-length F-gene of PVM strain J3666 :
First strand cDNA was synthesised from mRNA isolated from BS-C-1
I
cells infected with PVM strain J3666 as described in the methods section. 
Amplification of full-length F gene of PVM strain J3666 was carried out by PCR using
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\oligonucleotides F5 (Table 3.1) and oli-Tail (Table 3.1). Oligo F5 was designed to 
hybridise to the 5' gene start at positions 1 to 17 and oli-Tail was designed on the basis 
o f the PVM strain 15 sequences to hybridise to the poly A tail. Amplification was 
achieved using Taq DNA polymerase. Bands of 1450 and 1650 kilo bases (kb) were 
visualised following agarose gel electrophoresis (Fig. 3.1). The 1650 kb band 
corresponds to the full-length F gene i.e. amplification following hybridisation of oligo 
F5 to the 5' gene end and oli-Tail hybridising to the poly A tail. The 1450 kb band 
results from the 'incorrect' binding of oil-Tail to a stretch o f A residues approximately 
200 bases upstream of the poly A tail (Data not shown).
Since oligo F5 was designed using the F gene sequence o f PVM strain 
15, a consequence of this was that the 5' end of the amplified F gene o f PVM strain 
J3666 was identical to that of PVM strain 15. Consequently oligonucleotides G1 and 
F2 (Table 3.1) were used to amplify the true 5' sequence o f the F gene o f PVM strain 
J3666 from polycistronic cDNA (Fig 3.1). Oligo G1 was designed to hybridise to the 
nucleotide positions 1223 to 1245 at the 3' end of the G gene of PVM strain 15 
whereas oligo F2 hybridised to nucleotides 1102 to 1121 on the complementary (-) 
strand of the F gene of PVM strain 15.
3.2.2. Cloning and sequencing of the F gene PCR products :
The PCR product generated by amplification with oligo's F5 and oli- 
Tail, was restriction endonuclease digested with EcoRl and H indlll. The larger of the 
two bands (Fig. 3.1) corresponding to the whole gene was purified from a low melting 
point agarose gel and cloned into EcoRl and H indlll digested cloning vector 
Bluescribe (pBS). Two individual clones were subcloned into either M13 mpl8 or 
M l 3 mpl9 using a variety of oligonucleotides. Fig. 3.2 shows the strategy adopted for 
sequencing of PVM strain J3666 F gene. The nucleotide sequence was determined 
using a range of F gene (PVM strain 15) specific primers shown in Table 3.1. The PCR
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Oligo Sequence Position Strand Usage
Gl GCCTTACTGGTGTCCTAT (G-gene) 1223-1245 P PCR
Oli-Tail GGCCCGGG AAGC(T), < Poly A tail* C PCR
F2 GTCAGTACCGCTGTACTCAC 1102 -1 1 2 1 C SP
F4 GCCGGCCTGTTCTAAGGGCACTC 132-149** C PCR, SP
F5 GTATACCCGGGAATTCAGGACAA
ATATGATTCC
1-17*** P PCR
F6.5 CATCACGAGAATGCAACTCA 1031-1050 P SP
F7 TATTGAGTCATGCAAGAGCA 192-211 P SP
F8 AGGCTGTTGTT AGCCT AACC 431-450 P SP
F9 CATTGTAGGCGGATGGCTG 681-700 P SP
FIO GCT AGAGCTGAT AATGGCTG 901-920 P SP
Fl 1 ACTGTTTACT ATCTT AGC AA 1261-1280 P SP
F12 ATATACTAACAACTCTGCTC 1481-1500 P SP
F13 GTCCAATAACTGATCAGAGG 1440-1421 C SP
F14 AC AGTCT AT AGAACTTCTTA 851-870 C SP
F15 TGTGTGTTAATCCTGCATTA 621-640 C SP
F16 GGTT AGGCT AACAAC AGCCT 431-450 C SP
F17 TCCACTGCACTACTATAGATT 240-260 C SP
Table 3.1: PVM F gene specific primers and oligonucleotides.
showing nucleotide sequence and position o f oligonucleotides and 
primers used in either PCR or in sequencing reactions. C denotes complementary (-) 
strand whereas P represents (+) strand sequence; SP - sequencing primer and PCR - 
oligonucleotide used in the polymerase chain reaction. * : Oli-Tail contains restriction 
sites for Smal and H indlll. ** : Bases underlined are not found within F gene 
sequence. *** : Oligo F5 contains restriction sites for Kpnl, Sm al and EcoRI. 
Underlined bases are not located within the F gene sequence.
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Fig. 3.1 : PVM strain J3666 F gene PCR product.
Low melting point agarose gel stained with ethidium bromide showing
a) F gene of PVM strain J3666 amplified by PCR using oligonucleotides F5 and 
Oli-Tail and b) the PCR product representing the 5' end of PVM strain J3666 F gene 
following amplification with oligonucleotides F4 and G l. M represents the DNA 
marker track. The band indicated (arrowed) shows the PCR product purified following 
amplification with oligonucleotides FS and Oli-Tail.
product generated by amplification with oligos Gl and F4 was end-filled using T4 
DNA polymerase and cloned into M13 mpl8 . The 5' sequence was determined from 
six clones.
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Fig. 3.2 Sequencing strategy for PVM strain J3666 F gene.
Sequencing strategy for PVM strain J3666 F gene with arrows 
indicating location of oligonucleotides used in sequencing. Sequencing 
oligonucleotides shown represent their positions in relation to the F gene cDNA. The 
gene ends were sequenced using the -40 (universal) primer.
3.2.3. Sequence analysis of the F gene of PVM strain J3666 :
Figure 3.3 shows the nucleotide and amino acid changes found in the F 
gene of PVM strain J3666 compared to the published sequence of Chambers e ta l 
(1992) for PVM strain 15. As is the case with the F gene of PVM strain 15, the F gene 
of PVM strain J3666 encodes a large open reading frame of 537 amino acids with a 
nine base non-coding region at the 5' end and a non-coding region o f 37 bases at the 3' 
end. Only 6  nucleotide changes were found in the whole of the F gene when compared 
to the F gene sequence of PVM strain 15. All were found within the coding region of 
the F gene. Table 3.2 summarises the nucleotide and amino acid changes found in the F 
genes of the two strain of PVM. The substitution of a T residue for an A residue at 
position 92 results in an amino acid change of a Tyr to Phe whereas the substitution of
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Strain 15/J3666
M e t l l e P r o G l y A r g l l e P h e L e u V a l L e u L e u V a l l l e P h  
AGGACAAAUAUGAUUCCUGGCAGGAUCUUUCUAGUCCUUCUGGUGAUCUU 50
Strain 15
e A s n T h r L y s P r o I l e H i s P r o A s n T h r L e u T h r G l u L y s T y r T y r G l u S  
CAACAC CAAGC CAAUUCAC C CAAAUAC AUUAAC AGAAAAAUACUAUGAGU 100
Strain J3666 U
P h e
Strain 15/J3666
e r T h r C y s S e r V a l G l u T h r A l a G l y T y r L y s S e r A l a L e u A r g T h r G l y  
C C ACAUGUAGU GUUGAGAC UGC AGGUUAUAAGAGU GC C C UUAGAAC AGGU 1 5 0
Strain 15/J3666
T r p H i s M e t T h r V a l M e t S e r l l e L y s L e u S e r G l n l l e A s n l l e G l u S e  
UGGCAUAUGAC AGUUAUGUC AAUUAAGUUGUCUC AAAUAAAUAUUGAGUC 200
Strain 15/J3666
r C y s L y s S e r S e r A s n S e r L e u L e u A l a H i s G l u L e u A l a l l e T y r S e r S  
AU GC AAGAGC AGO AAC U C GUUAUU GGC U C AU GAGCUUGC AAUC UAUAGUA 2 50
Strain 15/J3666
e r A l a V a l A s p G l u L e u A r g T h r L e u S e r S e r A s n A l a L e u L y s S e r L y s  
GUGCAGUGGAUGAAUUGAGAACGUUAUCAUCCAAUGCCUUGAAGUCCAAA 300
Strain 15/J3666
A r g L y s L y s A r g P h e L e u G l y L e u I l e L e u G l y L e u G l y A l a A l a V a l T h  
AGGAAGAAGAGGUUCCUCGGUUUGAUUCUUGGUCUCGGAGCUGCAGUCAC 350
Strain 15/J3666
r A l a G l y V a l A l a L e u A l a L y s T h r V a l G l n L e u G l u S e r G l u I l e A l a L  
UGCCGGGGUGGCUUUAGCCAAGACAGUGCAACUUGAAAGUGAGAUUGCAU 400
Strain 15/J3666
e u l  1  e A r  g A s p A l  a V a  1 A r g A s n T h r  A s n G l u A l  a V a l V a l  S e r L e u T h r  
UGAUUAGAGAUGCAGUGAGAAAUACAAAUGAGGCUGUUGUUAGCCUAACC 450
Strain 15/J3666
A s n G l y M e t S e r V a l L e u A l a L y a V a l V a l A s p A s p L e u L y s A a n P h e l l  
AACGGCAUGUCAGUGUUGGCUAAAGUGGUGGAUGAUUUGAAAAACUUCAU 5 0 0
Strain 15/J3666
e S e r L y s G l u L e u L e u P r o L y s I l e A s n A r g V a l S e r C y s A s p V a l H i s A  
AUCUAAAGAAUUACUCCCAAAAAUAAACCGAGUCUCUUGUGAUGUGCACG 550
Strain 15/J3666
s p I l e T h r A l a V a l l l e A r g P h e G l n G l n L e u A s n L y s A r g L e u L e u G l u  
AC AU C AC UGC C GU C AUUAGAUU C C AAC AGC UC AAC AAAAGAC UUUU GGAA 600
Strain 15/J3666
V a l S  e  r A r g G l u P h e S  e  r S  e r A s n A l a G l y L e u T h r H i  a T h r V a l S e r S e  
GUAU C UC GU GAAUUUU C AU C UAAUGC AGGAUUAAC AC AC AC U GUUUC AUC 6 50
Strain 15
r P h e M e t L e u T h r A s p A r g G l u L e u T h r S e r l l e V a l G l y G l y M e t A l a V  
UUUUAUGUUAACAGACCGCGAACUCACCUCCAUUGUAGGCGGCAUGGCUG 7 00
Strain J3666 G
A r g
Strain 15
a l S e r A l a G l y G l n L y s G l u I l e M e t L e u S e r S e r L y a A l a l l e M e t A r g  
UUUC AGC AGGC CAAAAAGAGAUAAUGC UAUC UAGCAAAGC UAUAAU GAGA 7 50
Strain J3666 G
A r g
\P V M  F u s io n  G e n e s
Strain 15/J3666
A r g A s n G l y L e u A l a l l e L e u S e r S e r V a l A s n A l a A s p T h r L e u V a l T y  
AGAAAU GGGUUAGCAAUAUUAAGUU C AGU CAAC GC U GACACAC U GGUUUA 800
Strain 15/J3666
r V a l  I  l e G l n L e u P r o L e u P h e G l y V a l M e  t A s p T h r A s p C y s T r p V a l  I  
UGUAAUACAACUCCCAUUAUUUGGUGUUAUGGACACAGAUUGUUGGGUAA 850
Strain 15/J3666
l e A r g S e r S e r l l e A s p C y s H i s A s n l l e A l a A s p L y s T y r A l a C y s L e u  
UAAGAAGUUCUAUAGACUGUCAUAACAUAGCAGACAAGUAUGCUUGUUUG 900
Strain 15/J3666
A l a A r g A l a A s p A s n G l y T r p T y r C y s H i s A s n A l a G l y S e r L e u S e r T y  
GCUAGAGCUGAUAAUGGCUGGUAUUGUCACAAUGCUGGCUCAUUAUCAUA 950
Strain 15
r P h e P r o S e r P  r o T h r A s p C y s G l u I  1  e H i  s A s n G l  y T y  r A l  a P h e C y s A  
CUUCCCGUCGCCAACGGAUUGUGAGAUCCACAAUGGGUAUGCUUUCUGUG 1000
Strain J3666 U U 
T h r  V a l
Strain 15/J3666
s p T h r L e u L y s S e r L e u T h r V a l P r o V a l T h r S e r A r g G l u C y s A s n S e r  
ACACUCUAAAAAGUCUAACUGUACCUGUAACAUCACGAGAAUGCAACUCA 105 0
Strain 15/J3666
A s n M e t T y r T h r T h r A s n T y r A s p C y s L y s I l e S e r T h r S e r L y s T h r T y  
AAC AU GUAU AC C AC UAAC UAC GAUUGUAAGAUUU C C AC AAGU AAAAC UUA 1 1 0 0
Strain 15/J3666
r V a l S e r T h r A l a V a l L e u T h r T h r M e t G l y C y s L e u V a l S e r C y s T y r G  
UGUGAGUACAGCGGUACUGACUACAAUGGGUUGCUUGGUAUCUUGUUAUG 1150
Strain 15/J3666
l y H i s A s n S e r C y s T h r V a l l l e A s n A s n A s p L y s G l y l l e l l e A r g T h r  
GUCAUAACAGUUGCACAGUCAUCAAUAAUGACAAAGGUAUAAUAAGGACU 120 0
Strain 15/J3666
L e u P r o A s p G l y C y s H i s T y r l l e S e r A s n L y s G l y V a l A s p A r g V a l G l  
CUGCCAGAUGGUUGCCACUACAUCUCCAACAAAGGUGUGGACAGGGUUCA 125 0
Strain 15/J3666
n V a l G l y A s n T h r V a l T y r T y r L e u S e r L y s G l u V a l G l y L y s S e r l l e V  
AGUAGGUAAC AC UGUUUAC UAUC UTJAGC AAAGAAGUU GGC AAGUC AAUUG 1300
Strain 15/J3666
a l V a l A r g G l y G l u P r o L e u V a l L e u L y s T y r A s p P r o L e u S e r P h e P r o  
UUGUCAGAGGGGAACCAUUGGUCUUGAAAUAUGACCCITUUGAGUUUCCCU 1350
Strain 15/J3666
A s p A s p L y s P h e A s p V a l A l a l l e A r g A a p V a l G l u H i s S e r l l e A a n G l  
GAC GAUAAAUUUGAUGUUGC UAUAAGAGAU GU GGAGC AUAGC AU C AAU C A  1400
Strain 15 
Strain J3666
n T h r A r g T h r P h e P h e L y s A l a S e r A s p G l n L e u L e u A s p L e u S e r G l u A  
GAC AC GC AC AUUCUUC AAGGC C UC U GAU C AGUUAUU GGAC UUAAGUGAAA 1450  
G 
L e u
Strain 15/J3666
s n A r  g G lu A s n L y  s A a n L e u A s n L y  s  S e  r T y  r  1 1 e L e u T h r T h r  L e u L e u  
ACAGAGAGAAUAAAAAUUUAAACAAGUCAUAUAUACUAACAACUCUGCUC 1500
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P h e V a  1 V a lM e  t  L e u I  l e l l e l l e M e  t A l  a V a  1 1 1 e G l  y P h e  I  l e L e u T y
Strain 15/J3666 u u c g u u g u a a u g c u u a u u a u a a u a a u g g c u g u c a u a g g g u u c a u u c u g u a  1 5 5 0
Strain 15/J3666
r L y s V a l L e u L y s M e t l l e A r g A s p A s n L y s L e u L y s S e r L y s S e r T h r P  
UAAGGUAUU GAAAAU GAUC AGAGAC AAC AAGUU GAAAU C C AAAAGUAC AC 16 0 0
Strain 15/J3666
r o G l y L e u T h r V a l L e u S  e r
C U GGC C UC AC AGUUUUAU C AU GAC AAUUGUAC C AAAC C AUAAUUGAGUUA 16 5 0
Strain 15/J3666 GUUAAUU 1651
Fig. 3.3 : PVM strains 15 and J3666 F gene nucleotide and amino acid sequences.
Nucleotide and amino acid sequence of the F gene of PVM strains 15 
and J3666. Nucleotide sequence shown is mRNA sense and represents the sequence of 
PVM strain 15. Nucleotide bases indicated below the sequence for PVM strain 15 F 
gene represent nucleotide changes found in the F gene o f PVM strain J3666. The 
amino acid sequence shown below the nucleotide changes identified in the G gene of 
PVM strain J3666 represent changes in amino acid sequence of PVM strain J3666 F 
gene compared to that of PVM strain 15. A summary of the nucleotide and amino acid 
changes is shown in Table 3.2.
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Nucleotide Changes Amino acid changes
Position From To Position From To
92 TAC TTC 28 Tyr Phe
669 CGC CGü 2 2 0 Arg Arg
737 aAa aGa 243 Lys Arg
966 acG ACT 319 Thr Thr
992 GCT gTt 328 Ala Val
1416 ttC ttG 468 Phe Leu
Table 3.2 : PVM F gene nucleotide and amino acid sequence changes.
Summary of nucleotide and amino acid changes found in the F gene of 
PVM strain J3666 compared to the F gene of PVM strain 15. Nucleotide codons are 
represented as mRNA sense cDNA and base changes are shown in an enlarged and 
underlined font.
G residue for C residue at position 669 and T for a G at amino acid 966 conserves the 
amino acids. G residue substitutions for an A and G at positions 737 and 1416 result in 
the amino acid changes of Lys to Arg and Phe to Leu respectively. Substitution of a T 
residue for C at position 992 results in an amino acid change of Ala to Val.
3.3. D isc u ssio n  :
Sequence analysis of the fusion (F) gene of a pathogenic strain of PVM 
(strain J3666) showed only a few nucleotide and amino acid changes compared to the 
sequence of the fusion gene of a non-pathogenic strain. In total only four amino acid
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\changes were seen, all of which were conservative and unlikely to have a significant 
effect on the major structural regions identified previously (Chambers eta l, 1992).
Correlating the amino acid changes found in the F protein of PVM 
strain J3666 with the regions identified by Chambers et a l (1992) reveals that the 
amino acid change of Tyr (28) to Ser occurs within the F2h region whereas the Lys to 
Arg change at position 243 is located within the variable domain of the protein (Fig. 
1.3). The Ala (328) to Val change is located within the Cysteine-rich domain and the 
Phe to Leu change at position 468 occurs within the heptad repeat region located at 
the C-terminus o f the Fj subunit. The importance of these changes can be tentatively 
correlated with the antigenic sites identified within the HRSV F protein.
Two approaches to map the antigenic domains of the F protein of 
HRSV by monoclonal antibodies have been undertaken by researchers. Firstly, the use 
of synthetic peptides to locate the antigenic domains of the F protein of HRSV have 
proved somewhat successful. Trudel et al (1987) were the first to use such an 
approach in which synthetic peptides were used to identify the binding site o f a 
monoclonal antibody, 7C2. The binding site was mapped to a stretch of amino acid 
residues running from position 221 (lie) to 232 (Glu). This region is located within the 
heptad region located at the N-terminus of the F j subunit identified by Chambers et al 
(1992). However MAb 7C2 has also been shown by dot-blot assays to react with 
peptides spanning positions 221  to 232 and 275 to 288 (Trudel et al, 1991). So the 
precise epitope is not yet clear. Using similar approaches Bourgeois et a l (1991) 
identified two regions involved in antibody binding ; amino acids 220 to 225 and 259 
to 278. The first region is within that identified by Trudel et a l (1987) whereas the 
second is located within the variable domain (Chambers et al, 1992). Scopes et a l 
(1990) have also mapped a polyclonal antibody binding to a region of amino acids at 
position 483 to 488. By replacing certain amino acid within the synthetic peptides they 
determined that Pro (484) and Glu (487) were crucial in antibody binding. This region
p v m  f u s io n  G e n e s
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overlaps the C-terminus of the Cysteine-rich domain and the N-terminus of the heptad 
repeat region (located at the C-terminus) of the Fj subunit as identified by Chambers et 
al (1992). Martin-Gallardo et a l (1991) have mapped a virus-neutralising epitope to 
amino acids 289 to 298. This region maps to the variable domain of the fusion protein. 
Thus peptide mapping of the fusion protein has identified two regions for antibody 
recognition - 200 to 298 and 483 to 488, with the first containing multiple antibody 
recognition sites.
The second approach used to map antibody binding involves raising 
escapes mutants against neutralising antibodies and then pinpointing the nucleotide and 
amino acid changes. Lopez et al (1990) have adopted this strategy to identify epitopes 
involved in antibody binding in HRSV. The antigenic binding site of the neutralising 
MAb, 47F was initially mapped in a Western blot against purified F protein digested 
with trypsin. The MAb was found to react with 20.5 and 19 kDa fragments. The amino 
terminus of these fragments were found to be identical and matched the first eight 
residues of the F j subunit. Five escape mutants were raised against MAb 47F and 
nucleotide sequence analysis revealed two of these mutants to have changed amino 
acid 262 (Asp) to a Tyr residue whereas the other three mutants had amino acid 268 
(Asp) changed to lie. These results suggest that the 3-D conformation o f the F j N 
terminus is important in eliciting antibody response. Arbiza et a l (1992) adopted a 
combination of the above two strategies in that firstly neutralisation escape mutants of 
HRSV were raised against a selection ofMAb's - 11, 47F, AK13A2, 7C2, B4, 19 and 
20 (note that MAb 7C2 was initially used by Trudel et al (1987) in mapping linear 
epitopes using synthetic peptides). The nucleotide and subsequent amino acid changes 
in the F gene were pinpointed and the reactivity of synthetic peptides with the changed 
amino acid(s),' to MAb’s binding to the same region tested. Escape mutants raised 
against one MAb (e g. AK13A2) eliminated reactivity with other MAb’s (e g. 7C2 and 
B4). Similarly, synthetic peptides made against one MAb showed little or no reactivity
/
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with other MAb's that bound to the same region. Using this approach Arbiza et al 
(1992) identified two regions involved in antibody binding spanning amino acids 262 
to 272, the variable region (Chambers et al, 1992) and amino acids 422 to 438 (near 
that identified by Scopes et al, 1990) located within the cysteine-rich region identified 
by Chambers et al (1992). However MAb 7C2 failed to react with a synthetic peptides 
spanning the regions identified by Trudel et al (1991). These results suggest a single 
amino acid changes within the F protein enables the virus to escape MAb neutralisation 
and that although linear peptides can be used to map antigenic sites, neutralisation 
escape mutants should be preferred to identify conformational epitopes eliciting 
antibody response. YusofF et al (1989) obtained similar results in antibody-neutralising 
mutants in NDV in which the amino acid changes fell into three regions. The first 
being the "loop" between the F2  beta-turn domain and F2 I1 region, the second was the 
heptad repeat region at the N terminus of the Fj subunit and thirdly the variable 
domain of the Fj subunit (Chambers et al, 1992).
Taking the above reports into consideration it is possible that the amino 
acid changes located within the variable, cysteine-rich and C-terminus heptad repeat 
regions of the F protein o f PVM could reflect antibody driven changes in sequence. 
However it seems unlikely that these changes account directly for the difference in 
pathogenicity between PVM strain 15 and strain J3666.
Using a recombinant vaccinia virus Ebata et a l (1991) expressed the 
fusion and haemagglutinin-neuraminidase (HN) of human parainfluenza virus type 3 
(HPIV3) either independently or together. They were able to show independent 
expression and correct maturation o f both glycoproteins but could only induce fusion, 
characterised by syncytium formation and lysis o f human red blood cells, when cells 
were co-infected with both the fusion and HN recombinant vaccinia virus. Hu et al 
(1992) have also demonstrated the requirement for the expression of both the F and 
HN glycoproteins in human parainfluenza virus type 2 (HPIV2). In this study they
90
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infected cells with recombinant vaccinia virus containing (and expressing) T7 RNA 
polymerase. Infected cells were then transfected with recombinant plasmids containing 
the F and HN genes. No fusion activity was observed when HPIV2 F gene and HPIV3 
HN gene or HPIV3 F gene and HPIV2 HN gene were co-expressed. Additionally by 
mixing cells independently expressing the F or HN protein the fusion function was 
regained (Hu et al, 1992). These results indicate that for human parainfluenza viruses 
the F and HN proteins of the same virus type are required for fusion. Morrison et al 
(1991) used a retroviral expression vector to express the fusion protein of a virulent 
strain of NDV. No cell to cell fusion was observed in cells expressing the F protein 
even though the Fq polypeptide was cleaved into its Fj and F2 subunits. Subsequent 
transfection of the HN gene into these F protein expressing cells elicited cell to cell 
fusion. Unlike the findings of Hu et al (1992) fusion was only observed when both the 
HN and F proteins were expressed in the same cell. Sergei et al (1993) used Cos-7 
cells and a SV40 based vector (pSVL) to demonstrate similar results for NDV HN and 
F proteins. Wild et a l (1991) and Tanabayashi et a l (1992) demonstrated a requirement 
for co-expression o f the mumps H and F proteins to elicit cell to cell fusion in vaccinia 
recombinants. These findings contradict the work of Alkhatib et al (1990), who 
demonstrated cell to cell fusion by expression o f the mumps virus fusion protein in 
adenovirus recombinants. Work on Sendai virus (Bagai et al, 1993) has shown that 
although the fusion protein alone is responsible for fusion, the presence of the HN 
glycoprotein enhances this activity.
These findings are somewhat complicated by the results of Peeples and 
Bratt (1984) who found that a mutation in the matrix protein o f NDV resulted in the 
decreased fusion activity. However this work did not test the effect of the presence or 
absence of the NDV HN glycoprotein upon fusion activity. Thus, the above 
observations suggest a crucial role for the attachment glycoprotein in not only being 
responsible for attachment of the virus to the cell but also, in some paramyxoviruses,
P V M  F u s io n  G e n e s
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to be involved in the fusion process as well. The changes observed in the PVM strain 
J3666 F protein may affect interaction of the F and G proteins. If the Pneumovirus F 
protein requires the presence o f the G protein for activity any alterations in F may 
indirectly affect fusion activity. Thus, it remains possible that one or more of the 
observed changes in PVM strain J3666 F protein may be important for enhanced 
pathogenicity. Thus it would be interesting to determine at the molecular level whether 
the attachment (G) glycoprotein of PVM plays a role in viral pathogenicity and fusion.

4.1. In t r o d u c t io n  :
The G glycoprotein of HRSV has been shown to be responsible for 
virus attachment to the cell surface (Levine et al, 1987). In the preceding chapter the 
fusion protein of the pathogenic strain of PVM, J3666, was shown to possess only 
minor changes when compared to that of a non-pathogenic strain that has been 
passaged entirely in tissue culture. This lack of sequence variation suggests that the G 
protein may be important in determining pathogenicity. Although the fusion proteins of 
HRSV viruses are well conserved and have been demonstrated by the use of 
recombinant vaccinia virus and purified F protein to elicit production o f neutralising 
antibodies that protect immunised mice against HRSV challenge, a dilemma exists as 
to why HRSV is able to re-infect individuals. Work by Anderson et al (1988) suggests 
a mixture of anti- F and anti- G neutralising MAb's to be the key to this question. It is 
likely to be the G protein that is important in the ability of HRSV to re-infect 
individuals who have previously been infected and have good anti-HRSV antibody 
response. Sequence analysis of several HRSV G genes confirms the divergent nature 
of this protein (Anderson et al, 1985, Akerlind et al, 1988, Cane et al, 1991, Garcia- 
Barreno et al, 1989, Sullender et al, 1991). Furthermore the generation of HRSV 
escape mutants raised against neutralising anti-G MAb's suggest several types of 
modifications may be employed by the virus in the evolution of the G protein in 
response to immunological pressures. Escape mutants have been found to be generated 
by single amino acid substitutions, frameshifting due to insertion/deletion of 
nucleotides or the presence of premature stop codons (Garcia-Barreno et al, 1990, 
Rueda et al, 1991). Cane et al (1991) identified conserved and hypervariable regions 
within the G gene of HRSV natural isolates. The cytoplasmic and transmembrane 
regions were found to be conserved between these isolates whereas the extracellular 
domain consisted of alternating conserved and variable regions. The C terminus of the 
G protein was found to be variable with a hydrophilic hypervariable region located
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between amino acids 101 and 133 with amino acid differences ranging from 2-48%. 
These results support the findings of Garcia-Barreno et a l (1990) who determined 
frameshift mutations in HRSV mutants that escape neutralisation against an anti-G 
MAb to be localised to the C terminus o f the HRSV G protein. Thus, variation within 
the attachment protein of HRSV appears to be driven by immunological pressures. For 
these reasons, and the apparent lack of significant sequence differences between the F 
genes of the pathogenic and non-pathogenic strains of PVM, sequence determination 
of the G proteins may be useful in shedding light on the molecular basis for the 
differing pathogenicities observed for these two PVM strains.
4.2. R e s u l t s  :
4.2.1. Sequence analysis of the G gene of PVM strain J3666 :
4.2, l , l . C l o n in g  a n d  se q u e n c in g  o f  t h e  G g e n e  :
Amplified PVM strain J3666 G gene was kindly provided by Dr. J. 
Johnson. The G gene was amplified from cDNA synthesised from mRNA from PVM 
strain J3666 infected cells by PCR using oligonucleotide G4 
(CCCAAGCTTGGCCAGGATAAGTACTATCC, designed to hybridise to  the 5' 
mRNA end of the G gene at positions 1 to 16 (of the nucleotide sequence shown in 
Fig. 4.4) and containing restriction endonuclease sites for MscI, H ind lll) and 
oligonucleotide oli-Tail (GGCCCGGGAAGC(T)u, designed to hybridise to the poly 
A tail of the mRNA and containing restriction endonuclease sites for SmaT). The PCR 
product was digested with restriction endonucleases Sm al and MscI, purified from a 
low melting point agarose gel (Fig. 4.1) and cloned into the Smal restriction site o f the 
plasmid pBS (Bluescribe; Stratagene, La Jolla, CA, USA)
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Fig. 4.1 : PVM strain J3666 G gene PCR product.
Agarose gel stained with ethidium bromide showing the G gene of PVM 
strain J3666 (A) following amplification by PCR in the presence of Vent™ DNA 
polymerase and oligonucleotides G4 and oli-Tail. The G gene was kindly provided by 
Dr. J. Johnson. M represents the DNA marker lane.
The 5' ends of two independent clones containing the G gene of strain 
J3666 that were in opposite orientations to each other were linearised with either PstI 
or EcoRl and digested with exonuclease Bal31. At regular intervals aliquots were 
taken out, and the reaction stopped by the addition of EDTA to a final concentration 
o f 25mM. T4 DNA polymerase was used to blunt-end the Bal31 digested DNA as 
described in chapter 2. The truncated fragments were released by digestion with EcoRl 
or P stI and purified from a low melting point agarose (Fig. 4.2) prior to cloning into 
Sm al and EcoRl or PstI digested pBS. A selection of various sizes of these truncated 
inserts were subcloned into M13 m pl8  or mpl9 sequencing vectors following
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estimation of insert sizes on a 1% agarose gel of a number of EcoRl and P stI digested 
DNA prepared by the miniprep protocol. Nucleotide sequence of PVM strain J3666 
was determined using the commercially available Sequenase® kit. The deletions within 
the G gene of PVM strain J3666 were created not just to determine the nucleotide 
sequence of the gene but also for the potential use of such deletions in the mapping of 
antigenic sites.
4,2.1.2. CONFIRMATION OF THE 5' END NUCLEOTIDE SEQUENCE :
A consequence of the PCR amplification procedure adopted above for 
cloning of the PVM strain J3666 G gene was that the 5' end sequence would represent 
the sequence of oligo G4 used in the PCR reaction. To determine the correct sequence 
o f the 5' end of the G gene, amplification of the 5' end of the G gene was then achieved 
by PCR with the use of oligonucleotide 1A4 (CCCCGGGCCAGACAGCTTTACCC), 
designed to hybridise to the 3' end of the PVM 1A gene, and oligo G3 
(GTGAGCACACCTGCAATAAGCTTA) designed to hybridise to nucleotides 188 to 
211 of the sequence determined above (Fig. 4.3). The PCR product was digested with 
Sm al and H indlll (restriction sites located within oligonucleotides Oli-C and G3 
respectively) and cloned into M l3 m pl8 . Nucleotide sequence was confirmed using 
the commercially available Sequenase® kit.
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Fig. 4.2 : PVM strain J3666 G gene truncations.
Low melting point agarose gel stained with ethidium bromide showing 
3' and S' end truncated fragments o f the G gene o f PVM strain J3666 following 
linearisation with either a) EcoRl or b) Pstl, digestion with exonuclease Bal31, end- 
blunted with T4 DNA polymerase and released with digestion with either EcoRl or 
Pstl. Numbers, 1-10 represent intervals of 5, 15, 30, 45, 60, 75, 90, 105, 120 and 135 
mins at which aliquots of the Bal31 reaction were stopped by the addition of EDTA. 
Purified fragments were ligated into Sm al and EcoRl or P stl cut pBS.
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Fig. 4.3 : PCR product representing PVM strain J3666 5' end.
1% agarose gel stained with ethidium bromide showing the PCR 
product (A) following amplification with oligonucleotides 1 A4 and G3. M represents 
the DNA marker lane.
Fig 4.4 shows the nucleotide and predicted amino acid sequence o f the 
G gene of PVM strains J3666 and 15 (See later). PVM strain J3666 G gene is 1329 
nucleotides long and contains two non-overlapping open reading frames (ORF's), 
which are diagrammatically shown in Fig. 4.9. The first ORF codes for a small 
polypeptide of 12 amino acids whereas, as is the case for HRSV G gene, the second 
ORF codes for the major polypeptide of 396 amino acids with a predicted molecular 
weight of 43,584. The gene has 6  potential N linked glycosylation sites (indicated in 
Fig. 4.4) and a high percentage of serine, threonine and proline residues, which are 
potential sites for the O-linked glycosylation characterised by Ling and Pringle 
(1989b).
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Strain J3666
M e t A r g P r o V a l G l u G l n L e u I
AGGAUAAGUAC UAUC C UAUUGGAAUC AAAUGAGAC C UGUAGAGC AGC UC A  50
Strain 15 c  c
Strain J3666
l e G l n G l u A s n T y r  M e t G l y A r g A s n P h e G l u  
UAC AAGAGAAC UAC UAGUUGAC UUC AC UUAGUAUGGGAAGGAAC UUUGAA 100
Strain 15 C C A  C C A
M e t  G 1 y A r g A s n L e u G lu
Strain J3666
V a l S e r G l y S e r I 1 e T h r A s n L e u A s n P h e G l u A r g T h r G l n H i s P r o A s  
GUGAGUGGC AGC AUUAC UAAUUU GAAC UUU GAGAGAAC UC AGC AUC C U GA 150
Strain 15 A  C
G l u S e r G l y S e r I l e T h r A s n S e r A s n P h e G l u A r g T h r G l n H i s P r o A s
Strain J3666
p T h r P h e A r g T h r G l y V a l  L y s V a l A s n G l n M e t C y s L y s L e u I l e A l a G  
CACAUUUAGGACUGGUGUA-AAAGUGAACCAAAUGUGUAAGCUUAUUGCAG 200
Strain 15 U A
p T h r P h e A r g T h r V a l V a l L y s S e r G l u P r o A s n V a l
M e t ^ S t a r t  o f  G p r o t e i n
Strain J3666 
Strain 15
l y V a l L e u T h r S e r A l a A l a V a l A l a V a l C y s V a l G l y V a l l l e M e t T y r  
GUGUGCUCACAAGUGCUGCUGUGGCAGUUUGUGUGGGGGUCAUAAUGUAU 250/1 
o f  PVM s t r a i n  1 5
Strain J3666/15
S e r V a l P h e T h r S e r A s n H i s L y s A l a A s n S e r T h r G l n A s n A l a T h r T h  
UCUGUUUUCACAUCAAACCACAAGGCCAACUCCACGCAGAAUGCCACGAC 300/1
Strain J3666/15
r A r g A s n S e r T h r S e r T h r P r o P r o G l n P r o T h r A l a G l y L e u P r o T h r T  
CCGGAACAGCACAUCCACCCCUCCCCAACCAACCGCCGGUCUGCCCACCA 350/1
Strain J3666/15
h r G l u G l n G l y T h r l l e P r o A r g P h e T h r L y s P r o P r o T h r L y s T h r A l a  
CAGAGCAAGGGACCAUCCCCAGAUUCACCAAACCCCCCACCAAAACCGCC 400/1
Strain J3666/15
T h r H i s H i s G l u I l e T h r G l u P r o V a l L y s M e t A l a T h r P r o S e r G l u A s  
ACCCACCAUGAGAUCACAGAGCCCGUCAAAAUGGCAACACCUUCAGAGGA 450/1
Strain J3666/15
p P r o T y r G l n C y s S e r S e r A s n G l y T y r L e u A s p A r g P r o A s p L e u P r o G  
UCCCUACCAAUGCUCCAGCAAUGGUUAUUUGGACCGACCUGAUUUACCUG 500/1
Strain J3666/15
l u A s n P h e L y s L e u V a l L e u A s p V a l l l e C y s L y s P r o P r o G l y P r o G l u  
AAAAUUUCAAACUCGUAUUGGAUGUUAUAUGCAAGCCUCCAGGUCCUGAA 550/1
100
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Strain J3666/15
H i s H i s A s n T h r S e r C y s T y r G l u L y s A r g G l u I l e A s n P r o G l y S e r V a  
C AUC AC AAC AC C AGC UGUUAU GAGAAAC GU GAAAU C AAC C C AGGAAGUGU 600/1
Strain J3666/15
I C y s P r o A s p L e u V a l T h r M e t L y s A l a A s n M e t G l y L e u A s n A s n G l y G  
UUGCCCUGAUCUUGUAACAAUGAAGGCAAACAUGGGCUUAAACAAUGGUG 650/1
Strain J3666/15
l y G l y G X u A s p A l a A l a P r o T y r l l e G l u V a l T h r T h r L e u S e r T h r T y r  
GUGGGGAGGAUGCUGCACCUUAUAUAGAGGUUACCACCCUUUCUACGUAC 700/1
Strain J3666/15
S e r A a n L y s A r g A l a M e t C y s V a l H i s A s n G l y C y s A s p G l n G l y P h e C y  
UCCAACAAAAGGGCAAUGUGUGUCCACAAUGGGUGUGAUCAAGGCUUCUG 750/1
Strain J3666/15
s P h e P h e L e u S e r G l y L e u S e r T h r A s p G l n G l u A r g A l a V a l L e u G l u L  
UUUCUUCCUUUCUGGUUUAAGCACUGAUCAGGAGAGAGCUGUGCUAGAGC 800/1
Strain J3666/15
e u G l  y G l  y G ln G l  n A l  a l l  eM e tG lu L e u H i  s T y r A s p S e  r T y r T r p L y s  
UUGGAGGUCAACAGGCUAUCAUGGAGUUGCAUUAUGAUUCCUACUGGAAA 850/1
Strain J3666/15
H i s T y r T r p S e r A s n S e r A a n C y s V a l V a l P r o A r g T h r A s n C y s A s n L e  
CACUAUUGGAGUAACUCUAAUUGUGUUGUUCCCAGAACAAACUGCAACCU 900/1
Strain J3666/15
u T h r A s p G l n T h r G l u I l e L e u P h e P r o A r g P h e A s n A s n L y s A s n G l n S  
GACAGAC CAAAC UGAGAUUUUGUUUC C UAGGUUUAAC AAC AAGAAUC AGU 9Xyi
Strain J3666 
Strain 15
e r G l n C y s T h r T h r C y s A l a A s p S e r A l a G l y L e u A s p A s n L y s P h e T y r  
C U C AGUGUAC C AC C U GUGC AGAUUC AGC U GGC C UAGAUAAC AAAUUUUAU 1000/1 
G
G l u
Strain J3666/15
L e u T h r C y s A s p G l y L e u L e u A r g T h r L e u P r o L e u V a l G l y L e u P r o S e  
C UC AC AUGUGAUGGGC UUUUAAGAAC CCUCCCUC UAGUXJGGAC UACCCAG 1050/1
Strain J3666/15
1- L e u S e r P r o G l n A l a T y r L y s A l a V a l P r o T h r G l n T h r T h r G l y T h r T  
CCUAAGUCCUCAGGCUUACAAAGCUGUACCCACACAAACUACAGGCACCA 1100/1
Strain J3666 , 
Strain 15
h r T h r A l a P r o T h r S e r G l u S e r A r g H i s P r o T h r P r o A l a P r o A r g A r g  
CCACGGCACCAACAUCAGAGUCGAGGCACCCAACCCCUGCACCCAGGAGG 1150/1 
A
T h r
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Strain J3666/15
SerLysProLeuSerArgLysLysArgAlaLeuCysGlyValAspSerSe 
U C C AAAC C UC U C AGU C GGAAGAAGAGAGC UUUAU GU G G U  GUAGAC U C A A G  1200/1
Strain J3666/15
rArgGluProLysProThrMetProTyrTrpCysProMetLeuGlnLeuP 
CAGAGAACCCAAACCAACAAUGCCUUACUGGUGUCCUAUGCUCCAAUUAU 1250,1
Strain J3666/15
heProArgArgSerAsnSer
UUCCAAGGAGGUCUAAUUCUUAAGUGACCUAUUCCUGAAUUAACUUCAGA 1300/1
Strain J3666/15 AUAAGUAC C AAC C UUAUC AGUAGUUAAU G
Fig. 4.4 : PVM strains J3666 and 15 G gene nucleotide and amino acid sequences.
Nucleotide and amino acid sequence of the G gene of PVM strains 15 
and J3666. Nucleotide sequence shown is mRNA sense and represents the sequence of 
PVM strain J3666. The amino acid sequence of the first and second open reading 
frames (ORF) is shown above this sequence. Nucleotide bases indicated below the 
sequence for strain J3666 G gene represent nucleotide changes found in the G gene of 
PVM strain 15. The amino acid sequence shown below the nucleotide changes 
identified in the G gene of PVM strain 15 represent changes in amino acid sequence of 
the two ORF's of PVM strain 15 G gene compared to that of PVM strain J3666. A 
gap (indicated by a - sign) was introduced at position 171 of the nucleotide sequence 
of the G gene of strain J3666 to indicate the addition of an A residue in the nucleotide 
sequence of PVM strain 15.
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4.2.2. Sequence analysis of the G gene of PVM strain IS :
The sequence of the G gene of PVM strain 15 had been determined 
from two overlapping clones, designated 702 and 321, representing the nucleotide 
sequence spanning from positions 1 to 950 and 360 to 1330 shown in Fig. 4.4 
respectively (P. Chambers, personal communication). Additionally, two other clones 
843 and 221 contained the nucleotide sequence from positions 47 to 350 and 1073 to 
1330 respectively. Digestion of these clones with various restriction endonucleases 
generated fragments which were subcloned into either bacteriophage M13 m pl8 or 
mpl9. The nucleotide sequence of the G gene was determined using the method of 
Sanger et a l (1980) (P. Chambers, personal communication). A full length clone of the 
G gene was constructed following digestion of both fragments with H in d i, located 
within the gene sequence and other restriction sites found within the plasmid vector 
into which the G gene fragments had been cloned.. Full length clones were selected for 
by the ability to digest these constructs with H in d i (P. Chambers, personal 
communication). However confirmation that the constructs were truly representative 
of the full length clones was required from nucleotide sequencing. Furthermore, the 5' 
end of the G gene o f PVM strain 15 needed to be verified since the sequence derived 
from the clone 702 had an inverted 5' sequence resulting from the cloning procedure 
adopted by Barr et a l (1991).
4.2.2. l , Determination of the 5' end sequence :
Barr et al (1991) suggested an explanation for the presence of inverted 
repeat sequences at the 5' ends of the clones representing PVM strain 15 genes. Fig. 
4.5 is a diagrammatic representation of the proposed model for generation of 5' 
inverted sequences. During first strand cDNA synthesis a hairpin loop structure may 
have formed at the 5' end. Since DNA polymerase I, which possesses 5'—>3 
exonuclease activity, and not nuclease S1, was used to resolve such structures second
/'
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mRNA
1Reverse transcriptase
S '
1
v
r
RNase H
S’
5* ...........  .................  ............ ......................... ............... ....... .......... y
Self-priming via 
AGGA-TCCT
F
S '
Second strand synthesis
C - /  ........ 3*Production of gap 
by DNA polymerase I
"  ■ ]Unwinding
1Completion of duplex by DNA polymerase I
Fig. 4.5 : Model for generation of inverted repeat sequences at PVM strain 15 5' 
cDNA termini.
Diagrammatic representation of the proposed model for generation of 
inverted repeat sequences at the 5' end of PVM strain 15 clones (taken from Barr et 
al, 1991). First strand cDNA is synthesised in the presence of AMV reverse 
transcriptase and the mRNA strand removed following digestion with RNase H. 
Following second strand cDNA synthesis by DNA polymerase I, a gap is introduced 
into the first strand at the hairpin loop structure by the 5'—>3' exonuclease activity of 
DNA polymerase I which precedes its 5'—>3' polymerase activity. Replication of the 
loop and stem regions could then occur following unwinding of the molecule resulting 
in the creation of inverted repeat sequences at the 5' end.
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strand cDNA synthesis may have been primed from this hairpin structure.
Following second strand cDNA synthesis, the first strand cDNA 
synthesised may have been replaced by the action of DNA polymerase 5'—>3' 
exonuclease and 5'—>3' polymerase activities. It was argued that during such an event 
the hairpin loop may represent a physical barrier to further DNA synthesis and that 
since the DNA polymerase I 5'—>3' exonuclease precedes the 5'—>3* polymerase activity 
by a few nucleotides, a gap could have been generated at the end o f the duplex. 
Subsequent unwinding of the nicked loop structure could lead to DNA replication of 
the loop and stem regions, leading to the creation of inverted repeats at the 5' end. 
Thus it was necessary to determine the precise 5' sequence of the G gene of PVM 
strain 15.
A PCR method similar to that used for the 5' end of the N  gene by Barr 
et al (1991) was used to amplify the 5' end of the G gene from PVM strain 15 infected 
cell mRNA in order to determine the precise 5' end sequence o f the G gene. 
Homopolymer G residues were added to the 5' ends of cDNA synthesised from mRNA 
from PVM strain 15 infected cells in the presence of T4 DNA polynucleotide kinase. 
The 5' end of PVM strain 15 G gene was amplified by PCR using oligonucleotides 
oli-C (CCCGAGCTCTGCAGGATCCCCCCCCCCCC) and G3. The PCR product 
was digested with BamHI and H indlll (restriction sites located within oligonucleotides 
oli-C and G3 respectively) and cloned into M l3 mpl9. Seventeen independent M13 
mpl9 phage clones containing PCR amplified DNA were selected. Two o f these were 
sequenced individually and the remaining fifteen pooled together and sequenced 
collectively. The sequence obtained is shown in Fig. 4.6 and was found to be identical 
to that suggested by Chambers et al (1990b).
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G A T  C |G  A T C | G  A T C
____________>_______________ II_______________ I
Lane I Lane 2 Lane 3
Fig. 4.6 : Nucleotide sequence o f 5' end of PVM strain 15 G gene.
Autoradiograph showing the 5' nucleotide sequence of the G gene of PVM 
strain 15. The sequence shown is in mRNA sense. Lanes 1 and 2 are individual cDNA 
clones and lane 3 is a pool of 15 independent cDNA clones. The G residue preceding 
the AGGA sequence probably represents the cap of the mRNA. Numbers shown 
against individual nucleotides correspond to nucleotide positions shown in Fig. 4 4.
/
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Fig. 4.7 : PVM strain 15 G gene truncations.
Low melting point agarose gel stained with ethidium bromide showing 
1) 5' and 2) 3' end truncated fragments of the G(3) clone of PVM strain 15. Truncated 
fragments were released following end-filling of linearised, Bal31 digested DNA. 
Numbers A-H represent intervals of 5, 15, 30, 45, 60, 75, 90 and 105 mins at which 
aliquots of the Bal31 reaction were stopped by the addition of EDTA. M represents 
the DNA marker lane.
4 2.2.2. Confirmation of full length G gene clones :
CsCl purified DNA from a full length clone, designated G3, was 
linearised at the 5' end with EcoRI and at the 3' end with PstI, digested with 
exonuclease Bal31, cloned into the cloning vector pUC13 and subcloned into M l3 
mpl9. Fig. 4.7 shows Bal31 digested DNA of clone G3 purified from a low melting 
point agarose gel. Nucleotide sequencing of these truncated fragments confirmed the 
entire sequence of the G gene for PVM strain 15 (Fig. 4.4).
The nucleotide sequence of the G gene of PVM strain 15 when 
compared to that of strain J3666 shows several nucleotide changes. As was found for
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\strain J3666 the G gene of strain 15 also contains two ORF's at the 5' end of the gene. 
The first ORF potentially encodes a polypeptide of 35 amino acid residues whereas the 
second ORF codes for the major polypeptide (Fig. 4.9). The second ORF of strain 15 
G gene is 1089 nucleotides long coding for a polypeptide of 363 amino acids with a 
predicted molecular weight of 39,836 (which is close agreement to the molecular 
weight observed for the unglycosylated G protein of PVM strain 15 determined on 
SDS-PAGE (Ling and Pringle, 1989b), which is somewhat smaller by 33 amino acids 
than that of strain J3666. Only two nucleotide changes were found within the coding 
region for the putative extracellular domain. Nucleotide change of a U residue to A 
residue resulted in an amino acid change of Phe to Leu at position 97 (Fig. 4.4). A 
nucleotide change of a C residue to a G residue at position 953/4 (Fig. 4.4) resulted in 
amino acid substitution of Gin was changed to GIu whereas nucleotide substitution of 
a U residue to a A residue at position 1121/2 (Fig. 4.4) resulted in an amino acid 
substitution of Ser to Thr. Nucleotide changes of a U residue to A residue and U 
residue to C residue at positions 101 and 123 respectively resulted in amino acid 
changes of Val to Glu and Leu to Ser respectively. The most significant difference 
observed between the nucleotide sequences of the G genes of the two PVM strains 
was the addition of an A residue within PVM strain 15 G gene in the stretch of A 
residues spanning positions 169 to 172 of the G gene of strain J3666. This results in 
the deletion of 33 amino acid residues (in strain 15) at the N-terminus of the 
polypeptide synthesised from the major ORF of the G gene strain J3666. The number 
and position of potential N-link glycosylation sites (Asn-X-Ser/Thr) were conserved in 
both strains. No significant homology was found between the G genes of PVM strains 
15 or J3666 and HRSV virus G gene at both the nucleotide and amino acid level.
P V M  G  G e n e s
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Fig. 4.8 : Nucleotide sequence confirmation of PVM strain J3666 and 15 G gene 
between positions 163 and 177/8.
Nucleotide sequence showing the presence of a) four and b) five A 
residues within the G genes of PVM strains J3666 and 15 respectively. The nucleotide 
sequence shown is located between nucleotide positions 163 and 177/8 o f the 
sequence shown in Fig. 4.4.
To confirm that the addition of the A residue within the G gene of 
strain 15 between positions 169 and 172 of the sequence for the G gene of strain 
J3666 was not due to an error during the cloning procedure, a fragment containing the 
5' terminal 211 nucleotides of the G gene of PVM strain 15 was amplified using 
oligonucleotides G3 and G4 from cDNA synthesised from mRNA isolated from PVM 
strain 15 infected cells (Fig. 4.8). This procedure was deemed crucial since the absence 
of this additional A residue would result in the addition of 33 amino acids to the N 
terminus of the polypeptide synthesised from the G gene of PVM strain 15.
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J3666
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29
= First open reading frame.
11111 = Extracellular domain.
Fig. 4.9 : Open reading frames of PVM strains J3666 and 15 G genes.
Schematic representation of the two open reading frames of the G gene of 
PVM strains 15 and J3666. Numbers indicate the nucleotides at the start and end of each 
ORF. Positions of cysteine residues and potential N-linked glycosylation sites are 
indicated and were conserved in both strains.
Amplification was performed using Taq DNA polymerase as described in chapter 2. 
Sequence analysis of seventeen independent clones containing the region between 
nucleotides 75 and 190 was shown to be identical to that obtained above (Fig. 4.8).
A summary of the structure of the G genes of the two strains o f PVM is 
shown diagrammatically in Fig. 4.9. In strain J3666 a 5'-proximal AUG codon is 
located at positions 29 to 31. This is the beginning of a small ORF capable o f encoding 
a polypeptide of 12 amino acids. In strain 15 a mutation of U to C at position 30 has 
removed this AUG codon.
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4.3. D isc u ssio n  :
Sequence analysis of the F genes for these two strains, one a highly 
pathogenic variant and the other a non-pathogenic virus, revealed little nucleotide and 
amino acid differences (Chapter 3). These changes were considered to be conservative 
and therefore unlikely to be important in determining the pathogenicity of these strains. 
Nucleotide sequence of the G genes of these two strains of PVM has been determined. 
Although HRSV natural isolates have been shown to contain conserved and 
hypervariable regions within the extracellular domains and conservation within the 
cytoplasmic and transmembrane regions of the HRSV G proteins (Cane et al, 1991), 
the presence of only two amino acid changes observed within the extracellular domains 
of the predicted PVM G proteins is probably not a result of changes due to selective 
pressures but is more likely to be the result of the different passaging protocols used 
for the two strains since greater sequence divergence was observed within the 
cytoplasmically located domain of the PVM G proteins. PVM strain J3666 has to our 
knowledge been entirely passaged in mice whereas PVM strain 15 has been passaged 
in tissue culture since at least the late 1960's.
The nucleotide and amino acid sequence o f the G genes of either o f  the 
two strains of PVM show little homology with the G genes of either of the two 
subgroups of HRSV (Wertz et al, 1985; Johnson et al, 1987b; Sullender et al, 1990). 
However this is not surprising since the G genes of HRSV differ not only between the 
two subgroups but also between viruses within the same subgroup (Anderson et al, 
1985, Akerlind et al, 1988, Cane et al, 1991, Garda-Barreno et al, 1989, Sullender et 
al, 1991). The predicted polypeptides of 396 and 363 amino acids for PVM strain 
J3666 and strain 15 are similar in size to that of TRTV (Ling et al, 1992) but larger 
than those of HRSV. Since HRSV lacks demonstrable haemagglutination activity, the 
concatenation of a haemagglutinin like molecule to the attachment protein of a HRSV 
like protein, as suggested for other paramyxoviruses cannot be ruled out (Blumberg et
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al, 1985, Morrison and Portner, 1991). However, hydropathy analysis reveals some 
structural features common to the G proteins of pneumoviruses, most notably being 
the presence of a large hydrophobic domain at the N terminus of the protein (Fig. 
4.10). This region has been shown to contain both the signal sequence and membrane 
anchor region in HRSV (Lichtenstein et al, 1991). The amino acid sequence of the 
major polypeptides synthesised from the G genes of PVM strains 15 and J3666 have 
approximately equivalent serine (8%) and proline (9%) content but approximately half 
the threonine (11%) content of that of HRSV (strain A2). However the number of N- 
linked glycosylation sites found in the G genes of both PVM strains (6  in total) exceed 
those found in the G gene (4 in total) o f  HRSV (strain A2; Wertz et al, 1985). This is 
consistent with the presence of high proportion of N- and O-linked glycosylation 
observed for the G protein of PVM (Ling and Pringle, 1989b).
Another feature of the G genes of both strains of PVM and HRSV 
(Wertz et al, 1985) is the coding of the major polypeptide from the second available 
AUG. Although the major G polypeptide of strain J3666 is synthesised from the 
initiation codon, that in strain 15 would code for the small polypeptide o f 33 amino 
acids, another initiation codon is located upstream of this AUG in strain J3666 that 
would code for another smaller polypeptide of 12 amino acids (Fig. 4.4). Thus, the 
presence of two initiation codons and the fact that the major polypeptides of the G 
genes of PVM strains J3666 and 15 are synthesised from the second available AUG, 
but that the G gene of TRTV is transcribed from the first available open reading frame, 
suggest a role for the first initiation codons. Although the functional significance of the 
two open reading frames in PVM and HRSV are not known, one possibility is that the 
first AUG may act in down regulation o f  G gene expression since most ribosomes 
would initiate translation from the 5-proximal position. Since the gene order of TRTV 
is different to that of PVM and HRSV in that the G gene is located further from the
P V M  G  G e n e s
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A) PVM strain J3666 G protein :
B) PVM strain 15 G protein :
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C) HRSV G protein
Fig. 4.10 : Hydropathy profiles of PVM strains J3666 and 15 G proteins.
Hydropathy plots of predicted G proteins of a) PVM strains J3666 and
b) 15 and c) HRSV (strain A2). The procedure of Hopp and Woods (1981) with a 
window of 10 amino acids was used. The hydrophobic regions (indicated) at the N- 
termini are thought to be the transmembrane regions.
/
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*presumed single polymerase entry site (Dickens et al, 1984, Ling et al, 1992) than 
those of PVM or HRSV, relatively lower amounts of the TRTV G mRNA would be 
synthesised than for PVM or HRSV virus, thus resulting in the decreased expression of 
the TRTV G protein. Thus, the presence of an initiation codon upstream of the major 
ORF's of the G genes of PVM strains 15 and J3666 and HRSV suggest the possibility 
of down-regulation of gene expression at the translational level as an alternative to the 
low transcriptional level presumably found for TRTV. No evidence for the synthesis of 
polypeptides from upstream ORF's of PVM or HRSV have been reported.
As can be seen from Fig. 4.10, the hydropathy plots o f PVM strains 
J3666 and 15 resembles that of HRSV when considering the N termini of these 
proteins. The hydrophobic transmembrane regions of HRSV and PVM strain J3666 
are preceded by a short hydrophilic, cytoplasmically located region which is absent in 
the hydropathy plot of PVM strain 15. The absence of an apparent cytoplasmic tail in 
the G protein of PVM strain 15 results from the loss of the cytoplasmic tail present in 
the G protein of strain J3666 due to the addition of a single A residue (in PVM strain 
15 G gene) within the stretch of A residues located at positions 169 to 172 of strain 
J3666 (Fig. 4.4). The importance of this is unclear, but it is generally believed that 
cytoplasmic tails of the G and F glycoproteins of the Paramyxoviruses interact with 
the matrix protein during virus maturation (Peeples, 1991; Ray et al, 1991). However 
the first three amino acids of the G protein of PVM strain 15 may protrude into the 
cytoplasm and could be stabilised by the addition of a lipid chain to the cysteine 
residue (second amino acid) of this short tail. Veit et a l (1990, 1991) have shown the 
M2 protein o f influenza virus and the HA protein of influenza B and influenza C 
viruses to be acylated. The HA protein of influenza virus B was found to contain 
palmitic acid Whereas that of influenza C was modified by the addition o f stearic acid 
(Veit et al, 1990). Furthermore, Collins and Mottet (1992) demonstrated the 
palmitylation of the G protein of HRSV although the precise location for addition o f
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1palmitate was not identified. Arumugham et al (1989) also observed the addition of 
palmitate to the HRSV F protein. However in our hands, immunoprécipitation analysis 
revealed no incorporation of 3H-palmitic acid into PVM strain 15 G protein (data not 
shown).
Although virions of a ts mutant of VSV lacked visible G glycoprotein 
(seen as spike-like projections) at the non-permissive temperature, transmembrane and 
cytoplasmic remnants of the G protein were found within the viral envelope, 
suggesting the cytoplasmic tail to be indispensable for efficient virus budding 
(Schnitzer et al, 1979, Metsikko and Simons, 1986). Strieker and Roux (1991) 
demonstrated that a ts mutant of Sendai virus lacking not only the extracellular 
domain, but also the transmembrane and cytoplasmic domains of the HN glycoprotein 
at the non-permissive temperature, was able to bud from infected cells indicating that 
these regions are dispensable for virus maturation. They concluded that in VSV, which 
has only one major glycoprotein, the transmembrane and cytoplasmic tail of the G 
protein were both essential for virus budding whereas in Sendai virus which possesses 
two major surface glycoproteins (F and G proteins) only one of these proteins was 
required for efficient virus budding. Alternatively, a cytoplasmically located domain 
could be added to the N terminus of the G protein o f PVM strain 15 by either the 
insertion o f non-templated bases or the deletion o f a single residue during viral 
transcription.
Ling and Pringle (1989b) observed two species of virion associated G 
proteins in immunoprécipitations of supernatant from PVM strain 15 infected cells. 
Since the initiation codon for the major polypeptide of the G gene o f strain 15 is in a 
weaker context for initiation than that found upstream, then according to the ribosome 
scanning model (Kozak, 1989), a majority of ribosomes would translate from the 
initiation codon for the first ORF. Additionally, since the termination codon for this 
ORF is located downstream of A U G ^ , which initiates synthesis of the major
/
P V M  G  G e n e s
116
I
polypeptide, these ribosomes would bypass initiation at this AUG. Initiation of 
polypeptide synthesis at the AUG246 located in frame and downstream of AUG183 
would result in a polypeptide that would be secreted from infected cells and which 
should not be associated with the virions. Thus, it remains possible that by some 
mechanism, following initiation of polypeptide synthesis at the AUGg3, the reading 
frame switches to that of the major open reading frame. However, sequence analysis 
between the AUGg3 and AUG)83 reveals the presence of a termination codon (UAA; 
at position 168-170 of the sequence shown for strain 15 in Fig. 4.4) upstream and in 
frame with the AUGjg3. Thus any modifications that would lead to the switching of 
reading frames from that of the first ORF to that of the major polypeptide should be 
found between this termination codon and the termination codon for the small ORF 
located downstream of AUG]g3 positions 188 to 190 (Fig. 4.4).
Initiation of polypeptide synthesis has been shown to occur at non 
AUG codons. The C  proteins of human PIV1 isolates have been shown to initiate at 
GUG codons (Boeck et al, 1992, Power et al, 1992) whereas that for Sendai virus is 
known to initiate at an ACG codon (Curran and Kolakofsky, 1988, Gupta and 
Patwardhan, 1988). Analysis of the PVM G gene sequence would suggest that such an 
option is unlikely for PVM since initiation of a polypeptide from a non AUG codon 
from within the G gene of PVM strain 15 would not lead to the addition of a 
cytoplasmic tail because of the presence of a termination codon located just upstream 
and in frame with the initiation codon for the major polypeptide. Thus, if any 
polypeptide were to be initiated from a non AUG codon it would be terminated before 
translation of the major polypeptide sequence began. Insertion of non-templated bases 
resulting in a shift of reading frame during transcription of the P/V genes of SV5 
(Thomas et al,' 1988), measles virus (Cattaneo et al, 1989), Sendai virus (Vidal et al, 
1990) and human parainfluenza type 2 virus (Ohgimoto et al, 1990), mumps virus 
(Paterson and Lamb, 1990) and the P/D genes of HPIV3 (Galinski et al, 1992) has
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\been observed. These viruses can be divide into two group based on the resulting 
polypeptides following insertion of non-templated bases. In measles vims and Sendai 
vims the P gene which spans most of the length of the gene is transcribed from the 
major ORF whereas the V proteins are accessed following insertion of non-templated 
bases. For SV5, mumps vims and PIV2 the V proteins are synthesised from the first 
AUG and insertion of non-templated bases results in access to the P proteins. In all 
cases insertion of non-templated G residues occurs at a run of G residues located 
within the P genes. Vidal et al (1990) demonstrated this type of transcriptional 
modification to be a function of the vims encoded polymerase. Sequence analysis of 
mRNA isolated from cells expressing the P gene of Sendai vims following infection 
with a recombinant vaccinia vims revealed the absence of any mRNA species in which 
non-templated bases had been added. However sequence analysis of mRNA of the 
same cell line infected with Sendai vims contained species with insertion of non- 
templated G residues (Vidal et al, 1990). These results suggest the possibility that such 
an event might also occur during transcription of PVM strain 15 G gene to generate a 
polypeptide with a longer N-terminus region. The presence o f a stop codon (UAA; at 
position 168-170 of the sequence shown for strain 15 in Fig. 4.4) upstream and in­
frame with the major ORF of the G gene of PVM strain 15, indicates that insertion of 
non-templated bases could only occur between positions 168 and 180, most probably 
with the mn of A residues of the sequence shown in Fig. 4.4. Although non-templated 
insertion of bases within the P genes of Paramyxoviruses is thought to occur by 
stuttering of the viral polymerase at a mn of G residues by a mechanism similar to that 
of polyadenylation, it would be possible for insertion of non-templated bases to occur 
within the mn of A residues at positions 169 and 173 of the nucleotide sequence of the 
G gene of PVM strain 15. Nucleotide sequences of seventeen independent M13 m pl8 
phage clones containing DNA amplified by PCR representing the sequence between 
positions 83 and 180 of PVM strain 15 were found to be identical to that obtained by
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\sequence analysis of PVM strain 15 (Fig. 4.6). The results suggests insertion of non- 
templated bases during G gene transcription of PVM strain 15 is unlikely to occur at 
this position. One speculative possibility is that there could be fratneshifling due to 
pseudoknot formation between the first and second ORF, as found during translation 
for various retroviruses such as Rous sarcoma virus (Jacks and Varmus, 1985), mouse 
mammary tumour virus (Moore et al, 1987; Jacks et al, 1987) and the avian 
coronavirus, infectious bronchitis virus (Brierley et al, 1989). Such a phenomenon 
could alter the reading frame of the first ORF to that of the second ORF of the G gene 
of PVM strain 15 resulting in the addition o f amino acid residues to the N-terminus of 
the polypeptide synthesised from the second ORF.
However, the possibility exists that a secretory form of the G protein 
could have been precipitated from PVM infected cell supernatant, which would then be 
interpreted as virion associated. Two species of the HRSV G protein have also been 
observed although one of these is secreted into the medium (Hendricks, 1987). 
Hendricks et al (1988) suggested the soluble form was a result of cleavage within the 
transmembrane region of the HRSV G protein. However, Roberts et al (1993) 
presented evidence that this secreted form was a result o f initiation at an internal AUG 
located downstream (or within) of the transmembrane region producing a protein, 
which is proteolytically digested to a mature form. It is possible that the PVM G 
protein could be cleaved by signal peptidases at the sequence Ser-Asn-His-Lys found 
downstream of the internal methionine, thus releasing a soluble form of the protein. 
This cleavage sequence is very similar to the one found in the G protein of HRSV 
(Ala-Asn-His-Lys; Hendricks et al, 1988).
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\5.1. In t r o d u c t io n  :
In the previous chapter the determination of the nucleotide sequence of 
the G genes of PVM strains J3666 and 15 was described. Only two amino acid 
substitutions were found within the extracellular region of the predicted proteins. 
However, several differences were found within the N-terminus coding region of the G 
gene of PVM strain 15 when compared to that of PVM strain J3666. Most notable 
was the absence of a hydrophilic domain at the N terminus of the G gene of PVM 
strain 15 which presumably would form the cytoplasmically located domain with strain 
J3666. Additionally, the initiation codon (AUGjg3) of the major polypeptide of the G 
gene of strain 15 was in a less favourable context for initiation than that for the shorter 
ORF located upstream of the major ORF. Thus, expression from the major ORF is 
likely to be diminished or reduced by the presence of this upstream AUG. The aim of 
the work described in this chapter was to determine whether expression from AUGjg3 
resulted in the incorporation of the synthesised polypeptide into the cell membrane. 
Since the presence of the first AUGg3 might down-regulate expression of the major 
ORF, it was deemed necessary to remove this AUG for subsequent expression work.
5.2. R esu l t s  :
5.2.1. Removal of first AUG :
Fig 5.1 shows a diagrammatic representation of the procedure adopted 
for the removal of the first initiation codon (AUG83) of the G gene o f PVM strain 15. 
The 5' end of a clone, designated G(3), representing the G gene of PVM strain 15 was 
digested with exonuclease Bal31 following linearisation with EcoRl. At regular 
intervals aliquots were removed and the reaction stopped by the addition of EDTA. 
Truncated fragment ends were end-filled with Klenow DNA polymerase and the gene 
was released with digestion with Pstl. The truncated fragments were purified from a 
low melting point agarose gel (Fig. 5.2) and ligated into Sm al and P stl digested
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Fig. 5.1 : Removal o f first available AUG of PVM strain 15 G gene.
Diagrammatic representation of the procedure used in the removal of 
the first ATG located of the G gene of PVM strain 15 and the subsequent cloning of 
truncated inserts.
pUC13 DNA. The sizes of these truncated fragments were estimated from miniprep 
analysis following digestion of miniprep DNA with EcoRI and PstI (not shown). 
Clones in which the insert size was calculated to be reduced by approximately 100 
nucleotides were selected for nucleotide sequence analysis. EcoRI and PstI digested 
fragments of miniprep DNA were purified from a low melting point agarose gel and 
ligated into EcoRI and PstI digested M l3 mpl9 DNA. One of the resulting clones, 
designated 5.11, represented the nucleotide sequence starting at position 148 of the G 
gene of PVM strain 15 and was selected for expression work (Fig. 5.3).
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Fig. 5.2 : 5' end truncations of PVM strain 15 G gene.
Low melting point agarose gel stained with ethidium bromide showing 
fragments of the G gene of PVM strain 15 following linearisation with EcoRI, 
digestion with exonuclease Bal31, end-filled with Klenow DNA polymerase and 
released with digestion with the P stl. Numbers shown below each lane represent 
intervals (in minutes) at which aliquots of the Bal3J reaction were stopped by the 
addition o f EDTA. M represents the DNA marker lane.
5,2,2t Transient expression of full-length and truncated PVM G gene :
5.2.2, l. C onstruction  o f  transient  expression  DNA :
Clones representing full-length (G(3)) and truncated (5.11) PVM strain 
15 G gene were subcloned into the SV40 based transient expression vector, pSVL 
(Fig. 5.4). 5.11 plasmid DNA was digested with EcoRI and Xbal, end-filled with
*P V M  G  G e n e  E x p r e s s i o n
Fig. 5.3 : 5' nucleotide sequence of PVM strain 15 G gene clone lacking first available 
AUG.
Autoradiograph showing the nucleotide sequence at the 5' end of PVM 
G gene clone 5.11. The sequence was found to contain nucleotide sequence located 
after nucleotide 148 (indicated) of the sequence for the full-length PVM G strain 15 
shown in Fig. 4.4. PVM strain 15 G gene specific nucleotide sequences are shown in 
bold.
Klenow DNA polymerase and the insert purified from low melting point agarose gel. 
The insert was then ligated into Smal digested pSVL. Clones representing the 5.11 
insert in i) correct orientation for expression (designated pSVG) and ii) incorrect 
orientation for expression (designated pSVGR) were identified following digestion of 
miniprep DNA with restriction endonucleases HincUII or H in d i (Fig. 5.5).
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Xho I, Xba I, Sma I, Sac 1, BamHI
Fig. 5.4 : pSVL, a SV40 based expression vector.
SV40 based shuttle vector used for expression of PVM strain 15 G 
gene and the truncated form of this gene (clone 5.11). The genes were cloned into the 
multiple cloning site and expression directed by the SV40 late promoter as described 
in the text. Polyadenylation of mRNA occurs following correct splicing of transcripts 
using the SV40 VP1 processing signals.
Plasmid DNA of clone G(3) was digested with X bal to release a 
fragment containing the whole of the PVM G gene and this was purified from a low 
melting point agarose gel and ligated into Xbal linearised pSVL. Clones representing 
the full-length G gene in i) the correct orientation for expression (designated pSG(3)) 
and ii) the incorrect orientation for expression (designated pSGR(3)) were selected 
following digestion of miniprep DNA with restriction endonucleases H indlll or H in d i 
(Fig. 5.5).
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Fig. 5.5 : Restriction endonuclease analysis of pSVL-G gene constructs.
1% agarose gel stained with ethidium bromide showing 1) Hindi I I and 
2) H incII restriction endonuclease digestion of a) pSVG, b) pSVGR, c) pSCG(3) and 
d) pSCGR(3) pSVL vector constructs (see text for descriptions). M represents the 
DNA marker lane.
5.2 2.2. IN VITRO EXPRESSION OF PSGC31. PSGR(3) PSVG AND PSVGR :
CsCl density gradient purified DNA of pSVG, pSVGR, pSG(3) or 
pSGR(3) was introduced into Cos-7 or L cells using a variation o f the Chen and 
Okayama (1987) transfection protocol as described in the chapter 2, section 2.6.2.1. 
48 hours post-transfection, cells were seeded onto multi-spot slides and incubated 
overnight at 37°C. Expression of the G gene was visualised by indirect 
immunofluorescence using a G monoclonal antibody specific for PVM strain 15 G 
protein (19/1/C9; Ling and Pringle, 1989b) and FITC conjugated goat anti-mouse 
antibody. A very low percentage of transfected cells was found to express the full-
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length G gene and that from plasmid 5.11, although the intensities of expressing cells 
appeared to be equivalent. Fig. 5.6 shows indirect immunofluorescence o f acetone 
fixed transfected Cos-7 and L cells. The results indicate that the proteins produced 
from the both the full-length and truncated G gene of PVM strain 15 are located in the 
cytoplasm. No fluorescence was observed for either pSVGR, pSGR(3) or mock 
transfected cells (not shown). It was not possible to demonstrate surface expression of 
transfected cells, since unfixed cells did not adhere to the slides during the indirect 
immunofluorescence procedure. However, cells found to be expressing either the full 
length G gene or 5.11 appeared to have an abnormal morphology possibly due to the 
presence of membrane associated G protein.
5.2.3. Construction of recombinant vaccinia virus :
5.2.3, l , Construction  of shuttle plasm ids :
Full length G genes of PVM strain J3666 and strain 15 and 5.11, 
representing the G gene of strain 15 lacking the first initiation codon, were subcloned 
into a vaccinia virus shuttle vector, pSC ll (Fig. 5.7, Chakrabarti et al, 1985). This 
vector was chosen to construct recombinant vaccinia virus since expression o f foreign 
DNA is controlled by the vaccinia virus early promoter P7 Additionally the cloning 
site for this plasmid is flanked by segments of the vaccinia virus thymidine kinase (TK) 
gene to allow homologous recombination into super-infecting virus genomic DNA, 
and a copy of the E. coli lacZ gene used to identify true recombinant vaccinia virus. 
Homologous recombination (Fig. 5.8) occurs following transfection of wild type 
vaccinia virus infected cells with recombinant vaccinia virus shuttle plasmid. Since 
homologous recombination occurs within the TK gene DNA sequence and segments 
of the TK gene found within the shuttle vector, insertion of foreign DNA results in thet
inactivation of the TK gene in recombinant vaccinia virus to give a TK* phenotype.
P V M  G Gene Expressioin
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b)
Fig. 5.6 : Immunofluorescence of cells expressing PVM strain 15 G gene.
Immunofluorescence staining of Cos-7 cells transfected with either a) 
full-length PVM strain 15 G gene or b) construct 5.11 expressed from a SV40 based 
expression vector, pSVL (see text for details)
/
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Fig. 5.7 : pSCl 1, a vaccinia virus shuttle vector.
Vaccinia virus shuttle vector carrying the E. coli lacZ gene and 
segments of the vaccinia virus thymidine kinase (TK) gene used in construction of 
recombinant vaccinia virus. PVM G genes of strains J3666 and 15 and the 5.11 insert 
were cloned into the unique SmcJ of this vector.
Recombinant viruses are then selected for in HuTK* 143 cells in the presence of 5- 
bromo-2'-deoxyuridine (BrdU). Lethal incorporation of BrdU into the virus genome 
occurs only after phosphorylation of BrdU by thymidine kinase expressed by wild type 
vaccinia virus. True recombinant vaccinia virus is then distinguishable from 
spontaneous wild type revertants by their blue appearance when X-gal is added to the 
overlay medium. Thus, selection of recombinant vaccinia virus was considered to be 
more likely if pSCl 1 rather than a shuttle vector carrying the thymidine kinase markers 
but not the lacZ gene was used.
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Integration of PVM G and lacZ 
genes following double cross-over.
i -  ^  TKr
-- ' 1 1 * I
PVM G gene
Fig. 5.8 : Homologous recombination between genomic vaccinia virus DNA and 
pSCll.
Diagrammatic representation of the integration o f PVM G genes into 
the vaccinia virus genome following homologous recombination between the TK gene 
of wild type vaccinia virus and the TK gene segments in the pSC ll recombinant 
shuttle DNA in infected-transfected cells.
I
sThe full-length G gene of PVM strain J3666 was digested with EcoRI 
and PstI whereas that of strain 15, clone G(3), was digested with X bal in order to 
release the gene inserts from pBS and pUC13 vector DNA respectively. The insert 
from plasmid 5.11 DNA was released following digestion with EeoRI and Xbal. 
Digested DNA of all three samples was phenol/chloroform extracted and ethanol 
precipitated. The inserts were end-blunted with T4 DNA polymerase, purified from a 
low melting point agarose gel and ligated into Smal linearised pSCll. The orientation 
of the inserts within several clones for each construct was determined by digestion of 
miniprep DNA with either BamHI or H indlll and Xhol. Two clones for each ligation 
were selected, one representing the insert in the correct orientation for expression 
whilst the other in the incorrect orientation for expression. Fig. 5.9 shows BamHI, and 
H indlll and X hol digested CsCl density gradient purified DNA of the G gene of PVM 
strain J3666 in the correct orientation for expression, designated pSCG3666, and the 
incorrect orientation for expression, designated pSCGR3666. Similarly, constructs 
containing G(3) or 5.11-derived inserts in the correct orientation for expression were 
designated pSCG(3) and pSCG respectively whereas those in the incorrect orientation 
were designated pSCGR(3) and pSCGR respectively.
5.2.3.2 , Selection  of recom binant  vaccinia  virus :
HeLa cells were infected with a wild type vaccinia virus at a multiplicity 
of infection (m.o.i.) of 2 pfii/ml. At 1 hour post-infection, CsCl-density gradient 
purified DNA of pSCG, pSCGR, pSCG(3), pSCGR(3), pSCG3666 or pSCGR3666 
were introduced into these infected cells using either of the transfection protocols 
described in chapter 2, section 2.6.2. Transfected-infected cells were harvested once all
the cells had become detached from their support.
1
Aliquots of supernatants containing mixture of wild-type and 
recombinant vaccinia virus were serially diluted and used to infect monolayers of
P V M  G  G e n e  E x p r e s s io n
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Fig. 5.9 : Restriction endonuclease analysis of recombinant vaccinia virus shuttle 
vector.
1% agarose gel stained with ethidium bromide showing 1) Hindi I  I  and 
X hol digest and 2) BamHI restriction endonuclease digests of a) pSCG, b) pSCGR, c) 
pSCG(3), d) pSCGR(3), e) pSCG3666, and f) pSCGR3666 representing recombinant 
vaccinia virus shuttle vector containing the G genes of both strains of PVM (see text 
for detailed descriptions). M represents the DNA marker lane.
HuTK" 143 cells grown in 6 -well tissue culture plates. Following adsorption of virus, 
cells were overlaid with a 1% (w/v) agar overlay containing GMEM supplemented 
with FCS (final concentration of 2%) and 25 gg/ml BrdU and incubated for 48 hours 
at 37°C, 5% CO2. To distinguish recombinant vaccinia virus from spontaneous 
revertants, 1% (w/v) of agar containing 20 pg/ml X-gal was added to the infected cells 
and incubated overnight at 37°C, 5%. Fig. 5.10 shows blue colouration of recombinant 
vaccinia virus during the selection process. Visible individual blue plaques were 
transferred into 0.5 ml of GMEM supplemented with FCS to a final concentration of 
5%.
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Fig. 5.10 : Visualisation of recombinant vaccinia virus.
Photograph showing expression of the lacZ gene in TK* cells, of a) six- 
well plate and b) close up of one of the wells, of recombinant vaccinia virus plaques 
(blue) containing full-length PVM strain 15 G gene following infection with virus 
extracted from BS-C-1 cells that had been infected with wild type vaccinia virus and 
transfected with construct pSCG(3) DNA.
/'
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Several recombinant plaques (blue) from each construct were 
transferred into GMEM supplemented with FCS (final concentration of 2%) and 
underwent three cycles freeze-thaw. The plaque purification process involved 
amplification of recombinant vaccinia virus in tissue culture cells which would then 
undergo plaque purification. Aliquots of each recombinant vaccinia virus were added 
to monolayers of HuTK" 143 and incubated at 37°C, 5% CO2 in the presence of 
GMEM supplemented with FCS (2% final concentration) and containing 25 pg/ml 
BrdU. Unfortunately, no replication of these recombinant plaques was observed as 
measured by their ability to cause CPE. Similar results were obtained when 
recombinant plaques were amplified in HeLa cells. Attempts to isolate replicative 
recombinant vaccinia virus from overlays containing low melting point agarose gel or 
by sonication of selected plaques also proved fruitless
5.2.4. Expression of PVM G genes directed bv T7 RNA polymerase recombinant 
vaccinia virus :
The failure to construct recombinant vaccinia virus carrying the PVM G 
genes necessitated the adoption of an alternative strategy for demonstrating the surface 
location of the G proteins of both strains of PVM. However, expression of genes have 
been achieved by transfection of cells infected with recombinant vaccinia virus, vTF7-3 
(Fuerst et al, 1986) expressing the T7 RNA polymerase gene, following transfection 
with plasmid DNA in which expression of genes are directed from the T7 promoter. 
Thus, it was decided to express the G genes of both PVM strains using this system.
5.2.4, l. C o n s t r u c t io n  o f  pGEMI r e c o m b in a n t  p l a s m id s  :
The G gene of PVM strain J3666 was released from pBS vector DNA 
following restriction endonuclease digestion with EcoRI and PstI whereas that of 
strain 15, clone G(3) was released from pUC13 by digestion with Xbal. Plasmid 5.11 
DNA was digested with EcoRI and Xbal to release the insert. Following purification of
P V M  G  G e n e  E x p r e s s i o n
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the gene inserts from a low melting point agarose gel, the inserts were ligated into 
EcoRl and PstI, Xbal and EcoRI/Xbal digested pGEMl expression vector DNA 
respectively. This placed the transcription of the genes under the control of the T7 
RNA promoter. Bacterial colonies containing the appropriate recombinant plasmids 
were identified by digestion of miniprep DNA with EcoRJ and Pstl. Constructs of 
pGEMl and the G gene of strain J3666 and construct 5.11 were designated pGEMl - 
G3666 and pGEMl-5.11. Clones of pGEMl-G(3), constructed by ligation of Xbal 
digested pGEMl and G(3), that would result in transcriptional control from the T7 
RNA promoter were distinguishable following digestion of miniprep DNA with 
H indlll, since a single H indlll restriction site is located 3' of AUGjgj within the G 
genes of both strains of PVM and the other H indlll restriction site located within 
pGEMl vector (not shown).
5.2.4 2. E x p r e s s io n  o f  PVM G gf.nf.s :
BS-C-1 cells grown on glass coverslips overnight were infected with 
recombinant vaccinia virus carrying the T7 RNA polymerase gene at a multiplicity of 
infection of 5 pfu/ml. Following adsorption of the virus for 1 hour at 37°C, 
TransfectACE-DNA complex diluted in Opti-MEM reduced medium, containing the 
appropriate CsCl-density gradient purified DNA was added to the infected cells and 
incubated for 6  hours at 37°C in a 5% CO2 atmosphere. GMEM containing 20% FCS 
was added to give a final concentration of 10% and the cells incubated for 15-18 
hours. Expression of PVM G protein was visualised by indirect immunofluorescence 
following staining with Texas-red as described in chapter 2, section 2.7.10. 
Transfected/infected cells showing surface expression were fixed with 2% 
paraformaldehyde only after incubation with streptavidin-Texas red conjugate during 
the immunofluorescence staining procedure following incubation of the cells with MAb 
19\1\C9 (Ling and Pringle, 1989b). Fig 5.11 shows the surface location of G proteins
P V M  G  G e n e  E x p r e s s i o n
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Fig. 5.11: Cell surface location of PVM G proteins.
Photographs showing surface location of a) PVM strain J3666 G gene
c) full-length strain 15 and e) 5.11 inserts expressed under the control of the T7 RNA 
polymerase promoter in BS-C-1 cells infected with recombinant vaccinia virus 
expressing the T7 RNA polymerase. Phase contrast photographs of the expressing 
cells are shown for b) PVM strain J3666 G gene, d) full-length strain 15 G gene and f) 
5.11 insert. Cells were fixed in 2% paraformaldehyde only after incubation with 
streptavidin-Texas red conjugate during the immunofluorescence staining procedure
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yofPVM  directed from pGEMl-G3666, pGEMl-5.11 and pGEMl-G(3) recombinant 
plasmid constructs.
5.3. D isc u ssio n  :
The expression of the G genes of both strains ofPVM in tissue culture 
cells was visualised by indirect immunofluorescence. Since the predicted G protein of 
PVM strain 15 lacks the putative cytoplasmic domain, which is thought to stabilise the 
protein whilst imbedded within the lipid bilayer, it is possible that a cytoplasmic tail 
could be added following possible ribosomal frameshifting after initiation from the first 
available AUG. Additionally, it was possible that since A U G ^  ofPVM  strain 15 G 
gene is in a poorer context for initiation than AUG83 (Kozak, 1986), expression of the 
major polypeptide from the full-length clone (G(3)) may be down-regulated by the 
presence of this upstream AUG. To determine whether the G protein lacking this 
cytoplasmic tail could be correctly and stably inserted into the lipid bilayer, the first 
AUG was removed by digestion with exonuclease Bal31. Thus, any protein 
synthesised from this construct would be as a result of initiation from the second AUG 
codon alone.
Expression of the full-length and truncated form of the G gene of PVM 
strain 15 in Cos-7 and L cells directed by the SV40 late promoter was visualised by 
indirect immunofluorescence using MAb 19/1/C9 (Ling and Pringle, 1989b) and 
confirm the coding assignment of this gene. A very low percentage of transfected cells 
was found to express the full-length G gene and 5.11, although the intensities of 
expressing cells appeared to be equivalent. Although expression was observed in 
transfected cells that had been fixed in cold acetone prior to the immunofluorescence 
staining procedure, expression in unfixed cells could not be observed as they did not
l
remain attached to the slide during the detection procedure. Furthermore, cells shown 
to express either of the constructs had an abnormal appearance in which the cell
P V M  G  G e n e  E x p r e s s i o n
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Vmembrane appeared thickened possibly due to incorporation of the G proteins within 
the cell membrane. These results although not confirming the surface location of the 
proteins do suggest association of the G protein lacking the cytoplasmic tail with the 
cell membrane.
Attempts were made to isolate permanent cell lines expressing the PVM 
G proteins by co-transfection of cells with these pSVL-G constructs with plasmids 
carrying neomycin or puromycin resistance genes Although colonies of transfected 
cells resistant to either G418 (geneticin) or puromycin were obtained, FACS analysis 
did not show expression of the G genes of PVM strain 15. Numerous unsuccessful 
attempts were also made to construct recombinant plasmids in which the G genes 
would have been under the control of the major cytomegalovirus immediate early 
promoter or the metallothionine I promoter flanked by retroviral terminal LTR's that 
would have increased integration of the shuttle DNA into the cell chromosomes. 
Attempts to construct shuttle vector DNA with a view to construction of recombinant 
adenovirus or recombinant herpes simplex virus also proved fruitless due to apparent 
instability of the insert which appears to be a feature of some genes encoding 
glycoproteins.
Cloning of HRSV G gene into a variety of expression vectors has 
proved difficult (L. A. Ball, personal communication) although expression has been 
achieved by construction of recombinant vaccinia virus (Olmsted et a l, 1986; Elango et 
al, 1986; Stott et al, 1986). The presence of nucleotide sequences resembling those of 
prokaryotic promoters have been found in HRSV G genes (P. Cane, personal 
communication). Thus, expression from an internal AUG is possible with the resulting 
product toxic to the prokaryotic cell. Thus, attempts were made to construct 
recombinant vaccinia virus carrying the PVM G genes. Although recombinant plaques 
could be identified by their blue appearance in the presence of X-gal when grown in 
TK‘ cells in the presence of BrdU, no subsequent amplification of these plaques could
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Ibe achieved. It had been suggested that the larger, intense blue plaques (Fig. 5.10) 
were cells expressing the lacZ product from the recombinant shuttle vector DNA 
constructs and that the smaller, much fainter blue plaques, represented true 
recombinant virus. However, further amplification of these fainter plaques could not be 
achieved. Expression of the lacZ gene in transfected cells could only be achieved in the 
presence of vaccinia virus since the lacZ gene is under the control of the vaccinia virus 
P ll promoter. It is still unknown as to why amplification of these putative recombinant 
vaccinia virus plaques was not possible.
Recently, expression of a number of viral genes has been achieved by 
transfection of cells infected with recombinant vaccinia virus (vTF7-3) expressing the 
T7 RNA polymerase with plasmid DNA in which the gene to be expressed is under the 
control of the T7 promoter and it was decided to express the PVM G genes using this 
system. Expression of the PVM G genes was achieved in BS-C-1 cells infected with 
vTF7-3 following transfection with DNA plasmid constructs in which the G genes 
were under the control of the T7 promoter located within the pGEMl vector. 
Expression of the PVM strain J3666, full-length strain 15 G gene and 5.11 insert was 
demonstrated in these infected-transfected cells by indirect immunofluorescence. 
Furthermore, expression of all three constructs was demonstrated in unfixed infected- 
transfected cells showing the surface location of these gene products. The results 
confirm that at least a significant proportion of the gene product expressed from 
AUGig3 (in construct 5.11 which lacks AUGg3) which lacks the cytoplasmic tail, is 
transported to the cell surface following correct processing of the protein. The results 
indicate that signals required for correct processing of the PVM G protein probably are 
located within the transmembrane region and that the cytoplasmic N-terminal tail plays 
no significant role during processing of the protein. The significance of these findings 
are as yet unknown since it is generally believed that the cytoplasmic tails of the G and
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F glycoproteins of the paramyxoviruses interact with the matrix protein during virus 
maturation (Peeples, 1991; Ray et al, 1991).
Schnitzer et al (1979) failed to observe spike-like projections, 
corresponding to the G protein, on the surface of virions of a temperature sensitive 
mutant of VSV at the non-permissive temperature. However remnants of the 
transmembrane and cytoplasmic domains of the G protein were found associated with 
the viral envelope, suggesting the cytoplasmic tail to be indispensable for efficient virus 
budding (Metsikko and Simons, 1986). Owens and Rose (1993) constructed a 
chimaeric protein consisting of the cytoplasmic tail of the G protein of VSV linked to 
the transmembrane and extracellular domains of the HIV-1 envelope glycoprotein. 
Expression of this construct resulted in rescue with VSV defective in the G protein at 
the non-permissive temperature. The rescued mutant was able to bind CD4+ cells 
indicating the surface location of the chimaeric protein. Another construct in which the 
VSV G protein cytoplasmic domain was attached to the envelope protein o f the HIV-1 
which had a truncated cytoplasmic domain failed to rescue the VSV mutant. These 
results indicate that the cytoplasmic domain of the VSV G protein should be in very 
close proximity of the cell membrane in order for the M protein to interact with the 
cytoplasmic domain of VSV during virus budding. Additionally, the cytoplasmic 
domain of the VSV G protein contains sequences recognised by the VSV M protein 
(Owens and Rose, 1993). It seems unlikely that the 3 amino acid long cytoplasmic 
domain of the G protein of PVM strain 15 could interact with the PVM M protein. It 
is possible that the G protein could be stabilised by the addition of fatty acids to the 
cysteine residue located within the three amino acids that form the cytoplasmic 
domain. Collier et al (1991) demonstrated a decapeptide corresponding to the 
cytoplasmic domain of the influenza virus haemagglutinin protein to inhibit release of 
virus particles and infectious virions. Recently, Strieker and Roux (1991) 
demonstrated a ts mutant of Sendai virus lacking not only the extracellular domain, but
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\also the transmembrane and cytoplasmic domains of the HN glycoprotein at the non- 
permissive temperature, was able to bud from infected cells. A MAb raised against the 
N terminal 20 amino acids of the Sendai virus HN protein failed to react with any HN 
remnants in Western blot analysis. They concluded that in VSV, which has only one 
major glycoprotein, the transmembrane and cytoplasmic tail of the G protein were both 
essential for virus budding whereas in Sendai virus which possesses two major surface 
glycoproteins (F and G proteins) only one of these proteins was required for efficient 
virus budding.
Wilson et al (1990) investigated the effect o f deletion of the 
cytoplasmic tail of the NDV HN protein. 23 of the 26 amino acids comprising the 
NDV HN protein cytoplasmic tail were deleted and its effect upon translocation of the 
HN protein across the membrane in vitro was examined. The removal of the 23 amino 
acids leaves the mutant protein with a cytoplasmic tail of just three amino acids with a 
single positive charge. The level of the mutant protein inserted into membranes in in 
vitro translation experiments in wheat germ extracts was less than the wild type HN 
protein although approximately 50% of the mutant protein was found to be inserted 
into the membranes since it was resistant to extraction with EDTA or alkaline pH. 
Extraction with EDTA results in removal of peripheral proteins pelleted with the 
membrane fraction whereas alkaline pH treatment removes proteins that are secreted 
or are not integrated into the membranes. Both glycosylated and unglycosylated forms 
of the mutant protein were found to be inserted into the cells membrane although the 
unglycosylated form was sensitive to trypsin digestion suggesting an inverse 
orientation of this mutant protein in which the C terminus would be located internally. 
The wild type HN protein was not observed in this inverse orientation (Wilson et al, 
1990). The authors speculate that presence of the long hydrophilic cytoplasmic domain 
of NDV HN protein may prevent spontaneous insertion of the protein allowing 
interaction of the newly synthesised hydrophobic transmembrane domain with the cell
P V M  G  G e n e  E x p r e s s i o n
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\membrane and preventing the inverse orientation of the wild type protein. Although 
the mutant HN protein of ND V was inserted into the membranes in both orientations, 
it is not known whether the G protein of PVM strain 15 is also inserted in both 
orientations since there is no way of detecting cells expressing the PVM G protein in 
the inverse orientation in the absence of appropriate MAb's. Thus, cells expressing the 
PVM G protein in both the correct and inverse orientations would be positive in the 
immunofluorescence staining procedure. This area would be o f future interest
P V M  G  G e n e  E x p r e s s i o n
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6.1. INTRODUCTION :
The surface location of the G proteins of a pathogenic and non- 
pathogenic strains of PVM was described in the preceding chapter. Although the G 
protein of strain 15, the non-pathogenic strain, lacked the cytoplasmic tail which 
presumably acts in stabilising the protein while anchored within the cell membrane, it 
appeared to be processed and transported correctly to the cell surface following 
visualisation by indirect immunofluorescence in cells transfected with plasmid DNA 
constructs carrying the PVM strain 15 G gene. However, it remains to be determined 
whether two virion associated G protein forms can be observed for PVM strain J3666 
as was the case for PVM strain 15 (Ling and Pringle, 1989b).
6.2. RESULTS :
6.2.1. Haemagglutination (HA1 and inhibition (HD assays :
PVM differs from HRSV in its ability to agglutinate murine 
erythrocytes cells. Although it is not known whether the two amino acid substitutions 
located within the extracellular domain of PVM strain J3666 when compared to strain 
15 are as a result of immunological pressures, it can be tested whether these mutations 
result in a change in haemagglutination by the virus.
Although MAb 19/1/C9 does not neutralise PVM infectivity in vitro its 
ability to inhibit haemagglutination has been previously reported (Ling and Pringle, 
1989b). Thus, this MAb was used in haemagglutination inhibition assays to determine 
reactivity of the MAb to PVM strain J3666. Fig. 6 .1 shows the results of HI assays for 
PVM strains J3666 and 15. Serial dilutions of MAb 19/1/C9 were tested against 5 HA 
units of PVM strains 15 and J3666 in the presence of 3.2x10s mouse red blood cells. 
The results indioate reactivity of the MAb to be similar in both strains of PVM.
/
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Y)
Fig. 6 .1 : Haemagglutination inhibition of mouse erythrocytes.
HI assays of both strains o f P VM. Virus was added a concentration of 
5 HA units. X) HI assay for PVM strain 15. Y) HI assay for PVM strain J3666. A-L 
represent 2-fold serial dilutions of a 10-fold diluted stock of MAb 19/1/C9 such that A 
represents a dilution factor of 20. 1) Haemagglutination of mouse red blood cells, 2) 
haemagglutination inhibition assay and 3) negative control (PBS).
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6.2.2. Radioimmunoprecipitations of PVM polypeptides :
Polypeptides of PVM were analysed following immunoprécipitation of 
35S-methionine or 3H-glucosamine hydrochloride labelled infected BS-C-1 cells. 
Unfortunately, immunoprécipitation of infected cells or infected cell supernatants 
either in the presence of actinomycin D, tunicamycin or monensin proved unsuccessful. 
Thus, the G protein of PVM strain J3666 in infected cells was not characterised. One 
reason for the failure to immunoprecipitate the G protein of PVM strain J3666 could 
be the poor growth of the virus in tissue culture and that it is naturally temperature 
sensitive with no growth at 37°C (A. Easton, personal communication), although it 
does not explain the reason for why immunoprécipitation of PVM strain 15 G protein, 
which has been described by Ling and Pringle (1989b), also failed. One reason could 
be failure of the MAb (19/1/C9; Ling and Pringle, 1989b) to immunoprecipitate the G 
protein successfully.
6.2.3. In  vitro analysis of PVM G proteins :
An alternative approach to the study of the G proteins of both strains of 
PVM are by in vitro transcription and translation analysis.
6.2.3. l , IN v i t r o  t r a n s c r ip t io n  :
The construction of recombinant pGEMl plasmids in which transcription of 
full-length G genes of both strains of PVM and a truncated form o f the G gene of 
PVM strain 15 is under the control of the T7 RNA promoter has been described in the 
preceding chapter. pGEMl constructs were linearised with restriction endonuclease 
Sail and RNA synthesised in vitro using T7 RNA polymerase as described in chapter 
2, section 2.7.8. Fig. 6.2 shows the in vitro transcribed RNA analysed on a 1% 
agarose gel stained with ethidium bromide. Although the in vitro synthesised RNA 
appears as a smear possibly due to degradation of RNA, two distinct species of RNA 
are observed. The first corresponds to the expected size of the in vitro transcribed
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Fig. 6.2 : In vitro transcribed RNA.
1% agarose gel stained with ethidium bromide showing in vitro 
transcribed RNA of pGEMl constructs containing a) full-length PVM strain J3666 G 
gene, b) full-length PVM strain 15 G gene and insert from construct 5.11. Two species 
of RNA are prominent for RNA transcribed from strain J3666 although two species 
were also found for RNA transcribed from the other two constructs. M represents the 
DNA marker lane.
RNA at approximately 700 base pairs when compared to DNA size markers. The 
second species appears to be double the size of the first species running at 
approximately the same size as the insert from which it was transcribed. This species 
may represent inter-molecular pairing between the smaller species of RNA.
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Fig. 6.3 : Autoradiograph of in vitro translated products.
Autoradiograph showing in vitro translation products from pGEMl 
constructs containing a) full-length PVM strain J3666 G gene, b) full-length PVM 
strain 15 G gene, c) 5.11 insert, d) pGEMl vector alone and e) no RNA. Cell-free 
translation was carried out in the presence of wheat germ extract and the polypeptides 
analysed by SDS-PAGE electrophoresis on a 10% polyacrylamide gel. No wheat germ 
extract specific polypeptides were observed (lanes d and e).
6.2,3 2. I N  VITRO  TRANSLATION ;
In vitro transcribed RNA was used to synthesise proteins in vitro using 
wheat germ extract as described in chapter 2, section 2.7.9. Reactions were carried out 
for 1 hour at 27°C for wheat germ extract reactions. The products were analysed by 
SDS-PAGE gel electrophoresis. Fig. 6.3 shows an autoradiograph o f the in vitro 
translation products The primary translation products from PVM strain 15 and strain 
J3666 G genes, and 5.11 insert have a slightly lower mobility than their predicted 
unglycosylated molecular weights. For 5.11 and PVM strain 15 G gene, the
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\unglycosylated G protein is approximately 43K whereas that of strain J3666 is 47K. 
These sizes are approximately 3K larger than their predicted molecular weights. 
Interestingly, although similar amounts ofRNA transcribed from 5.11 and strain 15 G 
gene were used in the translation system, expression form the 5.11 insert is 
considerably greater than that of the full-length strain 15 G gene. Also, although the 
primary translation product of strain J3666 G gene is larger than that of either insert 
5.11 or strain 15 G gene, a translation product similar to the size of the primary 
products 5.11 or strain 15 G gene was clearly observed. Furthermore, several smaller 
products are seen in the wheat germ translated system.
6.3. D isc u ssio n  :
The failure to identify immunoprecipitated G protein form either PVM 
strain 15 or strain J3666 infected cells does not determine whether two forms o f the G 
protein, that were observed for PVM strain 15 (Ling and Pringle, 1989b), are also 
present in PVM strain J3666 infected cells. An alternative approach to study the 
number of G gene specific polypeptides synthesised from both strains of PVM was in 
the use of in vitro translation systems and translation of in vitro transcribed RNA in 
the presence of wheat germ extract showed good expression of the G gene products.
As expected, the major polypeptide species from translation o f RNA 
synthesised from either full-length G gene of PVM strain 15 or from insert from 
construct 5.11 have similar molecular weights of approximately 43K. These are in 
good agreement with the predicted molecular weight of the unglycosylated PVM strain 
15 G protein estimated from SDS-PAGE analysis of immunoprecipitated G protein 
from PVM infected cells in the presence of glycosylation inhibitors (Ling and Pringle, 
1989b). The difference between full-length strain 15 G gene and construct 5.11 is that 
construct 5.11 lacks the first initiation codon (AUG83) following digestion of the 5' 
end of PVM strain 15 G gene with exonuclease Bal31 (Chapter 5, section 5.2.1).
p o iy p e p t i p s  a n a l y s is
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\Although similar amounts of in vitro transcribed RNA representing these two 
constructs were used in the wheat germ extract translation system, following 
estimation of RNA on a 1% agarose gel, translation of construct 5.11 was greater than 
that of the full-length PVM strain 15 G gene. These results can be accounted for by the 
ribosome scanning model for translation (Kozak, 1986). During translation of the full- 
length PVM strain 15 G gene, most o f the ribosomes would initiate translation from 
the first available AUG codon which codes for a small polypeptide of 35 amino acids. 
Since the termination codon for this frame is located downstream of the initiation 
codon for the major ORF, at AUG83, only ribosomes that fail to start translation at the 
AUG83 will initiate translation from the second ORF which codes for the major 
polypeptide. Thus, the presence of an AUG upstream which is in a better context for 
initiation than that of the major ORF o f PVM strain 15 acts in down-regulation of 
expression of the G protein.
As expected the primary translation product following in vitro 
translation of RNA representing the G gene of PVM strain J3666 has a larger apparent 
molecular weight than that of PVM strain 15. This is reconciled with the fact that the 
G protein of PVM strain J3666 is 33 amino acids longer that of PVM strain 15. The G 
protein of PVM strain 15 appears to lack the amino acids sequence that forms the G 
protein cytoplasmic tail in PVM strain J3666. The observed molecular weight of 47K 
is somewhat larger than the predicted unglycosylated molecular weight of 43,584. 
Additionally, a polypeptide of similar size to the primary translation product of the G 
gene of PVM strain 15 is also observed following translation of the PVM strain J3666 
G gene RNA. Thus, it appears that internal initiation from AUG83 (in strain J3666) 
would result in expression of a polypeptide similar to that of PVM strain 15, which
t
also lacks its cytoplasmically located domain. It is not known whether the polypeptide 
synthesised from AUGj82 (in strain J3666) is present in PVM strain J3666 infected 
cells, since attempts to immunoprecipitate G gene specific polypeptides from PVM
J  1
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\strain J3666 infected cells were unsuccessful. Interestingly, the amounts of each 
polypeptide synthesised from either AUGg3 or AUGig2 appear to be similar even 
though AUG29 is located upstream and out of frame with AUGg3 . Thus, it appears 
that the presence of the upstream AUG does not inhibit significantly translation from 
an internal initiation site at least in the wheat germ system. Similar results were 
observed by Alkhatib et al (1988) were similar amounts of the C polypeptide were 
observed when full-length P/C gene and the C gene of measles virus were expressed 
from recombinant human adenoviruses. Here, an out of frame upstream initiation 
codon, coding for the P polypeptide, did not inhibit synthesis of the C polypeptide 
from an internal initiation codon. The authors suggest that the ribosomes may be 
binding directly to a site located internally within the mRNA or near the initiation 
codon for the C polypeptide. The results obtained for in vitro translation of PVM 
strain J3666 G gene contrast with those for strain 15 in which removal of the upstream 
initiation codon (AUGg3) results in increased expression of the primary translation 
products from the G gene of PVM strain 15. One drawback using the wheat germ 
extract translation system is the prevalence of premature terminations. Thus, it is not 
known whether the lower molecular weight polypeptides for both strains of PVM are 
as a result of internal initiation or premature terminations.
The presence of two amino acid changes within the extracellular 
domain of PVM strain 15 G protein when compared to that of PVM strain J3666 may 
represent in antigenic variation. Although both strains of PVM reacted with MAb 
19/1/C9 (see chapter 5), it is not known whether these changes are antigenically 
important since MAb 19/1/C9 does not neutralise PVM strain 15 infection in vivo 
(Ling and Pringle, 1989b). However, it is possible that either of these changes may be 
located within the heamagglutinin region of the G gene. Whilst the HA assay confirms 
the ability of both strains of PVM to agglutinate mouse erythrocytes, results obtained 
from HI assays confirm the ability of MAb 19/1/C9 to inhibit HA activity of both
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*7.1. I n t r o d u c t i o n  :
The failure to identify the G polypeptide species of PVM strain J3666 
in vivo leaves open the question as to whether the two species of the G protein 
identified for PVM strain 15 by Ling and Pringle (1989b) are also synthesised by PVM 
strain J3666. It is possible that the two species of G protein seen in PVM strain 15 
infected cells are generated by translation of the major ORF and also by the generation 
of a larger species by fusing the two ORF's together. Addition of a cytoplasmic tail to 
the G protein via insertion of non-templated bases or as a result of an error in 
determining the correct sequence of the 5' end of the G gene o f strain 15 have been 
discounted as discussed in chapter 4. An alternative possibility that could result in the 
addition o f such a cytoplasmically located domain is by ribosomal frameshifting.
The phenomenon of ribosomal frameshifting has been described for a 
number o f viruses and has been implicated in expression of polypeptides from 
overlapping reading frames. Such a frameshifting event appears to be particularly 
common in a number of retroviruses. The retroviruses can be divided into three groups 
depending on their gene order and how the pol genes is accessed. Fig. 7.1 shows the 
partial gene order of some retroviruses as examples. The retroviral p o l genes can be 
accessed in one of three ways. A read-through mechanism can occur in which the in­
frame gag and pol genes are separated by a stop codon and the 5' end o f the po l gene 
that lacks its own initiation codon may or may not overlap with the 3' end of the gag 
gene. Alternatively, the gag and pol genes may be separated by the protease encoding 
pro  gene, which overlaps both the gag  and pol genes (Jacks et al, 1988). When 
overlapping ORF's are present access to either the pro or p o l genes occurs by 
ribosomal framephifting resulting in a change of the reading frame in a -1 direction.
Ribosomal Frameshifting
I
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Ribosomal Frameshifting
MuLV
RSV, HIV-1 
MMTV, HTLV-1
Fig. 7.1 : Partial gene order of retroviruses.
Partial gene order of retroviruses showing the arrangement of retrovirus 
gag, pro and pol genes. A) gag and pol genes o f Moloney murine leukaemia virus 
(MuLV) are in-frame and separated by a stop codon. B) Overlapping of the 5' end of 
the gag gene with the 3' end of the pol genes o f Rous sarcoma virus (RSV) and human 
immunodeficiency virus type-1 (HIV-1). C) Separation of the gag and pol genes of 
human T-cell leukaemia virus type 1 (HTLV-1) and mouse mammary tumour mouse 
(MMTV) by a overlapping pro gene.
Jacks et al (1988) have proposed a model for ribosomal frameshifting 
which consists o f a heptanucleotide 'slippery' sequence with a stem-loop structure 
located 3' of this sequence. According to the proposed model, simultaneous slippage 
of the ribosomes in the A and P positions occurs in the -1 direction during translation. 
Mutational analysis of the suspected slippery sequence of Rous sarcoma virus (RSV) 
demonstrated that the heptanucleotide sequence, AAAUUUA is involved in ribosomal 
frameshifting (Jacks et al, 1988). The gag  and pro  genes were expressed in vitro in 
rabbit reticulocyte lysate following in vitro RNA synthesis. SDS-PAGE analysis
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revealed the presence of a gag encoded polypeptide and a gag-pol fusion polypeptide, 
indicating the occurrence of ribosomal frameshifting. Jacks et a l (1988) suggested that 
a heptanucleotide sequence consisting of two homopolymeric triplets is the site at 
which ribosomal frameshifting occurs, following comparison of presumed ffameshift 
sequences of a number of retroviruses. Mutational analysis of the slippery sequence 
allowed the identification of the nucleotides important in the frameshifting event. In the 
heptanucleotide sequence ^AAAUUUA-^ (if numbering begins at -4 through to +3) 
mutation of the U nucleotides at positions -1, +1, and +2 to either A, C or G to 
reduced the efficiency of ribosomal ffameshifting by greater than 1 0-fold, whereas 
mutation of the A nucleotides at positions -4, -3 and -2 reduced ffameshifting 5-fold. 
Mutation of the A residue at position +3 to either C or G had no effect on 
ffameshifting. However, changing this nucleotide to a U residue resulted in a 2-fold 
increase in ffameshifting. Mutations which disrupted a stem-loop structure located 3' 
of this slippery sequence resulted in a 10-fold decrease in ffameshifting. It is possible 
that the stem-loop structure could be involved in binding of a ribosomal protein, a 
soluble elongation factor or RNA which interferes with the stability o f the ribosomal or 
tRNA component of the translational complex (Jacks et al, 1988). Furthermore 
sequences which are complementary to and located downstream o f the stem-loop 
structure can interact to form a possible pseudoknot structure.
Ribosomal ffameshifting mechanisms in which the retrovirus pol gene 
overlaps the gag gene have been described for human immunodeficiency virus type-1 
(HIV-1) and feline immunodeficiency virus (FIV). Wilson et a l (1988) identified the 
slippery region of HIV-1 as a 16 nucleotide overlap between the HIV-1 gag and pol 
genes in an in vitro translation system. The data indicated that the ffameshifting event 
most probably involves a run of homopolymeric U residues. The construct containing 
the 16 nucleotide overlap region lacked a possible stem-loop structure that could have 
formed 3' of the slippery sequence if a longer overlapping region was used. Thus,
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ribosomal ffameshifting in HIV-1 appears to be independent of a stem-loop or 
pseudoknot structure. Reil et a l (1993) also demonstrated a ribosomal ffameshift event 
to occur between the gag and po l genes of HIV-1. Constructs were made in which the 
gag  and pol genes were replaced by the (3-galactosidase and luciferase encoding genes 
respectively. The P-galactosidase and luciferase genes were separated by a 59 base pair 
nucleotide sequence of HIV-1 that contained the slippery sequence (UUUUUUA) and 
a stem-loop structure located downstream of this sequence. Expression of the 
luciferase gene demonstrated that a ffameshift event had occurred whereas mutation of 
the slippery sequence to CUUCCUC reduced the expression of luciferase by 100-fold, 
and deletion of the stem-loop structure resulted in only a 3-fold decrease in luciferase 
expression. These results indicate the slippery sequence plays a major role in the 
ffameshifting event with the stem-loop structure acting as a positive modulator of 
ribosomal frameshifling (Reil et al, 1993). A complication with this hypothesis was the 
implication that mutagenesis of a heptanucleotide, GUUUUUA located within the 
coding region of the luciferase gene to the slippery sequence of HTV-1 (UUUUUUA) 
had occurred. Furthermore, the report implies that only the stem-loop structure of 
HIV-1 was inserted downstream of this sequence. Thus, the sequence located around 
this region the slippery sequence which is responsible for ffameshifting may not 
represent true HIV-1 nucleotide sequences. Parkin et a l (1992) transfected avian and 
Cos-7 cells with plasmid constructs containing the full-length HIV-1 gag  and pol 
genes under the control of the cytomegalovirus enhancer-promoter with the HTV-1 rev 
response element located 3' of the pol gene. The rev response element was inserted to 
allow trans-activation of gag and pol by rev. The HIV-1 rev was supplied by co­
transfection with a construct containing the rev gene also under the control o f the 
cytomegalovirus enhancer-promoter. Transfection of cells with constructs in which the 
stem-loop structure sequence had been mutated or deleted showed a 4-7 fold decrease 
in ffameshifting efficiency. In vitro expression, using rabbit reticulocyte lysate, of these
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iconstructs in which expression was under the control of the SP6  promoter also 
showed that frameshifting was reduced by 2 to 3-fold (Parkin et al, 1992). This 
confirmed that the stem-loop structure acts as positive modulator of ribosomal 
ffameshifting in HIV-1.
Using mutational analysis, Morikawa and Bishop (1992) identified the 
FIV slippery sequence to be near the heptanucleotide GGGAAAC. Recombinant 
baculovirus containing the FIV gag gene and the amino terminus of the protease 
protein of the pol gene was used to show frameshifting in baculovirus infected cells 
(Morikawa et al, 1991). In a construct in which a stop codon was inserted 5' of the 
slippery site , no product arising from a frameshifting event could be detected in insect 
cells infected with recombinant baculovirus. However, a protein arising from a 
frameshift event was observed when a stop codon was inserted 3' of the suspected 
slippery site. Furthermore, insertion of spacer nucleotides within the putative 
pseudoknot forming sequence located 3' of the slippery sequence had dramatic effects 
upon ribosomal frameshifting. These results suggest a role for pseudoknots in 
ribosomal frameshifting (Morikawa and Bishop, 1992).
Expression o f the pol gene in retroviruses where the gag and po l genes 
are separated by an overlapping pro  gene involves a double ribosomal frameshifting 
event. Jacks et al (1987) inserted the gag-pro-pol genes of mouse mammary tumour 
mouse (MMTV) in-frame with the 3' end of the gag gene of RSV which was under the 
control of the SP6  promoter. The RSV gag provided the initiation codon and also 
acted as an antigen for immunoprécipitation of the resultant translation products. 
Immunoprécipitation of in vitro synthesised polypeptides from this construct showed
the presence o f gag-pro-pol fusion polypeptide, indicating the occurrence of a double
\
ribosomal frameshift event. Synthetic oligonucleotides representing overlapping 
regions containing the slippery sequences of the gag/pro or pro/pol genes were 
inserted between the RSV gag  and HIV-1 pol genes. Expression o f the gag-pol fusion
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polypeptides was not observed, indicating the absence o f either the sequence or 
structurally important determinants for frameshifting. Nam et al (1993) cloned the 
gag-pro-pol genes of human T-cell leukaemia virus type 1 (HTLV-1) under the 
control of the SP6  promoter. Only synthesis o f polypeptides corresponding to 
expression of the gag gene and gag-pro fusion protein arising from ribosomal 
frameshifting between the gag-pro genes were observed in vitro. Insertion o f a single 
nucleotide in the gag-pro gene overlap region resulted in the gag and pro  genes 
becoming in-frame, but the pol gene remained in the -1 reading frame with respect to 
the pro  gene. Expression of this mutant construct in vitro resulted in expression of the 
gag/pro-pol fusion product which was immunoprecipitated with rabbit antisera 
directed against the C terminus of the HTLV-1 integrase (IN) protein expressed from 
the pol gene. Mutation of the HTLV-1 heptanucleotide sequence UUUAAAC to 
UUUAAGC severely inhibited frameshifting indicating this to be the slippery sequence.
Wills et al (1991) described a read-through mechanism for Moloney 
murine leukaemia virus (MuLV) dependent upon a pseudoknot structure. In MuLV, 
although the gag and pol genes are in-frame, the ORF's are separated by a UAG stop 
codon and the pol ORF does not contain an AUG initiation codon. Approximately 5- 
10% of ribosomes have been estimated to read-through this stop codon although the 
normal rate for ribosomal read-through is less than 10% (Capone et al, 1986 
referenced within Wills et al, 1991). Additionally, mutation of the UAG codon of 
MuLV to either UAA or UGA had no effect on the percentage of ribosomal read- 
through (Feng et al, 1989) although changing the UAG codon to CAG, encoding a 
glutamine residue inhibited viral release (Felsenstein and Goff, 1988). Cells carrying 
the mutant provirus constitutively expressed the gag-pol fusion polypeptide with 
expression of gag polypeptide completely inhibited. The gag-pol fusion polypeptide 
was not processed by the protease product of the gag  gene. Complementation of the 
mutant provirus by transfection into cells expressing the MuLV protease resulted in a
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low level of virus release. The authors suggest the high levels of the gag-pol fusion 
polypeptide may have inhibited virus release and that a correct ratio between the gag 
and gag-pol fusion polypeptides was required for efficient maturation o f the virus 
(Felsenstein and Goff, 1988). Wills et al (1991) identified the presence of a possible 
pseudoknot structure 3' of this termination codon. The stop-codon and pseudoknot 
encoding regions o f MuLV were fused 5' of the lacZ gene reporter gene. Although 
disruption of the stem structure of the pseudoknot by site-directed mutagenesis 
reduced the efficiency of the read-through mechanism, altering 4 G residues located 3' 
of the stem-loop structure, thought to pair with C residues located within the loop of 
the stem-loop structure of the pseudoknot, to C residues resulted in abolition of 
ribosomal read-through. Changing the C residues to T (U) residues within the loop 
resulted in decreased inhibition o f the read-through mechanism. It was suggested that 
4 T residues found within the lacZ gene could have base paired with these mutated 
nucleotides resulting in the formation of the pseudoknot (Wills et al, 1991). Thus, the 
pseudoknot appears to play a role in ribosomal read-through as well as in ribosomal 
frameshifting.
Ribosomal frameshifting is not restricted to the retroviruses. Tzeng et 
al (1992) have demonstrated a frameshift event to occur in the overlap region o f the 
cap and pol genes of Saccharomyces cerevisiae (yeast) virus type 1 (ScV). The 
slippery sequence was identified as GGGUUUA with a possible pseudoknot structure 
located 3' of this sequence. Site-directed mutagenesis of the sequence involved in the 
pseudoknot resulted in a reduced efficiency for frameshifting. Expression o f the cap 
gene and the cap-pol overlap region fused to the a-peptide of the (3-galactosidase gene 
in either wheat germ extract, E. coli or yeast demonstrated a ribosomal frameshift 
event to occur. The efficiency of frameshifting was 3.5% in wheat germ extract and 
20-29%  in yeast cells. These results demonstrate the influence o f the expression 
system used upon the frameshifting event. Using a similar expression system, in which
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a 396 bp fragment containing the ScV slippery sequence and the pseudoknot structure 
were fused 5' of the (3-galactosidase gene under the control of the SP6  promoter such 
that the cap reading frame is in frame with the AUG located within the multiple 
cloning site and the pol reading frame was in frame with the (3-galactosidase gene, Tu 
et a l (1992) identified the ribosomal pause site during the frameshifting event. The 
'heel-printing' technique was adopted to identify these pause sites in in vitro 
transcribed/translated constructs. In vitro synthesised SP6  transcripts translated in the 
presence of rabbit reticulocyte lysate were treated with micrococcal nuclease. Only the 
regions of RNA which bound proteins or ribosomes were protected from digestion by 
steric hindrance. Purified, undigested RNA fragments were hybridised to negative 
sense ssDNA encoding the 396 bp fragment used above. 5' extension of a radiolabelled 
primer that hybridises upstream of the slippery site was achieved by T4 DNA 
polymerase. Since T4 DNA polymerase lack 5'—>3' exonuclease activity, extension of 
the primer was strongly terminated when the T4 DNA polymerase encountered the 
RNA DNA hybrid region. This allowed identification of the ribosomal pause site to be 
mapped just 5' of the slippery sequence. Similar analysis of mutant constructs 
containing disrupted pseudoknot structures showed a decrease in termination o f primer 
extension in this region. The results indicate a slowing down or pausing o f ribosomes 
during translation 5' of the pseudoknot structure (Tu et al, 1992).
Prufer et al (1992) demonstrated ribosomal frameshifting to occur in 
the single stranded, positive sense RNA plant virus, potato leafroll luteovirus. The 
overlapping regions of the ORF2a and ORF2b genes were fused internally to the E. 
coli P-glucuronidase (GUS) gene. Site-directed mutagenesis was employed to identify 
the slippery sequence as UUUAAAU. Mutation analysis of the slippery sequence had 
little effect on the efficiency of ribosomal frameshifting. Although, the sequence 3' of 
this slippery sequence is capable of forming a stem-loop structure, it is not capable of 
forming a pseudoknot. Ribosomal ffameshift events have also been suggested in
* I 
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\expression of reverse transcriptase in retrotransposons (Mellor et al, 1985, Wilson et 
al, 1986, Clare et al, 1988) and has been described for E. coli dnaX  (Flower et al, 
1990, Tsuchihashi and Komberg, 1990, Tsuchihashi, 1991)
Brierley et a l (1987, 1989) described ribosomal ffameshifting in the la  
and lb (formerly called FI and F2 respectively) ORF's of IBV. The overlapping 
ffameshift region was cloned into a marker gene and expressed both in vitro and in 
vivo. Deletion analysis o f the suspected slippery sequence identified the motif 
UUUAAAC to be important in frameshifting. Site-directed mutagenesis o f the UUUA 
motif of the slippery sequence to CUUA reduced frameshifting by 10-fold. 
Mutagenesis of AAAC to ACAC reduced frameshifting dramatically and mutagenesis 
of AAAC to AUAC completely abolished ffameshifting. Furthermore, mutagenesis to 
destabilise a stem-loop structure with the potential to form a pseudoknot reduced 
frameshifting efficiency whereas mutagenesis of nucleotide sequences downstream of 
the stem-loop structure thought to base pair with the loop of the stem-loop structure 
reduced ffameshifting 10-fold. These results suggest a crucial role for the pseudoknot 
in ribosomal ffameshifting (Brierley et al, 1989). Further investigation o f the role of 
the IBV pseudoknot in ribosomal ffameshifting, by site-directed mutagenesis of the 
IBV pseudoknot determined that so long as the overall structure of the pseudoknot 
was maintained, alteration o f the nucleotide sequence within the pseudoknot had little 
effect of ffameshifting. Replacement of the pseudoknot with a simple stem-loop 
structure of similar stem length and composition resulted in a marked reduction of 
ffameshift efficiency (Brierley et al, 1991). Further mutagenesis of the IBV slippery 
sequence upon ribosomal ffameshifting determined that in the heptanucleotide 
sequence XXXYYYN corresponding to the IBV slippery sequence, UUUAAAC, 
triplets of A, C, U or G were functional in the ribosomal P-site (X residues) but that G 
and C residues were non-functional in the ribosomal A-site (Y residues). They
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\determined the identity of the nucleotide at position N to be crucial with the order of 
preference being C > A = U » G  (Brierley et al, 1992).
In summary, the general requirements for efficient ribosomal 
frameshifting involves the presence of overlapping reading frames, a slippery sequence 
corresponding to the heptanucleotide sequence XXXYYYN and presence of a stem- 
loop or pseudoknot structure 3' of this slippery sequence that may function as a 
enhancer o f  the ffameshifting event. Although, in the examples presented above 
frameshifting occurs predominantly in the -1 direction, frameshifting into the +1  frame 
has been observed when the heptanucleotide sequence consisted o f a run of 
homopolymeric residues following mutagenesis of the slippery sequences of IBV 
(Brierley e t al, 1992). Mutagenesis of the slippery sequence of IBV to U6N or Ug 
resulted in increased frameshifting in the +1 or -2 reading frames. Disruption of the 
pseudoknot structure downstream of these (UgN or Ug) slippery sequences gave 
different results. Whilst frameshifting in the construct containing the UgN sequence 
was reduced, no reduction in frameshifting efficiency was observed when the 
pseudoknot was disrupted in the construct containing the Ug slippery sequence. 
Brierley et a l (1992) suggest the pseudoknot structure to influence the direction of the 
frameshift event.
In relation to PVM strain 15 G gene, the reading frame initiating at 
AUGg3 overlaps the reading frame of AUGjg3 A change of reading frame in the -1 
direction would allow access to the reading frame of AUGig3, resulting in the addition 
of a cytoplasmic tail to the G protein. Sequence analysis of the 5' end o f the PVM 
strain 15 G gene reveals the presence of a termination codon, UAA, located in-frame 
but upstream of UAGi83 at position 168. Thus, any frameshift event that could occur 
must be between this termination codon and that for the small ORF of the gene at 
position 188. Although the G residue in position N of the heptanucleotide XXXYYYN 
was found to considerably inhibit frameshifting in IBV (Brierley et al, 1992), a G
R j b o s o m a l  F r a m e s h if t in g
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\residue in this position following mutagenesis of the slippery sequence of RSV (Jacks 
et al, 1988) had little effect upon frameshifting efficiency. Furthermore, the slippage 
sequence for the gag-pro genes of MMTV is GGAUUUA (Moore et al, 1987, Jacks et 
al, 1987) which does not conform to the heptanucleotide sequence suggested by Jacks 
et a l (1988) and Brierley et al (1992). Other examples of slippery sequences which do 
not conform to the suggested heptanucleotide sequence are GGAUUUU and 
GUUAAAC corresponding to the p27-pol and la-lb  overlap regions of red clover 
necrotic mosaic virus RNA-1 (Xiong and Lommel, 1989) and equine arteritis virus 
(den Boon et al, 1991) respectively. Thus, it is possible that the heptanucleotide 
sequences UAAAAAG or AACCAAA located between the two termination codons 
(at nucleotide positions 168 and 186) in the PVM strain 15 G gene may represent 
possible slippery sites. No pseudoknot structure is located 3' of this suspected slippery 
sequence for PVM although a stem-loop structure is present immediately after the 
second suspected slippery site (AACCAAA; Fig. 7.2a). However, a pseudoknot 
structure is possible in which the stem-loop structure is located immediately preceding 
the UAAAAAG sequence of the G gene (Fig. 7.2b). Brierley et al (1989) determined 
the length of the 6  nucleotide long sequence (spacer sequence) of IBV located 
between the slippery sequence and stem-loop structure to be essential for efficient 
frameshifting. Similarly, Morikawa and Bishop (1992) determined the requirement for 
the spacer sequence of FIV to be precisely 8 nucleotides. Addition or deletion of 
codon triplets in IBV or FIV resulted in a decreased efficiency of ribosomal 
frameshifting However spacer sequences of 1, 4, 4, 5, 6 , and 6  nucleotides have been 
identified for RSV (Jacks et al, 1988) yeast double-stranded RNA virus (Tzeng et al, 
1992), pro-pol overlap region of MMTV (Jacks et al, 1987), potato leaffoll luteovirus 
(Prufer et al, 1992), gag-pro genes of MMTV (Jacks et al, 1987) and HTLV-1 (Nam 
et al, 1993) respectively. Even within the same virus, MMTV, the length of the spacer 
sequence is not absolute between overlapping regions of the gag-pro and pro-pol
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Fig. 7.2 : Secondary structure formation within PVM strain 15 G gene
Diagrammatic representation of a) possible stem-loop structure located 
3' of the suspected slippery sequences (underlined) and b) pseudoknot structure 
located within the 5' end of the G gene of PVM strain 15 that encompasses the 
possible slippery sequence (underlined). The loop of the stem-loop structure is capable 
of pairing with a sequence located 3' of the slippery sequence. Numbers shown against 
individual nucleotides correspond to nucleotide positions shown in Fig 4.4.
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\genes. Furthermore, HIV-1 frameshifting has been reported to occur in the absence of 
any such structures 3' of the slippery sequence (Wilson el al, 1988). It is not known 
whether a pseudoknot structure 5' of slippery sequence enhances frameshifting. Thus , 
it may be possible that slippery sequence located within a possible pseudoknot may 
function correctly in a frameshifting event.
Thus, an investigation into the possibility of a ribosomal frameshifting 
event occurring at the 5' end of PVM strain 15 G gene was undertaken. The approach 
adopted involved mutagenesis of the AUG codons located at positions 83, 183 and 
246 of the G gene of PVM strain 15 and fusion of these constructs 5' of the CAT 
reporter gene. Expression of the CAT gene was then assayed in transfected cells. 
Presence of CAT activity found in cells transfected with a construct in which the AUG 
at position 183 and not 83 has been changed would indicate presence of a ribosomal 
frameshifting event occurring, since initiation from AUGg3 could not result in 
expression o f the CAT reporter gene by any other process.
7.2. Results :
7.2.1, Purification of PVM strain 15 G gene 5 end :
Clone G(3) containing the full-length G gene of PVM strain 15 was 
digested with restriction endonuclease PvuII to release a 600 bp fragment containing 
the 5' end o f the G gene. PvuII cuts at positions 563 and 976 o f the nucleotide 
sequence of PVM strain 15 G gene and also 5' of the binding site for the universal 
(-40) primer and 3' of the multiple cloning site of pUC13 plasmid vector (Fig. 7.3). 
(Digestion o f pUC13 vector with PvuII alone would result in the release of a fragment 
of approximately 300 base pairs.) These DNA fragments was then used in subsequent 
mutagenesis o f the AUG codons of the 5' G gene end located within this fragment.
R ib o s o m a l  F r a m e -s h if t in g
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Fig. 7.3 : PvuII digested clone G(3).
1% LMP agarose gel stained with ethidium bromide showing the 
release of the 600 bp DNA fragment containing the 5 end of PVM strain 15 G gene 
(arrowed) following digestion with restriction endonuclease PvuII. M represents the 
DNA marker lane.
7,2,2, Mutagenesis of PVM strain IS G gene AUG codons :
Digestion of clone G(3) plasmid DNA with PvuII resulted in the release 
o f a fragment containing the 5' end of PVM strain 15 G gene containing AUG codons 
at positions 83, 183 and 246. Since ribosomal ffameshi fling events were to be 
investigated in the region lying between AUG83 and AUGi83, AUG246 was altered to 
UUG*246 resulting in change o f a Met to Leu to prevent possible in-frame internal 
initiation at this point. Mutagenesis of the specific AUG initiation codon was achieved
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using PCR with synthetic oligonucleotides which contained a mutation at the required 
point. Amplification of PCR products was performed in the presence o f Vent™ DNA 
polymerase. Table 7.1 shows the nucleotide sequences of the oligonucleotides and 
primers used to mutate the AUG codons of the 5' end of PVM strain 15 G gene.
7.2.2.1. MUTAGENESIS OF AUG183^
Fig. 7.4 shows the PCR product (-40/G5) following amplification of the 
first 209 nucleotides which resulted in alteration of AUGig3 to UUGig3 using the
Oligonucleotides Nucleotide sequence Position Sense Restriction sites
Universal primer 
(-40)
GTTTTCCCAGTCACGAC + None
G5 GAGCACACCTGCAATAAG
CTTACACAATTGGTTCAC
209-174 - H indlll
G6 CCGGATCCCGGGAAAACA 
GAAT ACAATATGACCCCC 
AC
259-234 - H aelll, BamHI, 
Smal
G7 GTTCCTTCCAATACTAGG
TGAA
94-73 - None
GRev7 TTC ACCT AGT ATTGGAAG 
GAACT
73-95 + None
Table 7.1 : Primers and oligonucleotides used in mutagenesis of G gene AUG codons.
Nucleotide sequence of oligonucleotides and primers used in mutagenesis of 
AUG83, AUG183 and AUG24g and amplification of the 5' end sequences of the PVM strain 15 
G gene. The nucleotide coding for the mutational change is shown in bold and underlined 
whereas those not found within the G gene sequence are underlined.
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Fig. 7.4 : PCR product with altered AUGi83.
2% agarose gel stained with ethidium bromide showing PCR product 
(A) following amplification of PvuII digested PVM strain 15 G gene 5’ end with the 
universal (-40) primer and oligonucleotide G5. M represents the DNA marker lane 
whilst lane B contains DNA fragment not relevant to this study.
universal primer and oligo G5. The PCR product was digested with restriction 
endonuclease Xbal (site located 5' of the G gene start) and H indlll (site located within 
oligo G5), purified from a 1% low melting point agarose gel and cloned into X bal and 
H indlll digested pBS. Inserts from 5 individual colonies were released following 
analysis by the miniprep DNA protocol, digested with X bal and H indlll, sub-cloned 
into M l3 m pl8 and the nucleotide sequence determined (data not shown).
7 2.2.2. M u t a g e n e s is  o f  A U G ^ :
Fig. 7.5 shows the procedure adopted for changing initiation AUG83 to 
ATT83 which involved the use of back-to-back oligo's carrying the mutated nucleotide
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Fig. 7.5 : Diagrammatic representation o f protocol used for alteration o f AUGg3, 
AUGjgj and AUG246.
Diagrammatic representation of the two-step PCR process involved in 
mutagenesis of AUGg3 and AUG246 within the same construct. The first step involves 
amplification of two segments of the 5’ end of PVM strain 15 G gene with the -40 
primer/oligo G7 and oligo's Grev7/G6. The second step involves amplification o f a 
mixture o f the two PCR products (obtained from step one) with a combination o f the - 
40 primer and oligonucleotides G6  and G5.
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Fig. 7.6 : PCR products containing altered AUGg3 and AUG246
1% TAE agarose gel stained with ethidium bromide showing 
purification of PCR products amplified using oligonucleotides a) GRev7 and G6  and b) 
GR7 and -40 primer (arrowed). M represents the DNA marker lane.
that hybridised to AUGg3 . Two separate PCR reactions were carried out on dilutions 
of the 5' G gene end purified following PvuII digestion. The first reaction involves 
amplification of the first 94 nucleotides of PVM strain 15 G gene with the universal 
primer and oligo G7. Amplification with these primers results in alteration of AUGg3 
to AUUg3. A second PCR reaction using oligonucleotides GRev7 and G6  resulted in 
amplification of nucleotides 73 to 259 in which AUG83 and AUG246 had been changed 
to AUUg3 and UUG24^ respectively.
t
The PCR products obtained following amplification with the universal 
primer/G7 and Grev7/G6 were purified from 1% TAE agarose gel (Fig. 7.6) using the 
GeneClean™ kit (Bio 101, La Jolla, California, USA.). A second PCR reaction of
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Fig. 7.7 : PCR products containing altered AUGg3, AUGjgj and AUG246.
1% LMP agarose gel stained with ethidium bromide showing 
purification of (A) X bal and H indlll digested G7/G5 (see text) and (B) Xbal and Smal 
digested G7/G6 PCR products. M represents the DNA marker lane.
diluted aliquots o f the above PCR products were carried out and the full-length PCR 
product amplified using the universal primer and oligo G6 . The PCR product (G7/G6, 
Fig. 7.7) obtained from this reaction was digested with restriction endonucleases Xbal 
and Smal, purified from a 1% low melting point agarose gel and cloned into Xbal and 
Sm al cut pBS. This contains the first 259 nucleotides of PVM strain 15 G gene in 
which AUGg3 and AUG24^ had been changed to ATTg3 and TTG24^ respectively. The 
Xbal restriction site was present 5' of the G gene start in clone G(3) whereas Smal 
restriction site was located within oligo G6 . Colonies containing these constructs were 
screened by digestion with EcoRI and P stI o f  DNA prepared by the miniprep method.
1 7 3
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One of the released inserts was subcloned into EcoRl and PstI digested M13 mpl9 and 
the nucleotide sequence determined (data not shown). Unfortunately, it appeared that 
pBS digested with Smal lost 3 nucleotides, possibly due to contamination of during 
digestion pBS vector (data not shown).
7.2.2.3. Mutagenesis of both AUGg3 and AUG183j .
Mutations of AUGg3 and A U G j83 were introduced within the same 
DNA fragment by amplification with the universal primer and oligonucleotide G5 
during the second step of the mutagenesis procedure described above. Fig. 7.7 shows 
the PCR product (G7/G5) purified from a 1% low melting point agarose gel following 
digestion with restriction endonucleases Xbal and HindJII. The digested PCR product 
was cloned into Xbal and H indlll digested pBS and subsequently subcloned into M13 
m p l8 for nucleotide sequencing. Fig. 7.8 shows the nucleotide sequence o f two 
constructs in which AUG83 and AUG j83 have been changed to AUUg3 and UUG3g3 
respectively.
7.2.3. Purification of the B-galactosidase gene :
Oligonucleotide G6  was designed to enable the insertion of the CAT 
gene lacking its initiation codon to be inserted in frame with AUG3g3, following 
digestion of plasmid pSV2-CAT with restriction endonuclease M n ll, 3' of the Smal 
site located within oligonucleotide G6 . According to the manufacturers of M nll, this 
enzyme cut at the site CCTC(N)7  leaving a blunt end fragment. However, since the 
initial design of oligonucleotide G6  the restriction site for M nll has been modified to :
5 ' C C T C  ( N )  7 4 ,
3  ' G G A G  ( N  ) 6 4
which leaves a single base 3' overhang. Thus, blunting o f this M nll cut 
CAT fragment could only be achieved by removal of this one base overhang which 
would result in the open reading frame of M nll digested CAT gene to be out of frame
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Fig. 7.8 : Nucleotide sequence of PCR product containing altered AUGg3 and 
AUGi83.
Autoradiograph showing the nucleotide sequence o f a clone of the 
G7/G5 PCR product in which initiation codons at positions A) 183 and B) 83 of the G 
gene of PVM strain 15 have been altered. Mutated nucleotides are underlined and 
shown in bold. Numbers shown against individual nucleotides correspond to 
nucleotide positions shown in Fig. 4.4.
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Fig. 7.9 : Purification of E. coli P-galactosidase gene.
Sail, Xmnl and Sm al Restriction endonuclease digest of plasmid 
pMC1871 (A) from which the E. coli P-galactosidase gene (arrowed) was excised. M 
represents the DNA marker lane.
with AUG183. Thus, it was decided to place the E. coli P-galactosidase gene, that 
lacked its initiation codon, downstream of A U G ^ . Plasmid pMC1871 contains the E. 
coli P-galactosidase gene that lacks its initiation codon and allows insertion of DNA 
fragments at a Smal site located at the 5' end of the gene. Unfortunately, ligation of 
Sm al cut pMC1871 and the DNA fragment amplified using oligonucleotide G6  does 
not place the P-galactosidase gene in frame with AUGj83 . However, cloning of the p- 
galactosidase gene in frame with AUGi83 can be achieved by excision o f the gene with 
digestion with restriction endonucleases Smal and S a il and cloned into a suitable 
restriction site located 3' of the cloned DNA fragment amplified using oligonucleotide 
G6 . Fig. 7.9 show restriction endonuclease digest o f  pMC1871 with restriction 
endonucleases Smal, Xm nl and Sail. Plasmid pMC 1871 was digested with Xmnl so as 
to distinguish between the released P-galactosidase gene and the remainder o f the
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plasmid DNA since digestion with just Smal and Sail would result in generation of 
fragments of approximately equivalent sizes. The released P-galactosidase gene was 
purified from a 1% low melting point agarose gel and has yet to be sub-cloned 3' of the 
cloned DNA fragment amplified using oligonucleotide G6 .
7.3. D is c u s s io n  :
To investigate the possibility of the addition of a cytoplasmic tail to the 
N terminus of the G protein of PVM strain 15 by ribosomal frameshifting, AUG 
codons at positions 83, 183 and 246 of the PVM strain 15 G gene were mutated to 
AUUg3, UUGjg3 and UUG246 respectively. The use of a different oligonucleotides in 
the polymerase chain reaction was employed to amplify the 5' end of the G gene in 
which a combination of the AUG codons of the G gene were mutated. The mutation of 
AUG83 in a two step process was performed so that a PCR product representing the 
exact 5' end of the G gene only contained this mutated initiation codon. Mutation of 
the AUG246 was necessary so that expression o f the P-galactosidase reporter gene was 
not possible from an initiation codon located downstream of the suspected slippery 
sequences in the G-P-galactosidase fusion protein. Furthermore, it was desirable to 
include the sequence located 3' of the putative slippery sequences within the fusion 
construct so that a potential stem-loop structure, which is known to act as a positive 
modulator of ribosomal frameshifting, could be formed.
Oligonucleotide G6  contains the base change that results in the 
mutation of AUG246 to UUG246. This oligo also contains at its 3' end, restriction 
endonuclease sites for Smal, BamHI and H aelll. The sites were arranged so that 
insertion of a CAT reporter gene lacking its initiation codon could be fused into the 
Smal site of this construct. This would have resulted in the CAT gene being in-frame 
with AUGig3 and that expression of the CAT reporter gene could only occur from 
AUG183. It was anticipated that since the CAT reporter gene contains no internal
R i b o s o m a l  F r a m e s h i f t i n o
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PCR Product a u g 83 AUGl83 a u g 246
-40/G5 y X X
G7/G6 X y X
G7/G5 X X X
Clone G(3) y s X
Table 7.2 : Summary of mutated AUG codons within each G-CAT construct.
Table showing summary of oligonucleotides used in construction of 
fragments carrying a combination of mutated initiation codons.
HindlH  restriction sites that the constructs containing the mutated AUG83 and/or 
AUG183 could be interchanged within the G-CAT fusion gene by digestion with 
H indlll, since this site is located 3' of AUGig3 . However, a revision of the restriction 
site for endonuclease M nll after the synthesis of oligonucleotide G6  prevented the 
successful fusion o f the CAT gene that would have resulted in it being in frame with 
AUGi83. However, it is possible to fuse the (3-galactosidase gene lacking its initiation 
codon 3' of the G7/G6 construct. Expression of the P-galactosidase gene, lacking its 
first initiation codon, from internal initiations does not result in expression of a 
functional protein (D. Hodgson, personal communication). However, one drawback is 
that fusion of the P-galactosidase gene into the Smal site of oligo G6  does not leave it 
in-frame with AUGig3 . Manipulation of the plasmid vector specific restriction sites is 
necessary to circumvent this problem. Table 7.2 shows the various constructs 
containing mutated AUG codons that would have been fused to the reporter gene.
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sIn summary, expression of the reporter gene following fusion 3' and in 
frame of AUGi83 of the G7/G6 construct would only occur if AUG183 was present 
whereas in the absence of AUG183, no expression of the reporter gene should be 
detected. However, in the construct which contains AUG83 but not AUG183, if 
reporter gene expression is detected in transfected cells, and since AUG83 is out-of- 
frame with AUGi83, expression could only occur by a phenomenon such as ribosomal 
frameshifling No expression should be detected from the construct in which both 
AUG83 and AUG183 have been mutated. The mutagenesis of the different AUG 
codons of PVM strain 15 G gene represents the first step towards investigating 
ribosomal frameshifting within a negative strand virus.
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8.1. D is c u ss io n  :
To characterise the molecular basis of the different pathogenicities of 
two strains o f PVM molecular analysis of the genes encoding the two large surface 
glycoproteins was performed. PVM Strain 15, the non-pathogenic variant, has been 
passaged, to our knowledge, entirely in tissue culture whereas PVM strain J3666, the 
pathogenic variant has been passaged entirely in mice. Growth o f the two strains in 
tissue culture is extremely slow with PVM strain 15 showing cytopathic effect much 
earlier than PVM strain J3666 when cells are infected in vitro at the same multiplicity 
of infection and strain J3666 is a naturally temperature sensitive virus with no growth 
at 37°C (A. Easton, personal communication).
A comparison of the fusion protein gene sequences was considered to 
be essential since the pathogenicity of NDV isolates were attributed to amino acid 
changes within their fusion proteins (Glickman et ai, 1988, Toyoda et al, 1987, 
Morrison et al, 1993). Nucleotide sequence analysis of NDV isolates characterised 
these changes as occurring in the vicinity of the F protein cleavage site. The cleavage 
of F protein into disulphide-bonded Fj and F2 subunits is crucial to the functionality of 
the protein. Thus, changes that alter the susceptibility of the cleavage site to cleavage 
by host proteases play an important role in determining the pathogenicity of the virus. 
Similarly, mutation of Sendai virus F protein surrounding the cleavage site alters the 
susceptibility o f the protein to cleavage by extracellular proteases. For example, 
changing a single Arg residue to lie at position 116 within the F0 polypeptide of 
Sendai virus results resistance to cleavage by trypsin but confers susceptibility to 
cleavage by chymotrypsin (Blumberg et al, 1985). Similarly, mutation of amino acids 
around the F protein cleavage site of Sendai virus results in altered susceptibility to
t
extracellular proteases (Itoh et al, 1987, Itoh and Homma, 1988, Ogasawara et al, 
1992). Thus, nucleotide sequence analysis of the fusion glycoprotein of PVM strain 
J3666 was undertaken so that comparison with the nucleotide sequence of PVM strain
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15 fusion protein might reveal the molecular basis for the pathogenesis of the two 
viruses (Chambers et al, 1992).
Of the 1657 nucleotides encoding the F protein of PVM strain 15 
(Chambers et al, 1992), only six nucleotide changes were found. O f these, two did not 
result in alteration of the encoded amino acids whereas the remaining four resulted in 
amino acids changes. Furthermore, these changes were distributed throughout the F 
protein sequence. Although the effects of these changes were not characterised due to 
lack of appropriate MAb's it seems unlikely that they contribute significantly to the 
different pathogenicities of the two strains of PVM and may be a result of immune 
pressure since PVM strain J3666 has been passaged entirely in mice. Thus, these 
mutations may identify regions involved in eliciting an antibody response. However, 
the possibility can not be ruled out that one or more of these changes may be located 
within the 3-dimensional structure that forms the F0 cleavage site, thus, influencing the 
susceptibility o f the cleavage site o f the F0 polypeptide.
The second large glycoprotein of PVM is the G proteins which, by 
analogy to HRSV, acts as the virus attachment protein (Levine et al, 1987). The G 
protein of HRSV has been shown to be variable between isolates o f the two subgroups 
and also isolates from within the same subgroup (Mufson et al, 1985, Anderson et al, 
1985, Johnson et al, 1987b, Cane et al, 1991, Sullender et al, 1991). Thus it is 
possible that the attachment protein could play a role in the pathogenicity of both 
strains of PVM. A comparison of the nucleotide sequence of the G genes of both 
strains of PVM revealed several differences. Within the extracellular domain of the G 
protein only two nucleotide and resulting amino acid residue changes were observed. 
It is not known whether these result in some advantage for strain J3666 which could 
explain the enhanced pathogenesis. However, the most single important difference 
identified between the G proteins of PVM was the absence of amino acid sequences 
encoded by the major ORF at the N-terminus of the G protein of PVM strain 15 which
\are present in the G protein of PVM strain J3666. These amino acid sequences, in 
PVM strain J3666, which would form the cytoplasmic tail of the G protein were found 
to be absent in the G protein of PVM strain 15. Thus, the G protein of strain 15 
appears to lack a cytoplasmic tail that is present in strain J3666. The importance of this 
is unclear since it is generally believed that the cytoplasmic tail of the glycoproteins 
interact with the M proteins during virus maturation and its absence may detrimentally 
affect virus production.
Additionally, another difference highlighted by nucleotide 
sequence analysis of the G genes of PVM is the location of a short ORF located 
upstream of the major ORF within each virus. The major ORF of the PVM strain 
J3666 is encoded by an initiation codon located at position 83 of the nucleotide 
sequence with the short ORF initiating from an AUG located at position 29. The 
termination codon for this short ORF is located at position 65 of the nucleotide 
sequence for the G gene PVM strain 15. The insertion o f an A residue within a stretch 
of A residues located between AUG83 and A U G ^  (of strain J3666) results in the 
second initiation codon becoming out o f frame in the G gene of PVM strain 15. Thus, 
the major ORF of the G gene of strain 15 is initiated at the AUG that is located at 
position 183 o f the nucleotide sequence of PVM strain 15 G gene with a short ORF 
initiated by AUG83 which terminates 2 nucleotide bases downstream o f AUGj83. 
However, the initiation codon of the short ORF located within the G gene of strain 
J3666 has been altered in strain 15 so that no ORF exists. Thus, the G genes of either 
strain of PVM possess two ORF's in which the second ORF codes for the major 
polypeptide even though they are initiated from separate AUG codons. A 
diagrammatic representation of the gene structure is shown in Fig. 4.9.
The presence of an upstream ORF in both G genes may play a role in 
down-regulation of G gene expression in vivo. In vitro translation of the G genes 
result in expression of polypeptides with sizes that are approximately 3K larger than
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their predicted molecular weights. Expression of the G gene of PVM strain 15 from 
either a full-length clone or from a construct in which the first ORF has been deleted 
results in expression of polypeptides of similar size. However, although equivalent 
amounts of in vitro transcribed RNA, estimated from agarose gel electrophoresis, were 
used in the in vitro translation system, expression of the major polypeptide in the 
construct lacking the first ORF appeared to be increased when compared to expression 
from the clone containing the full-length G gene o f strain 15, suggesting the presence 
of the first ORF to down-regulate expression from the major ORF. Furthermore, in 
vitro expression of the G gene o f PVM strain J3666 results in synthesis of a 
polypeptide of approximately 47K and also a polypeptide of approximately 43K. This 
latter polypeptide is of similar size to that synthesised from constructs containing either 
the full-length or just the major ORF of PVM strain 15 G gene. Thus, this polypeptide 
may be a result o f internal initiation within the G gene of strain J3666 and by analogy 
to the G protein o f strain 15 may lack the cytoplasmic tail. It is not known whether this 
polypeptide is synthesised in vivo in PVM strain J3666 infected cells or whether it 
plays a role in virus maturation.
Expression of the G genes of PVM strains 15 and J3666 and the 
construct containing strain 15 G gene but lacking the first ORF were expressed in BS- 
C-l cells using recombinant vaccinia virus expressing the T7 RNA polymerase. 
Immunofluorescence straining of transfected/infected cells revealed the surface 
location of the polypeptides synthesised from both full-length G genes and also from 
the construct containing the major ORF of the G gene of PVM strain 15. The results 
indicate that the G protein of strain 15 is processed and transported correctly within 
the cell even though it appears to lack a cytoplasmic tail. Thus, signals for the correct 
processing are ndt located within the cytoplasmic domain of the G protein J3666.
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8.2. F u t u r e  W o r k  :
The identification of two translational products from in vitro expression 
of the G gene of PVM strain J3666 still leaves open the question as to whether the 
polypeptide synthesised due to internal initiation at A U G ^  >n vitro is also present in 
PVM strain J3666 infected cells.
Addition of a cytoplasmic tail to the N-terminus of the G protein 
synthesised from PVM strain 15 could be achieved by modification during translational 
of the mRNA. Sequences similar to those involved in ribosomal frameshifting which 
result in changing of the reading frame to that of -1 direction have been identified with 
relevant potential secondary structure elements in the RNA in the close proximity. The 
first steps in determining whether such a mechanism as ribosomal frameshifting occurs 
with the G gene of PVM strain 15 have been undertaken. Mutagenesis of the initiation 
codons coding for the major ORF or the short ORF of PVM strain 15 with a view to 
fusing these mutated sequences has been achieved with only ligation of these mutated 
sequences 5‘ of the E. coli P-galactosidase gene remaining. Subsequent, expression of 
these fusion constructs in tissue culture cells would help determine whether the 
frameshifting event occurs. Additionally, if ribosomal frameshifting was found to 
occur, then mutagenesis of the nucleotide sequence located within the two ORF's of 
PVM strain 15 would help identify the sequences responsible for such an event.
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